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Protein translocation systems are invaluable to pathogenic bacteria, facilitating 
the display of virulence factors on their surface or their release into the 
extracellular environment.  Some protein export systems are ubiquitous and 
essential to cell survival whereas others are horizontally acquired on prophages 
or pathogenicity islands (PAI), in many cases providing the bacterium with 
pathogenic advantages.  For the majority of the known protein export systems, 
their structure, function and secreted substrates have been characterised, yet 
some proteins have been identified that are secreted via unknown mechanisms.   
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 is an important cause of 
human foodborne disease worldwide.  The pathogenicity of this bacterium is 
mainly attributed to the secretion of toxins and the presence of a Type III 
Secretion System (T3SS).  The T3SS can translocate bacterial proteins, known as 
effectors, into the host cell which mediate an effect culminating in the 
formation of a characteristic attaching and effacing (A/E) lesion.  This system is 
encoded on a horizontally acquired PAI termed the locus of enterocyte 
effacement (LEE).  The LEE not only encodes the T3SS apparatus but also several 
effectors secreted by the system and transcription factors which regulate its 
expression.  However, it was recently found that T3SS not only secretes LEE 
encoded effectors but can also secrete proteins encoded on other prophages 
present in the EHEC genome.  Characterisation of these non-LEE encoded 
effectors is ongoing and this study investigates the expression, regulation and 
function of non-LEE encoded effector H1 (NleH1) and H2 (NleH2).  Non-LEE 
encoded effector H1 (NleH1) and H2 (NleH2) are secreted by the T3SS but are 
encoded on different prophages.  This study demonstrates that expression of 
NleH1 and NleH2 is induced in the same conditions which stimulate the 
expression of the LEE but expression is diminished upon initial host cell contact 
in vitro. Transcription of nleH1 and nleH2 is dependent upon factors specific to 
E. coli O157:H7 and these factors are regulated by LEE encoded regulators Ler 
and GrlA, as they have a positive effect on nleH transcription.  NleH1 and H2 are 
predicted serine/threonine protein kinases and are able to autophosphorylate.  
Yeast two hybrid screening and 2D differential gel electrophoresis did not 
elucidate a eukaryotic protein binding partner of NleH1 or NleH2 and they do not 
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have a significant effect upon NF-κB activation.  Determining the expression, 
regulation and function of non-LEE encoded effectors contributes towards 
further understanding of how this pathogen causes disease. 
Streptococcus pneumoniae, also known as the pneumococcus, is another globally 
important human pathogen.  It is a very diverse pathogen, with over 90 capsular 
serotypes and is naturally competent for DNA uptake.  Pneumococcal 
pathogenesis is facilitated by the production of a pore-forming toxin, 
pneumolysin.  Pneumolysin’s activities in pneumococcal pathogenesis extend 
beyond its cytolytic function as it can also activate the complement pathway 
and modulate the host cytoskeleton.  Pneumolysin is a member of a conserved 
family of toxins known as the cholesterol dependent cytolysins but differs due to 
the lack of a secretion signal peptide within its sequence.  This indicates that it 
is not secreted from the bacterium however it has been reported that some 
strains can release pneumolysin in a cell lysis-independent manner.  Additional 
to this, pneumolysin can also localise to the cell wall, and this localisation is not 
strain dependent.  This study characterised codon-optimised N-terminally 
labelled pneumolysin constructs were characterised and used to assess the 
localisation of pneumolysin.  In addition, the importance of autolysin and genes 
which are co-transcribed with Ply upon the localisation/secretion of pneumolysin 
was investigated by construction of a pneumococcal strain carrying an autolysin-
pneumolysin fusion which naturally occurs in equine strains.  These genes were 
not required for the translocation of pneumolysin or its association with the cell 
wall.  Growth of this strain, and its isogenic parent, in vitro at a low density and 
low temperature resulted in the pneumolysin being detected in the broth 
culture.  This indicates that pneumolysin can be released from the cell wall and 
that this action is not dependent upon the genes which were deleted in the 
mutant.  The distribution of pneumolysin on the pneumococcal surface was 
assessed with immunofluorescence, and LumioTM substrate fluorescence, 
microscopy and found to have a general distribution.  As a contribution to future 
pneumococcal research, codon-optimised fluorescent protein reagents were 
developed and can be used as reporters for gene expression and protein 
localisation.   
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1 Introduction 
1.1 Secretion systems in bacteria 
1.1.1 Overview 
Bacterial pathogenicity depends greatly on the ability to secrete virulence 
factors which are displayed on the bacterial cell surface, secreted into the 
extracellular milieu or even translocated directly into the host cell (Finlay & 
Falkow, 1997; Lee & Schneewind, 2001).  Gram-positive and Gram-negative 
bacteria have cell envelopes across which to secrete proteins; one with a thin 
layer of peptidoglycan and an outer cell membrane (Gram-negative) or one with 
a thick layer of peptidoglycan (Gram-positive) surrounding the plasma 
membrane, Figure 1-1.  
Peptidoglycan consists of glycan chains with repeating sugar molecules, N-
acetylglucosamine and N-acetylmuramic acid connected by β-1,4 linkages.  The 
glycan chains are linked together by oligopeptides, the amino acids used and the 
number of cross-links can differ between bacterial species (Madigan et al., 
2003).  Teichoic and lipoteichoic acids (LTA) contribute to the negative charge 
of the Gram positive cell wall, and can attract cations such as magnesium and 
calcium providing cell rigidity.  Lipopolysaccharide (LPS) contributes to the 
negative charge and structure of Gram negative cell walls and is comprised of 
Lipid A, core polysaccharide and O-specific polysaccharide (also known as O-
antigen).  The O-antigen of LPS can differ between bacteria which can allow 
classification of bacteria of the same species by serotype, for example 
Escherichia coli O157, E. coli O22 and E. coli O104.  As peptidoglycan, LTA and 
LPS have repetitive structures the host innate immune system has evolved 
receptors that recognise these structures, also known as pathogen-associated 




Figure 1-1  Outer layer arrangement of bacteria 
A.  Gram positive bacteria are characterised by the presence of a thick layer of 
peptidoglycan (purple).  The peptidoglycan provides an anchor for pili (green), wall-
associated proteins (blue) and (lipo)teichoic acids (pink), together constitute the cell wall.           
B.  Gram negative bacteria are characterised by the additional membrane layer which 
surrounds the thin peptidoglycan layer.  This outer membrane differs to the cytoplasmic 
membrane due to the incorporation of lipopolysaccharide (LPS).  The outer membrane is 
tethered to the peptidoglycan layer by Braun’s lipoprotein (LP; brown), and incorporates 
outer membrane associated proteins, porin proteins and pili.  The space between the inner 
and outer membranes is called the periplasm.  Figure is based on (Madigan et al., 2003) 
1.1.2 Translocation across the cytoplasmic membrane 
Protein translocation across the cytoplasmic membrane can follow one of 6 
different pathways; the general secretory (Sec) system, twin-arginine 
translocation (TAT) system, Flagellar Export Apparatus (FEA), Fimbrilin-Protein 
Exporter (FPE), the holins, and the ESX-1/Type VII secretion system (Nguyen et 
al., 2000; Desvaux & Hebraud, 2006; Saier, 2006; Abdallah et al., 2007).  With 
reference to translocation across the cytoplasmic membrane, only the Sec and 
TAT system will be described further. 
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1.1.2.1 The general secretory (Sec) system 
The Sec System is well conserved, and essential, among both prokaryotes and 
eukaryotes.  In eukaryotes, a Sec system analogue is necessary for translocation 
of proteins across the endoplasmic reticulum.  In prokaryotes, the Sec system is 
utilized for protein transport across the cytoplasmic membrane.  The structure 
and mechanism of this secretion system has largely been studied in Gram-
negative bacterium Escherichia coli (Economou, 2002), and Gram-positive 
bacterium Bacillus subtilis (van Wely et al., 2001).  The Sec system consists of 
three integral membrane proteins, SecY, SecE and SecG, which form the 
translocon pore, a cytoplasmic ATPase SecA and accessory membrane proteins 
SecD, SecF and YajC, Figure 1-2.  It has been proposed that SecA recruits and 
assembles four SecYEG complexes to form the translocase (Manting et al., 2000).  
However, the oligomeric state of functioning SecYEG translocase still appears to 
be inconclusive as recent reports have shown that active translocation occurs 
with SecYEG dimers (Gold et al., 2010; Deville et al., 2011) and that preprotein 
secretion can occur via a single SecYEG complex (Kedrov et al., 2011).  The 
SecYEG translocase is closely associated with accessory membrane proteins 
SecDF/YajC and YidC.  YidC is responsible for membrane protein insertion into 
the cytoplasmic membrane (Scotti et al., 2000).  SecDF is proposed to facilitate 
protein translocation by SecYEG (Matsuyama et al., 1993).  SecA is a 
homodimeric ATP-binding protein, which is involved in providing the system with 
energy, and acts as a receptor for precursor proteins (Driessen et al., 1998; 
Economou, 1998).  It exists in a compact, ADP-bound state and an extended, 
ATP-bound state (den Blaauwen & Driessen, 1996).  When associated with 
SecYEG, it is activated for precursor stimulated cycles of ATP binding and 
hydrolysis (Lill et al., 1990), which results in cycles of SecA membrane insertion 
and precursor translocation.  The proton motive force also assists this cyclic 
reaction by ensuring unidirectional translocation and providing a source of ATP 
(Driessen, 1992; Nishiyama et al., 1999).   
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Figure 1-2 Schematic representation of protein secretion via the Sec system 
Secretion can occur via one of two pathways: co-translational or post-translational for 
reasons explained in the text.  In the co-translational pathway, the secretion signal peptide 
is recognised by the signal recognition particle (SRP).  The SRP/ribosome complex interacts 
with FtsY to bring the polypeptide to be secreted in close proximity with SecA.  In the port-
translational pathway, the protein is synthesised and the signal peptide recognised by SecA 
or SecB/CsaA chaperones, which maintain the protein in a secretion-permissable 
conformation.  SecB/CsaA chaperones interact with SecA to ‘deliver’ the protein for 
secretion through SecYEG.  Signal peptidase (SP) cleaves the signal peptide from the 
polypeptide and the protein is secreted. 
 
Proteins that are to be translocated by the Sec system are synthesised as 
precursor with an N-terminal signal peptide, which is recognised by the 
translocase.  The signal peptide has a tripartite structure: a positively charged 
N-domain (normally due to presence of lysine and/or arginine residues), a 
hydrophobic H-domain and a C-domain which specifies the cleavage site for 
signal peptidase (Tjalsma et al., 2000).  Signal peptidase is present on the outer 
surface of the plasma membrane and is responsible, as its name suggests, for the 
cleavage of the signal peptide from the precursor protein to give rise to a 
mature protein.  Prior to translocation, the precursor protein associates with a 
cytosolic chaperone protein (also known as targeting factors) either co-
translationally or post-translationally, which maintains the precursor in a 
translocation-competent state by preventing their folding and aggregation 
(Tjalsma et al., 2000; Tjalsma et al., 2004).  The signal-recognition particle 
(SRP) is a complex consisting of Ffh (fifty-four homologue) protein, so-called as 
it is a GTPase which is homologous to the 54-kDa subunit of the eukaryotic SRP, 
and RNA (Keenan et al., 2001).  The SRP complex binds to the signal peptide of 
emerging polypeptide chains from the ribosome, and is targeted to the 
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membrane via FtsY protein, a SRP receptor protein.  In E. coli, the post-
translational targeting of preproteins to the Sec translocon is mediated by SecB.  
SecB binds to the precursor protein with low affinity, but to the C-terminus of 
SecA with high affinity (Knoblauch et al., 1999).  Therefore, it is considered that 
SecB acts as a general chaperone to the Sec translocase, by enabling the 
interaction of precursor proteins with SecA if they present the appropriate signal 
peptide.  A SecB homologue has not been found in B. subtilis, however a possible 
analogue is CsaA.  CsaA is a suppressor of the E. coli SecA (temperature 
sensitive) mutant, and was subsequently shown to have shared properties with 
SecB, such as an affinity for precursor proteins and SecA (Muller et al., 1992; 
Muller et al., 2000).  However, it does not bind SecA at the same conserved 
domain as SecB.  The pathway by which a precursor protein follows to be 
chaperoned to SecA, i.e. via SRP or SecB/CsaA, depends on the hydrophobicity 
of the signal peptide as more hydrophobic proteins follow the SRP pathway.  This 
may provide reason as to why B. subtilis does not have a SecB chaperone, as B. 
subtilis proteins tend to have more hydrophobic signal peptides (Tjalsma et al., 
2000) and are therefore targeted to the translocase via SRP.  Also, the 
hydrophobicity of a protein is greatly enhanced by the presence of 
transmembrane domains, which are present in cytoplasmic (or inner) membrane 
proteins.  However, proteins to be inserted into the outer membrane of gram 
negative organisms, e.g. porins, have a β-barrel conformation and thus a lower 
hydrophobicity, so these proteins are chaperoned by SecB.   
The distribution of the Sec translocon has been investigated in E. coli, B. subtilis 
and streptococcal species.  The SecA in Streptococcus pyogenes localises to a 
focal point in the cell surface, at the position of the old pole, which has been 
termed the ExPortal (Rosch & Caparon, 2004; Rosch & Caparon, 2005).  The 
ExPortal has also been characterised in S. mutans using immunogold electron 
microscopy (Hu et al., 2008) and also in Enterococcus faecalis (Kline et al., 
2009).  When the ExPortal was first characterised it was hypothesised that this 
could be a central paradigm for the localisation of the Sec system in all Gram-
positive bacteria, however studies in Bacillus subtilis demonstrated that the Sec 
system was distributed in a helical array along the longitudinal axis of the cell 
(Campo et al., 2004).  In E. coli, conflicting reports have been made on the 
distribution of the Sec translocon; that it is uniformly distributed around the 
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cytoplasmic membrane (Brandon et al., 2003) or in a helical array like that for 
B. subtilis (Shiomi et al., 2006).  It is proposed that the Sec translocons cluster 
in areas where cell wall synthesis occurs, as the cell wall is more permeable 
allowing the proteins to travel to the surface or extracellular environment 
(Campo et al., 2004; Rosch & Caparon, 2004).  It is also hypothesised that the 
presence of the Sec systems in clusters facilitates the interactions of secreted 
polypeptides with chaperones or other accessory factors for processing or 
efficient folding (Campo et al., 2004; Rosch & Caparon, 2005). 
1.1.2.2 Accessory Sec system 
Additional secA homologs have been identified in a number of Gram positive and 
Mycobacterial species (Rigel & Braunstein, 2008).  The second SecA shares less 
homology with the SecA of the general secretory pathway, and is therefore 
termed SecA2.  Staphylococci and Streptococci species have an accessory secY2 
which is part of an operon with secA2 and additional genes involved in the 
synthesis, glycolysis and transport of an adhesin.  The genetic arrangement of 
the accessory Sec system locus is conserved but the locus is not present in all 
strains, which indicate that these loci have been horizontally acquired (Rigel & 
Braunstein, 2008).  SecA2/Y2 systems in these species are responsible for the 
translocation of glycosylated serine-rich proteins (Bensing & Sullam, 2002; Obert 
et al., 2006).  In S. pneumoniae SecA2/Y2 translocates pneumococcal serine-rich 
repeat protein (PsrP), which is an adhesin that contributes to pneumococcal 
colonisation and pathogenesis (Hava & Camilli, 2002; Obert et al., 2006; Rose et 
al., 2008; Shivshankar et al., 2009; Sanchez et al., 2010).  Proteins which are 
translocated by the SecA2/SecY2 system have an N-terminal signal sequence 
with the traditional tripartite structure described for the Sec system.  However, 
glycine residues within the hydrophobic region have been shown to be necessary 
for translocation via SecA2/SecY2 and also interfere with translocation via the 
Sec system (Bensing et al., 2007).  A 20 amino acid motif present after the signal 
peptidase cleavage site has been shown to be essential for translocation via the 
SecA2/SecY2 system and termed the accessory Sec transport (AST) domain 
(Bensing & Sullam, 2010).  Characterisation of the translocation mechanism of 
this accessory secretion system and how its substrates are recognised is ongoing 
(Bensing & Sullam, 2010). 
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1.1.2.3 The Twin-Arginine Translocation (TAT) pathway 
The Tat system is so called due to the signal sequences of proteins translocated 
by this system contain two arginines (R-R) (Sargent et al., 1998).  The 
interesting aspect of the Tat system is its ability to secrete fully folded proteins 
and even multimeric enzyme complexes.  TatA monomers assemble to form a 
transmembrane channel, which is able to change diameter, presumably through 
the addition or loss of TatA monomers, enabling the passage of folded proteins 
of differing molecular weights and sizes (Gohlke et al., 2005).  The TatBC 
complex recognizes and binds a pre-protein containing a twin-arginine motif in 
its signal sequence before associating with the TatA oligomer in a proton-motive 
force dependent manner.  The secretory machinery is fully assembled to 
translocate the protein across the membrane via the channel formed by TatA 
monomers.  Once the protein has been translocated, the system returns to a 
resting state with the TatA complex dissociating from the TatBC complex 
(Palmer et al, 2005). 
The Tat system has been shown to be important for virulence, for example an E. 
coli O157:H7 strain with the Tat operon deleted significantly reduced its 
virulence in vitro (Pradel et al., 2003).  It was determined that the lack of a Tat 
system affected the secretion of Shiga-like toxin 1 (Stx1) and affected motility 
by abolishing the synthesis/stability of flagellin H7, both of which are important 
virulence factors of E. coli O157 (Pradel et al., 2003). 
1.1.2.4 Non-classical secretion 
Proteomic analyses of the secretome or surface subproteomes of bacterial 
species have identified cytoplasmic proteins in the extracellular fractions, 
without obvious evidence of cell lysis.  Often, these cytoplasmic proteins have 
demonstrated an alternative function extracellularly compared to their function 
within the cell.  Such proteins with multiple unrelated functions are described as 
‘moonlighting’ proteins (Jeffery, 1999).  Across a number of Gram-positive 
bacteria, including Listeria, Streptococcus, Staphylococcus and Bacillus species, 
the cytoplasmic protein enolase is displayed on the bacterial cell surface, and  
when extracellular, binds plasmin(ogen) (Pancholi & Fischetti, 1998; Bergmann 
et al., 2001; Bergmann et al., 2003; Carneiro et al., 2004; Ge et al., 2004; 
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Schaumburg et al., 2004; Tjalsma et al., 2004; Agarwal et al., 2008; Esgleas et 
al., 2008).  Recently, a study investigating non-classical secretion in B. subtilis 
found that secretion of predicted cytoplasmic proteins, including enolase, 
occurred during early stationary phase of growth (Yang et al., 2011).  Secretion 
of enolase was demonstrated to occur in an autolysin-negative strain and in the 
absence of cell lysis, indicated by viable count, secretion without active protein 
synthesis and lack of SecA protein in the extracellular milieu.  However, enolase 
secretion was abolished by the mutation of an α-helical membrane-embedding 
domain present in its protein structure (Yang et al., 2011).  This provides 
evidence that protein structure contributes to non-classical secretion in Bacillus.  
However, secretion of proteins via this non-classical pathway is controversial as 
the mechanism of translocation and whether it is an active form of secretion 
remains to be elucidated. 
 
1.1.3 Translocation of proteins across the outer membrane 
In Gram-negative bacteria, specialized secretion systems have evolved in order 
to translocate proteins across the largely impenetrable outer membrane.  These 
secretion systems have been categorized in a number system (I-VI) and some 
pathways are dependent on the ubiquitous pathways present in the cytoplasmic 




Figure 1-3 Schematic diagram of Gram-negative bacteria secretion systems 
Simple representation of secretion systems, which is not to any scale and complexes 
consist of multiple proteins.  ATPase, is represented by dark red symbol, which provides 
energy for protein secretion by ATP hydrolysis.  The red star represents a chaperone, 
complexed with an ‘unfolded’ protein, as part of the chaperone usher (CU) pathway.  Protein 
secretion via type 2, type 5 and CU pathways is a two-step process, where the protein is 
translocated into the periplasm via the general secretory (Sec) or Twin-Arginine 
Translocation pathway before translocation across the outer membrane.  Protein secretion 
via type 1, type 3, type 4 or type 6 occurs across both membranes in one step and is 
therefore described as Sec-independent. 
The Type I secretion system (T1SS) is described as a Sec-independent system, as 
proteins, up to 800kDa in size (Holland et al., 2005), are secreted across both 
the cytoplasmic and outer membrane. The prototypical example of this system 
consists of an ABC transporter (HylB), membrane fusion protein (HylD) and outer 
membrane protein (TolC) which together translocate alpha-haemolysin (HylA) 
from E.coli (Hartlein et al., 1983; Lee & Schneewind, 2001).  Type II secretion 
(T2S) is a two step process where the protein is first translocated across the 
cytoplasmic membrane via the Sec or Tat system (Coulthurst & Palmer, 2008; 
Ferrandez & Condemine, 2008) then across the outer membrane via a secretin 
(Nunn, 1999).  The Type III Secretion System (T3SS) is Sec-independent, like 
Type I, and is dedicated to the translocation of proteins directly into host cells.  
The genes encoding the apparatus required for Type III secretion are usually 
encoded on horizontally acquired islands, which are regions on genomes/plasmid 
of pathogenic strains; they are absent in closely related non-pathogenic strains.  
T3SS have been identified in a broad range of Gram negative bacterial species 
including Yersinia, Salmonella, Shigella, Escherichia coli, Pseudomonas, and 
Erwinia (Galan & Collmer, 1999).  This system is described further in Section 
1.2.1.1.  The Type IV secretion system (T4SS) is related to the conjugative pilus 
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system in bacteria and can translocate proteins, protein-DNA complexes or DNA 
across both membranes in a one step process (Cascales & Christie, 2003).  
However, the pertussis toxin from Bordetella pertussis is translocated via a Sec-
dependent Type IV secretion pathway into the extracellular environment 
(Rambow-Larsen & Weiss, 2004).  The Type V secretion system (T5SS) includes 
the autotransporter (AT) and two-partner (TpsA and TpsB) proteins, which are 
first translocated into the periplasm via the Sec system,  AT or TpsA are 
processed by signal peptidase into an active proenzyme, the C-terminal end of 
the AT protein or TspB inserts into the outer membrane in a β-barrel 
conformation assisted by the BAM complex (Knowles et al., 2009), providing a 
pore for the N-terminal end of the AT protein or TpsA repectively, to translocate 
to the surface (Henderson et al., 2004).  The Type VI secretion system (T6SS) is 
analogous to T4SS and has only recently been described.  It is characterised by 
its requirement for a ring-forming AAA+ ATPase (ClpV) to provide energy to the 
system (Mougous et al., 2006; Bingle et al., 2008; Filloux et al., 2008). 
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1.2 Enterohaemorrhagic E. coli (EHEC) 
Enterohaemorrhagic E. coli (EHEC) are Gram negative facultative anaerobic 
bacteria which are important causative agents of severe foodborne disease 
worldwide (Kaper et al., 2004).   EHEC was first identified in 1982 as a cause of 
bloody diarrhoea and HUS.  EHEC causes sporadic but deadly outbreaks of 
haemorrhagic colitis (bloody diarrhoea), which can lead to the serious 
complication of haemolytic uremic syndrome, in developed countries such as 
Scotland, USA and Japan.  The incidence of EHEC infections is greater in young 
children and the elderly.  There are many serotypes of EHEC, such as O111, O26, 
O104, but the World Health Organisation considers EHEC serotype O157 as the 
most important serotype with regards to public health.   
EHEC can colonize ruminants, such as sheep and cattle, asymptomatically 
(Borczyk et al., 1987; Orskov et al., 1987; Chapman et al., 1996).  The 
persistence and tropism of EHEC O157 colonisation in cattle was assessed by 
experimental challenge of cattle, which determined that EHEC O157:H7 is found 
in high numbers in bovine faeces and displays a tropism for the mucosa of the 
terminal rectum of cattle (Naylor et al., 2003).  It was also found that the 
faeces from cattle with EHEC O157:H7 colonised terminal rectum displayed a 
high EHEC O157:H7 distribution on the outer surface of the faeces, whereas 
other colonising species of E. coli were distributed throughout (Naylor et al., 
2003).  Further studies assessing the colonisation of cattle after slaughter 
confirmed EHEC O157:H7 tropism for this site of the intestinal tract and 
indicated that colonisation of this site facilitates bacterial shedding in the 
faeces (Low et al., 2005).  EHEC O157:H7 infections in humans typically arise 
from the consumption of faecal contaminated meat, vegetable or other animal 
by-products, such as milk.  EHEC O157:H7 infections can also occur via the 
faecal-oral route which commonly occurs with children visiting petting 
zoos/farms, for example the outbreak in 2009 at Godstone Farm, Surrey resulted 
in 93 EHEC infections, of which 17 resulted in HUS 
(http://www.griffininvestigation.org.uk/).   
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EHEC O157 is considered to have evolved from an enteropathogenic E.coli (EPEC) 
O55 strain, through the acquisition of bacteriophages encoding Shiga toxins (Reid 
et al., 2000).  Shiga toxins (Stx-1 and Stx-2) are AB5 toxins which have been 
shown to play an important role in EHEC pathogenesis, as these toxins are 
cytotoxic and can inhibit host cell protein synthesis (Endo et al., 1988).  Using 
purified toxin, it was shown that the toxin induces fluid acculumation and loss of 
adsorptive villus epithelial cells in rabbits in vivo (Keenan et al., 1986).  Stx is 
also known as verotoxin (VT) due to the cytotoxicity observed when incubated 
with Vero cells (Scotland et al., 1985).  The production of Stx has been linked to 
the pathology associated with haemolytic colitis and HUS (Karmali et al., 1983).  
This is supported by a recent E. coli outbreak in Germany, with over 3,000 
infections reported of which 25% resulted in HUS, caused by an E. coli O104:H4 
strain acquiring the stx gene, as well as antibiotic resistance genes and 
alternative fimbrial adhesins (Rohde et al., 2011).  Therefore, EHEC is a subset 
of verotoxin/shiga-toxin producing E. coli (VTEC/STEC). 
EHEC are members of the ‘attaching and effacing’ (A/E) family of bacterial 
pathogens, with enteropathogenic E. coli (EPEC) and Citrobacter rodentium, so 
named due to the lesion formed during the bacterium’s colonization of the 
intestinal mucosa (Moon et al., 1983).  The histopathology is characterised by 
the loss of microvilli (effacement), cytoskeletal rearrangements resulting in the 
formation of a ‘pedestal’ structure and intimate bacterial attachment (10-12 nm 
gap) to the gut enterocyte (Polotsky et al., 1977; Rothbaum et al., 1982; Moon 
et al., 1983; Knutton et al., 1987).  This lesion is caused by the effector proteins 
which are delivered into the host by way of a T3SS, hijacking the host cell 
cytoskeleton enabling an intimate attachment between the bacterium and the 
host cell to be formed.  This T3SS is encoded by a pathogenicity island named 
the locus of enterocyte effacement (LEE) (McDaniel et al., 1995). 
 
 27 
1.2.1 Locus of Enterocyte Effacement (LEE) 
The LEE PAI is about 35kB (Perna et al., 2001) and consists of at least 41 open 
reading frames (ORFs) arranged in five operons, Figure 1-4.  LEE1, 2, and 3 
contain 22 ORFs and primarily encode the constituents of the type III secretion 
apparatus, the esc (E. coli secretion) and sep (secretion of E. coli)  proteins.  
LEE4 encodes the proteins which form the conduit between the bacterium and 
the host cells, namely the EscF needle complex protein and the translocator 
proteins EspA, B, and D.  LEE5 contains the translocated intimin receptor (Tir), 
its chaperone CesT and the adhesin intimin.  The LEE also carries its own 
transcriptional regulators, Ler (LEE encoded regulator) and GrlRA (global 
regulator of LEE repressor and activator). 
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Figure 1-4  Genetic arrangement of EHEC LEE 
The image was adapted from coliBASE (http://www.xbase.ac.uk/genome/escherichia-coli-o157h7-edl933).  Additional annotations from (Garmendia et al., 
2005; Pallen et al., 2005; Tsai et al., 2006; Su et al., 2008; Younis et al., 2010; Yu et al., 2010; Biemans-Oldehinkel et al., 2011; Garcia-Gomez et al., 2011). 
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1.2.1.1 T3SS apparatus 
The T3SS is constructed from many different proteins, many of which are 
conserved across bacterial species, and some components also share protein 
homology with flagellar proteins. The Type III secretion apparatus has been 
shown to have a common evolutionary origin with the export apparatus for the 
flagellum (Cornelis, 2006).  This is because they both consist of an ATP-
dependent basal apparatus spanning the cytoplasmic membrane and a hollow 
needle-like complex spanning the periplasm and outer membrane.  This 
structure allows the translocation of the proteins which form the filament 
structure that spans outwith the bacterium and mediates attachment with the 
host cell.  T3SS translocates pore-forming toxins, via this filamentous structure 
(translocon), that perturb the host membrane for the translocation of T3 
effector proteins.  The components that make the basal apparatus are secreted 
by the Sec system.  EscV forms the major component of the inner membrane 
part of the complex, and the protein is conserved in all T3SS.  EscJ spans the 
periplasm, shares sequence similarity with the flagellar protein FliF and is 
required for the secretion of the distal components of the complex (Crepin et 
al., 2005).  EscC forms the main complex in the outer membrane of the 
bacterium, and the monomers are secreted via both the Sec and basal apparatus 
(Gauthier et al., 2003).  EscN is the ATPase which provides the system with 
energy for the secretion of translocators and effectors.  EscN can also interact 
with effector proteins complexed with their chaperone, facilitating translocation 
(Gauthier & Finlay, 2003). 
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Figure 1-5 Model of Type III Secretion Apparatus 
Representation of EHEC T3SS based upon (Pallen et al., 2005; Tree et al., 2009). EscC/D/J/Q-
V proteins which make the basal apparatus which spans the bacterial membranes, EscF is 
the needle complex, EscN provides the energy for secretion/translocation, SepD and SepL 
form the gate and mediate the switch from secretion of translocon proteins (EspA/D/B), 
which form the filament extension to mediate attachment and pore formation in the host 
membrane developing a conduit between the two cell types, to effector protein 
translocation.   
The T3SS apparatus in EPEC and EHEC differs from the Yersinia and Salmonella 
T3SS in that it has a filamentous extension from the needle EscF structure to 
‘reach’ the host cell (Wilson et al., 2001).  This translocon filament is composed 
of EspA (Ebel et al., 1998; Knutton et al., 1998), with EspB and EspD forming the 
pore, of 3-5nm diameter, in the host cell membrane (Ide et al., 2001).  EspA has 
functional homology to flagellin, and it has been shown that the EspA filament 
extends in a similar mechanism to that of the flagella (Delahay et al., 2005).  
Polymerisation of EspA is dependent on the presence of EspD that is proposed to 
act as the translocon cap (Kresse et al., 1999; Daniell et al., 2001).  Once EspA-
mediated cell contact is made, EspD oligomerises in the host cell membrane, 
and pores are formed in association with EspB.  Translocation of effector 
proteins can then proceed. 
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1.2.1.2 Effector proteins of the LEE 
The effectors encoded by the LEE PAI include Tir, Map, EspB, EspF, EspG, EspH, 
SepZ (EspZ), which have all been characterised over the years, some better than 
others, and are summarised in Table 1-1.  Tir (translocated intimin receptor) 
mediates intimate attachment of the bacterium to the host cell, by translocating 
into the host cell, presenting itself on the host cell membrane to bind to the 
bacterial adhesin intimin (Kenny et al., 1997; DeVinney et al., 1999).  Tir is 
therefore essential for the formation of the A/E lesion, as it also facilitates 
recruitment of N-WASP, resulting in the polymeration of actin through Arp2/3 
(Goosney et al., 2001).  The dynamics of actin polymerisation differs between 
EPEC and EHEC as it was observed that TirEHEC did not complement a Tir 
deficient strain of EPEC (Kenny, 1999; Kenny, 2001).  The recruitment of N-WASP 
differs between EPEC and EHEC, as EPEC Tir is tyrosine phosphorylated before 
recruiting N-WASP via host protein Nck, but EHEC Tir does not require Nck for 
actin polymerisation (DeVinney et al., 2001; Gruenheid et al., 2001; Kenny, 
2001; Campellone et al., 2002).   It was hypothesised that for actin 
polymerisation, EHEC must also translocate an adaptor protein with Tir, and 
systematic deletion of O-Islands in E. coli O157:H7 EDL933 confirmed that this 
product was on prophage element CP-933U, homologous to EspF and called EspFU 
(Campellone et al., 2004).   Functional analysis of this effector in vitro by two 
independent groups demonstrated that it interacts with Tir and binds N-WASP 
acting as a functional homolog of Nck and was also named TccP (Tir cytoskeleton 
coupling protein) (Campellone et al., 2004; Garmendia et al., 2004).  Recently, 
the interaction of Tir with EspFU/TccP has been shown to be mediated in vitro 
by a host insulin receptor tyrosine kinase substrate p53 (IRKSp53) (Vingadassalom 
et al., 2009; Weiss et al., 2009).  However, actin polymerisation can occur in a 
mechanism independent of TccP in vivo as demonstrated using a bovine ligated 
ileal loop model of infection (Vlisidou et al., 2006a).  This study also shows that 
pedestal formation is not necessary for E. coli O157:H7 persistence in bovine and 
ovine models of infection.  The polymerisation of actin at the base of bacterial 
attachment was exploited by (Knutton et al., 1989) to develop a new method of 
lesion detection, other than through electron microscopy (EM), called 
Fluorescent actin staining (known as the ‘FAS test’), whereby fluorescein-
isothiocyanate (FITC) or rhodamine (TRITC) labelled phalloidin, a phallotoxin 
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that can specifically bind polymerised actin, labels this area underneath the 
attached bacteria.  This technique has since been widely applied to test EHEC 
mutants to determine which genes affect intimate bacterial attachment and A/E 
lesion formation. 
Table 1-1  Effector proteins encoded on the LEE PAI 





LEE5 Inserts into the host cell membrane and mediates 
intimate attachment with intimin (Kenny et al., 
1997; DeVinney et al., 1999). 
 
Recruits N-WASP and Arp2/3 causing cytoskeletal 
rearrangement resulting in pedestal formation 
(Goosney et al., 2001). 
 
Represses filopodia formation (Kenny et al., 2002) 
 
Controls epithelium damage caused by EspG-





LEE Localises to the mitochondria in the host cell 
(Kenny & Jepson, 2000). 
 
Mediates filopodia formation at site of infection 
by activating Cdc42 GTPase (Kenny et al., 2002) 
 
Disrupts host tight junctions and intestinal 
barrier, dependent upon the presence of intimin 
(Dean & Kenny, 2004) 
 
Binds Na+/H+ exchanger regulatory factor 2 
(NHERF2) (Martinez et al., 2010)  
EspB LEE4 Expression in host cells in vitro redistributes actin 
filaments resulting in a reduction of actin stress 
fibres observed (Taylor et al., 1999) 
 
Directly interacts with α-catenin, contributing to 
A/E lesion formation (Kodama et al., 2002) 
 
Increases α-catenin affinity for binding actin 
filaments to form bundles and inhibit Arp2/3 
mediated actin polymerisation in vitro 

















Is associated with reduction in transepithelial 
resistance and redistribution of tight junction 
proteins disrupting host intestinal barrier 
(McNamara et al., 2001; Elliott et al., 2002; Dean 
& Kenny, 2004; Viswanathan et al., 2004; Dean et 
al., 2006; Guttman et al., 2006; Peralta-Ramirez 















Inhibits phagocytosis of EPEC (Quitard et al., 
2006) and EHEC (Marches et al., 2008) 
 
Modulates the host cytoskeleton (Marches et al., 
2006; Alto et al., 2007; Peralta-Ramirez et al., 
2008) 
 
Targets the nucleolus once the mitochondrial 
membrane potential is reduced, redistributing 
nucleolin into the cytoplasm (Dean et al., 2010b). 
 
Reviewed in (Holmes et al., 2010) 
EspG/EspG2 LEE Mutant in C. rodentium displays reduced 
colonisation and unable to cause colonic 
hyperplasia (Hardwidge et al., 2005) 
 
Binds to tubulin destabilising the microtubule 
networks, triggering the activation of GEF-H1 and 
induces the formation of actin stress fibres 
(Matsuzawa et al., 2004; Hardwidge et al., 2005; 
Matsuzawa et al., 2005; Shaw et al., 2005; 
Tomson et al., 2005) 
 
Activates host cysteine protease calpain resulting 
in the destruction of the epithelium in vitro (Dean 
et al., 2010a) 
 
EspH LEE3 Represses filopodia formation and promotes 
pedestal formation in a mechanism independent 
from Tir (Tu et al., 2003) 
 
Mutant is attenuated in rabbit model of infection 
and reduced colonisation of GI tract (Ritchie & 
Waldor, 2005) 
 
Binds Rho guanine exchange factors (RhoGEF) 
preventing Rho activation and disrupting the actin 
cytoskeleton.  Also plays a role in inhibiting 
phagocytosis of EPEC in vitro (Dong et al., 2010). 
 
SepZ (EspZ) LEE2 Binds CD98 counteracting cytopathic effect and 





In summary, the effectors encoded on the LEE (Table 1-1) are required for 
bacterial intimate attachment, the formation of the A/E lesion and disrupting 
the intestinal barrier by modulating the host cytoskeleton and inhibits 
phagocytosis.  The effectors can work in concert to mediate the multiple effects 
they exert upon the host cell. 
 
1.2.2 Regulation of the LEE 
Horizontally acquired genetic elements require appropriate regulation of 
expression which can be managed by both endogenous and exogenous elements.  
LEE expression is extremely complex, influenced by a number of environmental 
signals and regulated by an interplay of LEE-encoded, global and other 
horizontally-acquired regulators.  
The LEE encodes 3 regulatory elements; LEE-encoded regulator (Ler), Global 
Regulator of the LEE Activator (GlrA) and Grl repressor (GlrR).  Ler is the first 
open reading frame of LEE1 (orf1) and belongs to the H-NS family of nucleoid-
associated proteins which positively regulates transcription of both LEE and non-
LEE genes (Elliott et al., 2000; Haack et al., 2003; Roe et al., 2007).  Ler 
activates gene transcription by counteracting the effects of global regulator H-
NS (Bustamante et al., 2001) which silences transcription of genes by binding to 
curved AT-rich regions (Dorman & Deighan, 2003).  H-NS has been shown to 
repress the LEE, with LEE1 repression being dependent upon temperature in 
EPEC (Umanski et al., 2002).  In EHEC, H-NS represses ler and LEE4 transcription 
(Beltrametti et al., 1999; Laaberki et al., 2006).  Osmolarity can reduce the 
repression of gene transcription by H-NS owing to the change in DNA topology in 
these conditions (Dorman & Deighan, 2003), and it has been shown that the LEE 
PAI in EHEC is upregulated in conditions with high osmolarity (Sperandio et al., 
1999).  GrlA and GrlR are encoded between LEE1 and LEE2, and were identified 
through analysis of a systematic deletion of each gene in the LEE of C. 
rodentium (Deng et al., 2004).  The genes are co-transcribed and their 
expression is dependent upon Ler (Deng et al., 2004; Laaberki et al., 2006).  
Expression of GrlA in turn positively regulates expression of Ler through 
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interacting with the LEE1 promoter (Laaberki et al., 2006; Huang & Syu, 2008) 
forming a positive feedback loop (Barba et al., 2005).  GrlR binds GrlA (Barba et 
al., 2005; Jobichen et al., 2007; Huang & Syu, 2008) and this interaction is 
proposed to act as a check-point to downregulate the feedback loop.  GrlA can 
also co-ordinate enterohaemolysin expression with the LEE (Saitoh et al., 2008) 
and negatively regulates expression of the flagella (Iyoda et al., 2006), 
ultimately facilitating intimate attachment of the bacterium to the host cells.  
This is controlled through the degradation of GrlR by ClpX protease (Iyoda & 
Watanabe, 2005), releasing GrlA and thereby reducing transcription of flagella 
genes, as overexpression of the flagella has been shown to have an overall 
negative effect on attachment (Iyoda et al., 2006), and increasing transcription 
of the LEE.  Hfq is a RNA chaperone which post-transcriptionally regulates Ler 
expression during stationary phase of growth, and GrlRA expression during the 




Figure 1-6 Schematic diagram of LEE regulation in EHEC O157:H7 
The figure is adapted from (Mellies et al., 2007).  Thin black arrows represent positive 
regulatory signals, grey blunt arrows represent negative regulatory signals.  Solid black 
arrows represent expression of protein from gene.  Dashed arrows indicate an indirect 
effect on regulation of gene expression.  Dotted line represents an effect on mRNA stability, 
seen with Hfq.  Jagged line represents protein degradation by ClpXP protease.  Star-P 
represents phosphorylation, and white arrows represent phosphate transfer.  Horizontally 
acquired elements have a black background and elements endogenous to E. coli have a 
white background.  See text for detailed explanation. 
Quorum sensing regulates the LEE in EHEC through responding to environmental 
signals such as temperature, osmolarity and pH through signalling molecules 
(Sperandio et al., 1999).  These signalling molecules are hormone-like molecules 
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called autoinducers.  AI-2 was the first quorum sensing molecule identified in E. 
coli due to its homology to lux genes in Vibrio fischeri, and luxS gene is required 
for its production in E. coli.  Another autoinducer, AI-3, is part of an 
interkingdom communication system which enables cross-talk with epinephrine 
(Epi) and norepinephrine (NE) from mammals with bacteria.  This cross-talk has 
been shown to be mediated through a histidine kinase QseC, which 
autophosphorylates upon sensing these hormone signals (Clarke et al., 2006) and 
transfers this phosphate to its response regulator QseB.  The transcription factor 
activated in this cascade is QseA which has been shown to directly interact with 
the distal promoter of ler (Sharp & Sperandio, 2007; Kendall et al., 2010), 
thereby directly activating its expression, and through the action of Ler, 
indirectly activating expression of the LEE PAI (Sperandio et al., 2002a).  QseA 
can also activate grlRA transcription in a Ler-independent manner (Russell et 
al., 2007).  QseBC has also been shown to positively regulate motility through 
transcriptional regulation of the flagella regulator genes flhDC (Sperandio et al., 
2002b; Clarke & Sperandio, 2005b).  An additional quorum sensing two-
component system QseEF was identified in a microarray study comparing 
differential gene expression in EHEC and an isogenic luxS mutant (Sperandio et 
al., 2001) and characterised (Reading et al., 2007).  This two-component system 
responds to phosphate, sulphate and Epi/NE, and is transcribed in an operon 
with an outer membrane protein QseG (Reading et al., 2009).  QseEF does not 
regulate LEE expression, like that of QseBC, but regulates the transcription of 
T3SS effector espFu/TccP (Reading et al., 2007).  The transcription of espFU is 
dependent upon the presence of QseF, but not QseE as QseF can be activated by 
other sensor kinases, such as QseC (Reading et al., 2007).  As mentioned 
previously, EspFU/TccP is required by EHEC Tir to form A/E lesions, therefore 
QseEF can regulate the expression of this effector in co-ordination with the LEE, 
and it has been demonstrated that Tir cannot be translocated without the 
presence of QseG in vitro (Reading et al., 2009). 
Other global regulators which regulate the LEE include stringent response 
signalling molecule ppGpp (Nakanishi et al., 2006), stress sigma factor rpoS 
(Sperandio et al., 1999; Iyoda & Watanabe, 2005; Laaberki et al., 2006), RNA 
chaperone Hfq (Hansen & Kaper, 2009; Shakhnovich et al., 2009), integrated 
host factor (IHF) (Friedberg et al., 1999), and Hha (Sharma & Zuerner, 2004).  
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The stringent response molecule ppGpp accumulates in nutrient-starved cells, 
which mediates transcription of genes by binding RNA-polymerase in 
coordination with DksA, and together positively regulate the transcription of ler 
and pch (Nakanishi et al., 2006).  RpoS sigma factor, which is involved in gene 
regulation during stationary phase (Lange & Hengge-Aronis, 1991), directly 
activates LEE3 transcription (Sperandio et al., 1999) and differentially controls 
ler transcription (Laaberki et al., 2006; Dong & Schellhorn, 2009).  Hfq is an RNA 
chaperone which in concert with small non-coding RNA (sRNA) binds mRNA, 
controlling translation and mRNA stability.  Hfq has been shown to negatively 
regulate ler transcription and translation (Shakhnovich et al., 2009) and grlRA 
mRNA stability during the exponential phase of growth, indirectly controlling LEE 
expression (Hansen & Kaper, 2009).  Hfq is a global regulator, as it is involved in 
regulating the translation of RpoS and H-NS with sRNA DsrA.  This regulation of 
RpoS translation by DsrA has been shown to promote the transcription of ler 
(Laaberki et al., 2006), and dsrA transcription is positively regulated by QseA 
(Kendall et al., 2010).  IHF directly activates ler transcription demonstrated by 
gel motility shift assays and DnaseI footprinting (Friedberg et al., 1999).  IHF has 
also been shown to negatively regulate transcription of the flagella regulator 
genes flhDC indirectly via an un-identified EHEC specific factor (Yona-Nadler et 
al., 2003).  Hha was identified by transposon mutant screening of an EHEC 
O157:H7 strain expressing esp::lacZ, and purified Hha protein was shown to 
directly bind and negatively regulate ler transcription (Sharma & Zuerner, 2004). 
Horizontally acquired elements which regulate the LEE include PerC (plasmid 
encoded regulator) in EPEC or PerC-like homologues (Pch) in EHEC, of which 
there are seven PchA-E, PchX and PchY.  PchABC have been shown to globally 
positively effect transcription of LEE, via ler, and non-LEE encoded genes (Iyoda 
& Watanabe, 2004; Porter et al., 2005; Abe et al., 2008).  Transcription of pch is 
negatively regulated by RpoS (Iyoda & Watanabe, 2005).  GrvA (global regulator 
for virulence A) is an EHEC specific regulator of LEE1, and therefore ler (Tobe et 
al., 2005).  Pch and GrvA are transcriptionally regulated by the same His-Arp 
phosphorelay system RcsDCB, negatively and positively respectively (Tobe et al., 
2005).  The authors propose that the RcsDCB system positively regulates the 
transcription of grvA directly. The negative regulation of pch by RcsB has been 
proposed to be an indirect effect as it was growth medium dependent, 
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indicating RcsB represses pch expression by the repression of another gene (Tobe 
et al., 2005).  The probable candidate for RcsB-dependent pch repression is LrhA 
(LysR-homologue A), which is a direct positive regulator of pchABC transcription 
in EHEC (Honda et al., 2009) and RscB represses lrhA transcription in E. coli K-12 
(Peterson et al., 2006).  It has recently been demonstrated through microarray 
analysis of differential gene expression in EHEC and isogenic single mutants in 
FqseE/F/G, that the QseEF two component system represses rcsB transcription 
(Reading et al., 2010), thereby contributing to the co-ordination of LEE 
expression with the effectors it secretes, such as EspFU/TccP.  Expression of pch 
is also positively affected by butyrate concentrations in the extracellular media, 
which is sensed by Lrp (leucine-responsive regulatory protein) (Nakanishi et al., 
2009).  The influence of Lrp on pch is also indirect, as chromatin-
immunoprecipitation and sequence analysis did not reveal direct Lrp binding.  
The effect of Lrp on pch transcription is possibly mediated via Lrp positive 
regulation of lrhA transcription, which has been shown in E. coli K-12 (Cho et 
al., 2008).  LrhA is also involved in the negative regulation of the flagellar genes 
in K-12 strains (Lehnen et al., 2002) and in O157 strains, independent from grlA 
(Honda et al., 2009) and RcsB also negatively regulates flagellar gene expression 
directly in K-12 (Francez-Charlot et al., 2003).   
Other EHEC specific regulators of the LEE are the regulators etrA and eivF which 
are encoded alongside a second, non-functional, T3SS (ETT2).  These regulators 
negatively regulate the LEE, demonstrated through microarray analysis of FetrA 
and FeivF compared to wildtype and reduced protein secretion when introduced 
episomally in a high secretor EHEC strain (Zhang et al., 2004).  Prophage-
encoded secretion regulator (Psr) genes were identified through a systematic 
analysis of the level of T3S dependent secreted proteins from TUV93-0 O-Island 
mutants, and found to indirectly repress LEE expression (Tree et al., 2011).  This 
study demonstrates that PsrA positively regulates the GAD acid stress response 
by inducing transcription of gadE, particularly after adhering to host cells.  GadE 
is a member of the LuxR regulator family which represses the LEE by interacting 
with the promoter regions of LEE1 and LEE2/3 (Tatsuno et al., 2003; Tree et al., 
2011).  GadE is also positively regulated by RpoS (Dong & Schellhorn, 2009) and 
negatively regulated by pch (Abe et al., 2008). 
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Overall, regulation of LEE expression is complex, as expression is controlled by 
LEE-encoded regulators (Ler and GrlRA), global endogenous regulators (H-NS and 
IHF), and other horizontally acquired regulators (Pch).  The regulation of LEE has 
integrated into the complex endogenous regulatory network including quorum-
sensing (QseABCDEFG), phosphorelay systems (RcsBCD) and metabolite activated 
factors (Lrp).  This demonstrates the strict control of LEE expression so that it is 
only expressed at the optimum moment cued by environmental signals such as 
bicarbonate ions (Abe et al., 2002), when flagellar expression is repressed, and 
in co-ordination with the effectors that is translocated by the T3SS. 
 
1.2.3 Non-LEE encoded effector proteins 
1.2.3.1 Overview 
It was soon discovered that the T3SS apparatus not only translocated proteins 
encoded within the LEE but also others encoded elsewhere in the genome.  As 
described previously, EspFU/TccP is encoded on CP-933U, and is required for Tir 
dependent actin polymerisation and pedestal formation by acting as an Nck 
mimic (Campellone et al., 2004; Garmendia et al., 2004).  Cycle inhibiting factor 
(Cif) was identified through a transposon mutant of EPEC strain E22 screen for 
the inhibition of the cytopathic effect, identified by focal adhesion plaques, in 
FAS-test positive cells (Marches et al., 2003).  EspI/NleA was identified from two 
independent approaches; signature-tagged mutagenesis of C. rodentium (Mundy 
et al., 2004) and proteomic analysis of culture supernatents from EHEC and a 
T3SS deficient mutant (Gruenheid et al., 2004).   
Studies in C. rodentium, an A/E bacterial pathogen of mice, thus routinely used 
as small animal in vivo model of A/E infections, shown that SepL and SepD acts 
as a switch controlling the secretion of translocators (EspA, B, D) and effectors 
(e.g. Map, EspH) (Deng et al., 2004).  When tested in EHEC and EPEC, SepL and 
SepD deletion mutants were shown to hypersecrete effector proteins, but cease 
to secrete translocators (Deng et al., 2005).  Studies of these ‘hypersecretor’ 
mutants lead to the discovery of additional proteins, or putative effectors, 
translocated through the T3SS apparatus which were not encoded on the LEE.  
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These 7 proteins were named Non-LEE encoded effectors (Nle): NleA, NleB, 
NleC, NleD, NleE, NleF, and NleG.  This led to the speculation that ‘the 
repertoire of E. coli effector genes might be much larger than (currently) 
recognised’ and this hypothesis was tested using a systematic bioinformatics and 
proteomics approach (Tobe et al., 2006), identifying a total of 39 putative 
effectors, classed into 20 families.  Since the publication of this study, research 
into determining the function of these non-LEE encoded effector, and how they 
contribute to EHEC, and EPEC, pathogenicity has increased and ongoing.  The 
function(s), and/or contribution to pathogenesis, of non-LEE encoded effectors 
are summarised in Table 1-2.  It can be seen that many of these non-LEE 
encoded effectors contribute towards colonisation in vivo but only EspFu/TccP is 
required for the formation of A/E lesions in vitro. 
Table 1-2  Characterised non-LEE encoded T3S effectors (O Island designation is according 
to the systematic nomenclature design in (Perna et al., 2001) 
Effector Location Function(s) 
TccP/EspFU OI-79 Interacts with Tir via IRKSp53 and binds N-WASP for 
actin polymerisation via Arp2/3 for pedestal 
formation (Campellone et al., 2004; Garmendia et 






OI-71 A cyclomodulin which inhibits mitosis, recruits focal 
adhesion plaques and induces stress fibres (Marches 
et al., 2003; Charpentier & Oswald, 2004; 
Nougayrede et al., 2005; Taieb et al., 2006) 
 
Inhibits cell cycle transition by blocking the 
proteosomal degradation of cyclin-dependent kinase 
inhibitors (Samba-Louaka et al., 2008) by binding 
NEDD8 blocking E3 ubiquitin ligase function (Cui et 
al., 2010; Jubelin et al., 2010; Morikawa et al., 
2010).  
Induces apoptosis (Samba-Louaka et al., 2009) 
NleA (EspI) OI-71 Required for full virulence in C. rodentium mouse 
infection and EHEC gnotobiotic pig model of 
infection (Gruenheid et al., 2004; Mundy et al., 
2004). 
 
Localises to the Golgi apparatus (Gruenheid et al., 
2004; Creuzburg et al., 2005). 
 
Interferes with protein trafficking and secretion in 
mammalian cells through binding with Sec24, part of 
the COPII complex (Kim et al., 2007). 
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Has a PDZ binding domain which is necessary for 
binding to Sec24 and NHERF (Lee et al., 2008; 
Martinez et al., 2010). 
 
Involved in disrupting intestinal tight junctions in 
concert with EspF and Map (Thanabalasuriar et al., 
2010). 
 
EspJ OI-79 E. coli O157:H7FespJ persists longer than wild-type 
in animal models of infection (Dahan et al., 2005). 
 
Inhibits opsono-phagocytosis (Marches et al., 2008). 
 
Localises to the mitochondrion (Kurushima et al., 
2010). 
 
EspK OI-50 Localises to host cytosol.  EspK deficient EHEC is less 
persistent than WT in colonising calves, but no 
effect seen in mouse model with C. rodentium 






Modulates actin dynamics through RhoA activation 
forming stress fibres and regulates actin pedestal 
formation (Arbeloa et al., 2008; Arbeloa et al., 




Sp4 in EHEC 
Sakai 
strain). 
EPEC homolog identified in 10% EHEC strains by PCR.  
Locations in EHEC are not characterised.  When 
ectopically expressed in mammalian and yeast cells 
it induces morphological changes (Arbeloa et al., 
2011) 
 
NleB OI-122 Essential for C. rodentium colonisation and 
development of colonic hyperplasia (Kelly et al., 
2006) 
 
Inhibits IL-1β stimulated NF-κB activation (Nadler et 
al., 2010; Newton et al., 2010) 
 
 
NleC OI-36 Does not contribute to E. coli O157:H7 virulence or 
colonisation in animal models (Marches et al., 2005). 
 
Is a zinc metalloprotease which cleaves p65 (Yen et 
al., 2010; Baruch et al., 2011; Muhlen et al., 2011; 
Pearson et al., 2011) and p300 (Shames et al., 
2011), thereby inhibiting transcription of NF-κB 
dependent genes, modulating the host immune 
response. 
 
Inhibits p38 MAPK activation (Sham et al., 2011) 
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Mutant in C. rodentium leads to greater pathology in 
vivo and greater chemokine induction in cecal loop 
model of infection (Sham et al., 2011) 
 
NleD OI-36 Does not contribute to E. coli O157:H7 virulence or 
colonisation in animal models (Marches et al., 2005) 
 
Is a zinc metalloprotease which cleaves the JNK 
serine/threonine protein kinase, modulating the 
host immune response (Baruch et al., 2011) 
 
NleE OI-122 Mutant in C. rodentium is attenuated in mouse 
model of infection and colonisation (Wickham et al., 
2007) 
 
Modulates NF-κB activation by inhibiting 
phosphorylation of IKK by an unknown mechanism 
(Nadler et al., 2010; Newton et al., 2010) 
 
Inhibits IL-1β stimulation of NF-κB activation in 
dendritic cells (Vossenkamper et al., 2010) 
 
NleF OI-71 Localises to cytosol of host cell and plays a role in 
colonisation (Echtenkamp et al., 2008).   No host 
protein interactions have been characterised. 
 
NleG OI-71, OI-57, 
CP-933R,  
OI-108 
E3 ubiquitin ligase activity (alleles G2-3, G5-1, G6-2 











EPEC NleI localises to host cytosol and membranes 
and translocation is dependent upon CesT (Li et al., 
2006).  Only 1 allele in EPEC; four in EHEC and CR.  





OI-50 E3 ubiquitin ligase activity which specifically 
regulates pedestal formation (Piscatelli et al., 
2011); not present in EPEC. 
 
1.2.3.2 Non-LEE encoded effector H 
NleH1 and NleH2 were identified in the aforementioned bioinformatic and 
proteomic screen as putative T3SS effector proteins and BLAST analysis revealed 
that they are homologs of a characterised Shigella flexneri T3S effector (Tobe et 
al., 2006).  With this preliminary data, NleH became an interesting candidate for 
further research into its role in A/E pathogenesis. 
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Citrobacter rodentium was found to contain only one NleH gene, which shares 
the same gene organization as to that of NleH1 in EHEC and EPEC but a higher 
predicted protein identity with NleH2 (Garcia-Angulo et al., 2008).  The same 
study of C. rodentium NleH (CRNleH) show that secretion and translocation into 
an intestinal cell line in vitro required a functional T3SS, and that it is post-
transcriptionally regulated in coordination with the LEE. 
NleH may be required during the early stages of infection, as a CRNleH knockout 
has a reduced ability to colonise the mouse (Garcia-Angulo et al., 2008) and is 
outcompeted by wild-type C. rodentium in a mixed infection (Hemrajani et al., 
2008).  Similar results were found with an EHEC O157FnleH1nleH2 double 
mutant in the bovine and ovine models of infection, where the mutant was shed 
in greater numbers than, or outcompeted by, the wild-type strain in the 
respective models (Hemrajani et al., 2008).   
NleH share protein homology with OspG, an effector protein of Shigella flexneri. 
Using a yeast two hybrid screen, OspG was found to interact with E2 ubiquitin-
conjugating enzymes, thereby inhibiting NF-κB activation and interfering with 
the host innate immune response (Kim et al., 2005).  The effects of NleH on NF-
κB activation with regards to A/E infections have been investigated, and its 
effects appear to depend on the A/E pathogen studied.  CRNleH has been shown 
to activate NF-κB in vivo (Hemrajani et al., 2008); EHEC NleH1 represses, and 
NleH2 activates, NF-κB dependent promoters in vitro (Gao et al., 2009).  
Conflicting reports arise for EPEC NleH, where it does not affect NF-κB signalling 
(Ruchaud-Sparagano et al., 2007) or both alleles attenuate its activation in vitro 
(Royan et al., 2010).  Through three independent co-immunoprecipitation 
assays, NleH has been shown to interact with ribosomal protein subunit-3 (RPS3) 
(Gao et al., 2009) modulating the activation of NF-κB; Bax inhibitor-1 (BI-1) 
(Hemrajani et al., 2010) interfering with host cell apoptosis pathways; and 
NHERF2 (NleH1 only) (Martinez et al., 2010).  NleH appears to be a 
multifunctional effector protein, which is not an uncommon trait for these 
proteins; as described previously, EspF is able to elicit various responses in the 
host, reviewed in (Holmes et al., 2010).   
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1.2.3.3 Modulation of NF-κB activation by bacterial T3S effector proteins 
NF-κB is a transcription factor which can be made up of a homodimer or 
heterodimer of Rel proteins; p65 (RelA), RelB, c-Rel, p50 and p52.  Under resting 
conditions, free NF-κB is sequestered by IκB (inhibitors of NF-κB), which under 
stimulating conditions is phosphorylated by IKK and subsequently ubiquitinated 
for degradation by the proteosome, thereby releasing NF-κB enabling it to travel 
from the cytoplasm into the nucleus (Winston et al., 1999).  When in the 
nucleus, it can bind to its promoters, known as κB sites, and activate 
transcription of many genes involved in cellular processes, including the immune 
response.  The canconical NF-κB pathway is stimulated by a number of receptors 
such as TNF receptor, IL-1 receptor, TLR and T-cell receptor but all cascades 
converge at IKK-mediated phosphorylation of IκB (Chen & Greene, 2004; Hayden 
& Ghosh, 2004). Bacterial T3S effector proteins have evolved many different 
strategies to alter the transcription of NF-κB dependent genes, modulating the 
hosts’ responses to bacterial infection. 
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Figure 1-7  T3 effector modulation of the canconical NF-κB activation pathway 
Hexagons represent T3S effector proteins; note B. bronchiseptia T3 effector (BBE) has not 
been identified or chracterised fully.  Blunt arrows indicate inhibition of the pathway, details 
of which are in the text.  Jagged arrows indicates degradation. 
 
NleC is a metalloprotease which cleaves p65 demonstrated by in vitro infections 
of HeLa cells with various EPEC strains and analysing cell lysates for p65 
degradation by western blotting (Yen et al., 2010; Baruch et al., 2011; Pearson 
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et al., 2011) and by an in vitro digestion assay with recombinant NleC, which is 
dependent upon a functional protease domain HExxH (Yen et al., 2010; Baruch 
et al., 2011).  Additional work from Prof Brendan Kenny’s group demonstrate 
using transfection assays that NleC can also degrade p50 and IκB in a 
proteosome-independent manner (Muhlen et al., 2011).  Host acetyltransferase 
p300 was identified as a substrate of NleC by stable isotope labelling of amino 
acids in cell culture (SILAC) (Shames et al., 2011).  This interaction was 
confirmed by co-immunoprecipitation, and in vitro protease assay confirmed 
NleC mediated degradation of p300.  p300 is necessary for the expression of IL-8 
and p65 is acetylated by p300 (Shames et al., 2011).   
NleE inhibits phosphorylation of IKKβ and its activity is enhanced by NleB (Nadler 
et al., 2010).  In vitro assay tested IKKβ and IκB phosphorylation by extracting 
proteins from cells infected with EPEC strains, WT, FnleE, and FescV then adding 
TNFα/IL-1β to stimulate phosphorylation.  Western blotting analysis showed that 
TNFα and IL-1β stimulated phosphorylation of IKKβ in uninfected cells and cells 
infected with EPECFescV and FnleE but not EPEC WT.  Complementing the FnleE 
mutant with a plasmid expressing NleE only partially restored the inhibition of 
IKKβ phosphorylation.  NleB is proposed to enhance the activity of NleE as an 
nleBE double mutant inhibited IκB degradation greater than the nleE single 
mutant.  NleE inhibition of IL-1β stimulated NF-κB activation has also been 
demonstrated by EPEC infection of dendritic cells (Vossenkamper et al., 2010).  
The inhibition of IκB degradation and nuclear translocation of p65 by NleE and 
NleB was supported by work from Prof Elizabeth Hartland’s group (Newton et 
al., 2010).  The authors demonstrate through a transfection assay that NleB 
inhibits TNFα stimulated NF-κB activation to similar levels as NleE, but does not 
have an effect on the IL-1β stimulated pathway.  Therefore, the authors propose 
that NleB acts upstream of NleE in the NF-κB activation pathway.  NleH EHEC 
inhibits IKKβ mediated phosphorylation of RPS3, inhibiting its translocation from 
the cytoplasm into the nucleus, inhibiting transcription of RPS3-dependent NF-κB 
genes (Gao et al., 2009; Wan et al., 2011). 
Using yeast-two hybrid analysis OspG was shown to interact with ubiquitinated 
E2 enzymes, and this interaction was confirmed by co-IP and in vitro binding 
assays (Kim et al., 2005).  This results in OspG inhibiting proteosomal 
degradation of phosphorylated IκB and subsequently inhibits NF-κB activation, 
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which is dependent upon the inherent kinase activity of OspG (Kim et al., 2005).  
OspF from Shigella affects NF-κB recruitment at subset of genes through 
dephosphorylation of MAP kinase preventing subsequent phosphorylation of 
Histone 3 thereby modulating chromatin structure (Arbibe et al., 2007).  OspF 
interacts with retinoblastoma protein (Rb), which recruits other factors which 
post-translationally modify histones, thereby controlling chromatin remodelling 
and gene transcription, specifically repressing IL-8 secretion (Zurawski et al., 
2009). 
YopJ from Yersinia has deubiquitinase activity (Orth, 2002; Zhou et al., 2005) 
and removes ubiquitin from IκB (Zhou et al., 2005).  YopJ can also act as an 
acetyltransferase, acetylating functional residues in the activation loop of 
kinases (Collier-Hyams et al., 2002; Mittal et al., 2006; Mukherjee et al., 2006).  
The acetylation of serine or threonine residues in these loops blocks subsequent 
phosphorylation and IKKβ undergoes acetylation by YopJ (Mittal et al., 2006; 
Mukherjee et al., 2006).  The acetylation activity of YopJ has recently been 
shown to be activated by binding a eukaryotic host factor, inositol 
hexakisphosphate (IP6) (Mittal et al., 2010). 
AvrA from Salmonella is a member of YopJ/Avr family of deubiquitinases (Orth, 
2002).  Transfection of HEK293T cells with an NF-κB reporter and plasmids 
expressing AvrA, MEKK1, IKKβ and p65 shows that AvrA inhibits NF-κB activation 
downstream of IKKβ without affecting phosphorylation of IκB (Collier-Hyams et 
al., 2002).  Recombinant AvrA can deubiquitinate IκB in vitro, thereby 
preventing its degradation by the proteosome and subsequently inhibiting NF-κB 
activation (Ye et al., 2007).  SseL (Salmonella secreted factor L) is encoded on 
SPI-2 and can also deubiquitinate IκB in vitro and in vivo (Le Negrate et al., 
2008).  
Bordetella bronchiseptia infection of rat lung epithelium cell line results in NF-
κB aggregation in the cytoplasm, suppressing its activation and this was 
dependent upon the T3SS (Yuk et al., 2000).  Reduced transcription of 
antimicrobial peptide genes from B. bronchiseptia infected bovine tracheal 
epithelial cells is also dependent upon the presence of the T3SS (Legarda et al., 
2005).  The authors also report that they did not observe any differences in IκB 
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phosphorylation or ubiquitination levels, therefore this mechanism of NF-κB 
modulation differs from YopJ, AvrA and SseL (Legarda et al., 2005).
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1.3 Streptococcus pneumoniae 
Streptococcus pneumoniae (the pneumococcus) is a Gram positive facultative 
anaerobic bacterium and an important human pathogen worldwide.  
Pneumococci are a common cause of invasive diseases (septicaemia and 
meningitis) and respiratory-tract infections, such as otitis media, sinusitis, and 
community-acquired pneumonia.  Diseases are caused particularly in young 
children, the elderly and immuno-compromised persons (Bogaert et al., 2004).  
In 2008, just over 5,500 cases of invasive pneumococcal disease (IPD) were 
reported in the UK, contributing to a total of approximately 15,000 IPD cases 
reported across Europe (Annual epidemiological report on communicable 
diseases in Europe 2010 http://ecdc.europa.eu).  S. pneumoniae infections can 
result in an estimated 40,000 hospitalisations, 40,000 GP consultations and 
63,000 cases of otitis media annually in England and Wales 
(http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/120300886
4027).  Pneumococci are classed by the immunochemistry of the polysaccharide 
present in the capsule that surrounds them, using the Quellung reaction.  The 
Quellung reaction is evident under a microscope where incubation of positive 
reactive antibodies against a capsular serotype results in the bacterium 
‘swelling’.  Currently, there are 93 different serotypes of the pneumococcus 
identified (Henrichsen, 1995; Park et al., 2007; Jin et al., 2009; Calix & Nahm, 
2010), which include cross-reactive subtypes, such as the serotype 6 group (A, B, 
C and D). 
Although S. pneumoniae is a serious human pathogen, it is part of the normal 
flora of the upper respiratory tract (URT), i.e. the nasopharynx, of healthy 
individuals.  Colonisation of the nasopharynx is pivotal to pneumococcal spread 
and disease but can be limited to asymptomatic carriage (Bogaert et al., 2004).  
Risk factors for S. pneumoniae nasopharyngeal colonisation include antibiotic 
use, asthma, smoking, ethnicity and over-crowding (Hoge et al., 1994; 
Greenberg et al., 2006; Roche et al., 2007; Cardozo et al., 2008).  Bacterial 
colonisation of nasopharynx is complex as pneumococci have to compete for the 
same niche as Haemophilus influenzae, Neisseria meningitidis, Staphylococcus 
aureus and other Streptococcal species (Bogaert et al., 2004).  Therefore 
colonisation of the nasopharynx is a dynamic process due to the continuous 
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turnover of colonising species and serotypes present.  Nasopharyngeal 
colonisation is likely to happen to every individual at some stage of life (Bogaert 
et al., 2004). 
The ability of the pneumococcus to colonise the URT, and to cause disease, 
largely depends on the virulence factors the bacterium produces.  For example, 
neuraminidase, an enzyme which decreases the viscocity of the mucus layer 
protecting the epithelium and thereby exposes host-cell receptors, e.g. N-
acetyl-glycosamine.  NanA gene expression is upregulated in pneumococci in the 
nasopharynx, but not in lungs or blood (LeMessurier et al., 2006), indicating a 
role in pneumococcal colonisation.  Exposing the host cell receptors enables 
interaction with other pneumococcal surface-associated proteins, e.g. 
pneumococcal surface protein A (PspA).  Expression of NanA also facilitates 
pneumococcal growth in the presence of other colonising species, such as N. 
meningitidis, as NanA removes the sialic acid that these species use to decorate 
their cell walls to evade the innate immune response (Shakhnovich et al., 2002).  
The pneumococcus produces hydrogen peroxide (H2O2) during growth which can 
inhibit the growth of, and kill, other nasopharyngeal colonising species (Pericone 
et al., 2000).  The pneumococcus expresses a pore-forming toxin, pneumolysin 
(Ply), which can allow peptidoglycan from another bacterial species, such as H. 
influenzae, to translocate into the host cell (Ratner et al., 2007), inducing an 
immune response against the other bacteria.  These actions provide the 
pneumococcus with a competitive advantage over other colonising species to 
eliminate them and colonise the common niche. 
 
1.3.1 Pneumococcal virulence factors 
The pneumococcus produces a number of virulence factors which contribute to 
the bacterium’s ability to colonise and cause disease and/or pathology.  Well 
characterised factors include the polysaccharide capsule and the toxin 
pneumolysin (Ply).  Additional putative virulence factors have been identified 
through signature-tagged mutagenesis (Polissi et al., 1998; Lau et al., 2001; 
Hava & Camilli, 2002), lambda-phage libraries (Beghetto et al., 2006) and full 
genome sequencing (Tettelin et al., 2001; Hiller et al., 2007).  A large number 
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of these putative factors remain uncharacterised, yet studies are regularly being 
published demonstrating ongoing research in this area (Frolet et al., 2010), and 
Table 1-3 outlines the virulence factors important in pneumococcal colonisation 
and/or pathogenesis.  It should be noted that not all of the virulence factors are 
conserved amongst different strains of pneumococci, with some displaying 
variance (PspA, PspC, ZmpB and IgA protease) or have been horizontally 
acquired (pilus pathogenicity islands and PsrP) or not present (Pht proteins) 
(Donati et al., 2010). 
Proteins can be linked to the cell surface of the pneumococcus by way of one of 
three processes; via a sortase recognizing an LPXTG-motif for covalent linkage to 
the peptidoglycan present in the cell wall, via non-covalent linkage to 
phosphorylcholine in the cell wall teichoic and lipoteichoic acids (choline-
binding proteins) or via signal peptidase II-mediated covalent integration into 
the plasma membrane (lipoproteins).  The importance of protein display on the 
cell surface is evident in S. pneumoniae where the sortase A gene has been 
deleted, resulting in attenuation of pneumococcal colonisation and pathogenesis 
in vivo (Chen et al., 2005; Paterson & Mitchell, 2006).  Before these proteins can 
be expressed on the cell wall surface, or secreted into the extracellular milieu, 
they must be exported across the cytoplasmic membrane, by way of the Sec 
system.  The Sec system was shown to be significantly (P=0.004) up-regulated by 
2.2-fold when in contact with an epithelial cell line by microarray analysis 
(Orihuela et al., 2004b). 
Table 1-3 Characterised pneumococcal virulence factors 
Virulence 
Factor 
Role in colonisation/pathogenesis Pneumococcal 
Location 
Capsule Protects the bacterium from opsonisation 
and phagocytosis  
 
Provides protection from complement 
 
Hides pneumococcal antigens from the 
innate immune system (Abeyta et al., 
2003) 
 
Covers the entire 
surface area 







Degrades pneumococcal peptidoglycan cell 









Has a role in murine models of pneumonia 
and bacteraemia (Berry et al., 1989a; 
Berry et al., 1992; Berry & Paton, 2000) 
 
Contributes to pneumococcal replication in 
the lung (Orihuela et al., 2004a) 
 
Has a role in the rat model of 
pneumococcal meningitis (Hirst et al., 
2008) 
 
Related enzymes LytB and LytC contribute 





Contributes to pneumococcal virulence 
(Berry & Paton, 2000) 
 
Inhibits alternative pathway of 
complement (Yuste et al., 2005) 
 
Required for pneumococcal colonisation, 







C [PspC; aka 
choline binding 
protein A 
(CbpA) or SpsA] 
Contributes to pneumococcal colonisation 
(Rosenow et al., 1997; Ogunniyi et al., 
2007b) 
 
Binds factor H (Dave et al., 2001) 
facilitating pneumococcal invasion of 
tissues in vivo (Quin et al., 2007b) 
 
Mutants show reduced virulence in 
pneumonia and bacteraemia (Iannelli et 




IgA1 protease Degrades host IgA thereby evading the 
immune response (Poulsen et al., 1996; 
Wani et al., 1996) 
 
Processed IgA by protease may promote 
pneumococcal adherence to host cells 
(Weiser et al., 2003) 
 
Cell wall; LPXTG 
anchored 
Pili Adheres to respiratory and epithelial cells 
and the extracellular matrix (ECM) 
(Barocchi et al., 2006; LeMieux et al., 
2006; Nelson et al., 2007; Hilleringmann et 
al., 2008; Izore et al., 2010) 
Second pilus type has been identified and 
shown to be involved in host cell adhesion 
(Bagnoli et al., 2008) 






Promotes pneumococcal persistence in the 
lung and antibodies against this antigen 
protects against challenge (Rose et al., 
2008) 
 
Bacterial adhesin which interacts with 
Keratin-10 on lung epithelial cells 
(Shivshankar et al., 2009) 
 





Induces inflammation in the lower 
respiratory tract by stimulating TNF-α 
production (Blue et al., 2003) 
 




Degrades hyaluronic acid present in the 
host connective tissues and associated 
ECM, possibly promoting pneumococcal 
dissemination (Paton et al., 1993) 
 
Contributes to pneumococcal meningitis 
(Kostyukova et al., 1995) 
 





Cleaves sialic acid from mucin, 
glycoprotein and gangliosides (Scanlon et 
al., 1989), possibly to reveal host receptors 
for pneumococcal adherence  
 
Removes sialic acid from the cell walls of 
competitor colonising species (Shakhnovich 
et al., 2002) 
 
Role in pneumococcal colonisation and 
infection of the respiratory tract, and 
bacteraemia (Manco et al., 2006) 
 






Reduce complement binding to pneumcocci 
by recruitment of human factor H 







Essential for pneumococcal colonisation, 
bacteraemia and pneumonia (Berry & 
Paton, 1996; Johnson et al., 2002) 
 
Substrate (Manganese) binding lipoprotein 








Contributes to pneumococcal virulence 
(Overweg et al., 2000) and colonisation 
(Cron et al., 2009) 
Lipoprotein, 
surface exposed 
PavA Binds fibronectin and is essential for 






Cytolytic toxin which binds to cholesterol-
containing membranes, such as respiratory 
epithelium (Feldman et al., 1990) 
 
Required for exponential pneumococcal 
growth in the blood to cause acute sepsis 
(Benton et al., 1995) 
 
Mutant is unable to cause pneumococcal 






Pneumolysin (Ply) is a member of a family of toxins called cholesterol dependent 
cytolysins (CDCs), which are present in over 20 species of Gram positive bacteria 
including Clostridia and Bacillus.  CDCs are pore-forming toxins which bind to 
cholesterol containing membranes (Johnson et al., 1980).  The CDCs are highly 
conserved and play important roles in the pathogenesis of the organisms that 
produce them. 
The molecular structure of two cytolysins has been resolved, perfringolysin 
(PFO) from Clostridium perfringens and intermedilysin (Ily) from Streptococcus 
intermedius (Polekhina et al., 2004).  Many of the structure and function studies 
of Ply are based on the structure model of PFO, Figure 1-8.  CDCs consist of four 
domains, labelled 1-4, each playing a role in the function of the molecule. 
 
Figure 1-8 Structure of a typical cholesterol dependent cytolysin (CDC) 
CDC comprises of four domains in its tertiary structure, figure adapted from (Rossjohn et 
al., 1997) co-ordinates available at Protein Data Bank ref 1M3I 
(http://www.pdb.org/pdb/explore/explore.do?structureId=1M3I). 
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Domain 4 has been shown to be the domain responsible for cholesterol binding, 
due to the presence of a conserved 11 amino acid (ECTGLAWEWWR) region 
within the domain (Jacobs et al., 1999).  The exception to the family of CDCs is 
intermedilysin as it has specific toxicity to human cells (Nagamune et al., 1996) 
due to its requirement for a receptor, CD59, to bind to host membranes 
(Giddings et al., 2004; Soltani et al., 2007).  Domain 4 can bind to the 
membrane prior to oligomerisation (Nakamura et al., 1995) and recombinant 
domain 4 protein competes for binding with full-length toxin (Baba et al., 2001).  
There are two proposed models for pore formation, whereby the individual 
monomers insert into the membrane then oligomerise to form pores or they bind 
first to the membrane, oligomerise to form a pre-pore, then insert into the 
phospholipid bilayer. 
 
Figure 1-9 Two models of pore formation by CDCs; adapted from (Gilbert, 2002) 
A  Model of toxin insertion followed by oligomerisation leading to gradual pore formation 
(Palmer et al., 1998)  B Model of toxin monomer binding, oligomerisation to form a prepore 
followed by membrane insertion to create the pore (Shepard et al., 2000) 
The insertion followed by oligomerisation model was first proposed through 
studies with streptolysin O, where electron-microscopy of treated red blood cells 
shown arc-like structures on the membrane surface alongside complete pores 
(Palmer et al., 1998).  The formation of these arc structures was investigated 
further using SLO mutants that inhibit oligomerisation and it was found the 
membrane was permeable to small molecules in the absence of complete pores 
(Palmer et al., 1998).  The pre-pore theory was proposed by Tweten and 
coworkers through their studies with perfringolysin (Shepard et al., 2000).  They 
have shown that toxin insertion is coupled with oligomerisation therefore a 
prepore is formed (Hotze et al., 2001), and pore formation is controlled by 
monomer-monomer interactions (Hotze et al., 2002).  Studies with Ply show that 
the monomers can oligomerise in high concentrations without the need for 
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cholesterol or membranes (Gilbert et al., 1998).  Ply pore formation fits with the 
pre-pore theory as the oligomeric structure first assembles on the membrane 
prior to membrane insertion, shown through cryo-EM (Gilbert et al., 1999; Tilley 
et al., 2005).  By rigid-body fitting the structure of PFO onto a cryo-EM map of 
Ply pores, the conformational changes from pre-pore to pore were determined 
(Tilley et al., 2005).  Domain 3 is responsible for oligomerisation once the 
prepore assembles, Domain 2 folds in half, dissociating away from Domain 3.  
Domain 3 can then undergo further conformational change to insert 2 
amphipathic β-sheets into the membrane (Tilley et al., 2005).  A tryptophan in 
Domain 4 (W433) has been shown to be essential for lysis as it penetrates the 
upper leaflet of the phospholipid bilayer after Domain 3 has underwent its 
conformational change (Mitchell et al., 1992; Hill et al., 1994). 
The Ply gene was first sequenced in 1987 from a serotype 2 strain of 
pneumococcus, D39, and termed allele 1 (Walker et al., 1987).  Due to its ability 
to form pores on cholesterol containing membranes, Ply is toxic to most 
eukaryotic cell types, including epithelial and endothelial cells present in the 
respiratory tract and brain (Rubins et al., 1992; Rubins et al., 1993; Zysk et al., 
2001).  The pore forming activity can also induce apoptosis of neutrophils (Zysk 
et al., 2000), brain cells (Braun et al., 2002; Braun et al., 2007), macrophages 
(Srivastava et al., 2005; Garcia-Suarez Mdel et al., 2007), cochlear cells (Beurg 
et al., 2005) and dendritic cells (Littmann et al., 2009).  Ply can also inhibit the 
ciliary beat of respiratory epithelium and this inhibition was relieved by addition 
of cholesterol or anti-Ply antibodies (Steinfort et al., 1989; Feldman et al., 
1990).  Ply was originally thought to be produced in a lytic form in all disease 
causing strains, until the identification of reduced haemolytic versions in 
serotype 7F and 8 strains (Lock et al., 1996) and non-lytic form in serotype 1, 
ST306 (Kirkham et al., 2006) which is a prevalent cause of invasive 
pneumococcal disease in Scotland.  This ST306 Ply was able to bind the 
membrane but cannot form pores, only arc structures could be seen with 
transmission EM, and analysis of the sequence identified 6 amino acid mutations 
(Tyr150His, Thr172Iso, Lys224Arg, Ala265Ser, FVal270, and FLys271) compared 
to allele 1 (Kirkham et al., 2006).  The mutation of tyrosine to histidine at 
position 150 had not been previously described with the other 5 mutations found 
in the previous study (Lock et al., 1996).  Therefore the abrogation of 
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haemolytic activity seen in ST306 Ply allele was attributed to the combinational 
effect of T172I and Y150H mutations (Kirkham et al., 2006).  It was 
demonstrated before identification of this Ply allele that the function of Ply 
extends beyond that of cell lysis; it can interact with the classical complement 
pathway (Paton et al., 1984).   
Ply is able to interact with C1q both directly due to its homology to C-reactive 
protein (CRP) and indirectly through interaction with the Fc region of IgG 
(Mitchell et al., 1991).  This activation of complement inhibits C3 deposition on 
S. pneumoniae thereby reducing opsonophagocytosis and, using Ply deficient 
strains, it is specifically dependent upon Ply in vitro (Yuste et al., 2005) and in 
vivo (Quin et al., 2007a).  Ply can also induce cytokine production which has 
been shown to be both pore-formation dependent and independent (Baba et al., 
2002).  The relationship between cytolytic activity and complement activation 
has been shown to act independently of one another during experimental 
infection models (Benton et al., 1997a). 
 
1.3.2.1 Role of Ply in pneumococcal colonisation 
The role of Ply in colonisation is not well defined due to conflicting reports.  
Studies comparing a Ply deficient strain with its isogenic parent indicate that Ply 
contributes to pneumococcal adherence to respiratory epithelium in vitro 
however, in the murine model of colonisation the mutant is present in 
comparable or greater numbers than wild-type (Rayner et al., 1995; Rubins et 
al., 1998).  The role of Ply in colonisation is considered minor in comparison to 
other virulence factors, such as PspC and PspA (Ogunniyi et al., 2007a; Ogunniyi 
et al., 2007b).  The effects of Ply on the host innate immune response can 
contribute to both pneumococcal persistence and bacterial clearance, thus 
implying that a fine balance must be mediated.  The evidence that supports this 
is that Ply can induce the apoptosis of many inflammatory cell types such as 
macrophages, neutrophils and monocytes.  Ply induces nitric oxide production in 
macrophages, leading to macrophage apoptosis (Braun et al., 1999; Marriott et 
al., 2004).  However, Ply can also induce inflammatory response thereby 
increasing pneumococcal clearance (van Rossum et al., 2005).  Host-mediated 
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apoptosis of alveolar macrophages promotes bacterial clearance in a murine 
model of resolving pneumococcal lung infection (Dockrell et al., 2003).  
Pneumococcal clearance by the host has been shown to be dependent upon the 
direct interaction of Ply with Toll-like Receptor (TLR) 4, as TLR4 deficient mice 
are more susceptible to colonisation by Ply producing pneumococci (Malley et 
al., 2003).  The interaction of Ply with TLR4 also induces host-mediated 
macrophage apoptosis in the upper respiratory tract, promoting pneumococcal 
clearance in a murine model (Srivastava et al., 2005).  The role of Ply in 
pneumococcal persistence in the nasopharynx is seen in the colonisation model 
described by Richards and authors, where a Ply deficient mutant is cleared 
within 7-14 days but its serotype 2 isogenic parent can still be detected 28 days 
post-infection (Richards et al., 2010). 
 
1.3.2.2 Role of Ply in pneumococcal disease 
The contribution of Ply to pneumococcal pathogenesis has been tested in many 
animal models of infection, including bacteraemia, pneumonia, meningitis and 
otitis media.  In the murine model of pneumonia, Ply deficient mutants are 
attenuated compared to their isogenic parent strains (Berry et al., 1989b; Berry 
& Paton, 2000; Ogunniyi et al., 2007a; Ogunniyi et al., 2007b).  Production of 
Ply enables the pneumococci to replicate in the alveoli and penetrate the 
interstitium of the lung (Rubins et al., 1995).  The lytic and complement 
activating functions of Ply play two distinct roles in the progression of 
pneumonia (Rubins et al., 1996).  The cytolytic function contributes towards 
neutrophil recruitment and the complement activating function accumulates T 
cells (Jounblat et al., 2003).  Sublytic concentrations of Ply are present in vivo 
and contributes towards pathology in the lung by inducing apoptosis of host cells 
and localised inflammation (Garcia-Suarez Mdel et al., 2007).  The role and 
importance of Ply in pneumococcal pneumonia is further supported by the 
observations where immunisation of mice with Ply protein or α-Ply antibodies 
offers protection from subsequent pneumococcal infection (Musher et al., 2001; 
Briles et al., 2003; Garcia-Suarez Mdel et al., 2004).   
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Bacteraemia commonly arises from the progression of pneumococcal infection in 
the lungs to the blood and Ply production has been shown to be an important 
influence in this transition (Rubins et al., 1995; Jounblat et al., 2003).   Ply 
production is advantageous for exponential pneumococcal replication in the 
blood, and growth of a type 2 strain with its Ply mutant shows that the 
production of Ply from the parent can contribute to the growth of the mutant in 
the blood in vivo (Benton et al., 1995).  Further studies demonstrated that the 
contribution of Ply to pneumococcal replication in the blood can depend upon 
the genetic background of the mouse used in the model of infection (Benton et 
al., 1997a).  The same study also showed that the complement activating and 
cytolytic properties of Ply do not contribute individual roles to virulence in the 
blood (Benton et al., 1997a).  This may be due to the route of challenge as 
Jounblat and authors report that these two functions can influence the 
progression of bacteraemia when mice were challenged via an intranasal route 
of infection (Jounblat et al., 2003).  Pneumococci expressing Ply with its 
complement activating activity inactivated were detected in the blood 6 hours 
after infection, pneumococci expressing wild-type toxin were detected after 12 
hours and pneumococci expressing Ply with its cytolytic activity inactivated were 
not detected until 24 hour post-infection (Jounblat et al., 2003).  In a rat model 
of infection, Ply contributes to survival in the blood by inhibiting clearance and 
reducing the opsonising activity of serum (Alcantara et al., 1999; Alcantara et 
al., 2001). 
Ply has been reported to be an important contributing factor to the progression 
of pneumococcal meningitis (Kostyukova et al., 1995).  Ply can destroy brain 
ependymal cells and reduce ciliary beat, shown by using an ex vivo model and 
comparing recombinantly expressed Ply with a cytolytic inactivated mutant 
(Mohammed et al., 1999) and D39 pneumococci with its Ply deficient mutant 
PLN-A (Hirst et al., 2000).  The production of hydrogen peroxide by pneumococci 
works in concert with Ply to induce pathology and apoptosis of brain cells (Hirst 
et al., 2000; Braun et al., 2002; Braun et al., 2007).  Ply causes damage to 
cerebral endothelial cells in an in vitro blood brain barrier (BBB) model, and the 
authors postulate that this Ply-mediated damage may enable pneumococci to 
traverse the BBB to cause meningitis (Zysk et al., 2001).  This is supported by 
results from animal models of meningitis where pneumococci were injected 
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directly into the brain.  Murine models of meningitis infection demonstrate that 
pneumococcal strains deficient in Ply, but not neuraminidases or hyaluronidase, 
are attenuated compared to the parent type 2 strain (Wellmer et al., 2002).  
This importance of Ply in the pathogenesis of meningitis is supported by 
additional corroborating reports using rabbit (Braun et al., 2002) and rat (Hirst 
et al., 2008) models of pneumococcal meningitis.  Sub-lytic concentrations of Ply 
have important implications in the pathology associated with pneumococcal 
meningitis.  Ply can activate Rho and Rac GTPases resulting in the formation of 
actin stress fibres, filopodia and lamellipodia (Iliev et al., 2007).  The authors 
show that this activation occurs prior to macropore formation, and postulate 
membrane depolarisation induced by toxin binding, results in lamellipodia 
formation (Iliev et al., 2007).  Ply can also induce microtubule stabilisation and 
bundling in an in vivo rabbit model of pneumococcal meningitis and in vitro with 
neuronal and non-neuronal cell lines (Iliev et al., 2009).  The authors 
demonstrated that this action depended upon cholesterol binding but not 
macropore forming abilities of the toxin by using sub-lytic concentrations, 
0.1µg/ml, which are found in pneumococcal meningitis patients (Iliev et al., 
2009).  Further studies showed that the pore-forming ability of Ply does play a 
role in affecting the host cytoskeleton in vitro by comparing wild-type toxin to 
two pore-forming mutants (W433F and FA146R147), which can still bind to 
cholesterol (Förtsch et al., 2011).   
1.3.2.3 Ply release and localisation 
Ply exerts its function outwith the pneumococcal cell, however Ply differs from 
the other CDCs in that it does not possess a consensus N-terminal secretion 
signal (Walker et al., 1987).  This correlated with earlier reports that Ply was 
retained in the pneumococcal cytoplasm (Johnson, 1977) and resulted in the 
observation that Ply was not detected until the onset of cell lysis mediated by 
autolysin A (LytA) in stationary phase cultures in vitro.     
Autolysin (LytA) is a choline-binding protein with N-acetylmuramyl-L-alanine 
amidase activity.  This enzyme degrades the peptidoglycan of the bacterial cell 
wall (Howard & Gooder, 1974).  The enzyme naturally degrades the cell wall 
during cell growth, for cell wall turn-over and cell-cell separation (Jedrzejas, 
2001).  This action releases cell wall components into the external milieu which 
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can trigger an immune response.  When a cell enters stationary phase of growth, 
or is exposed to antibiotics and/or detergents, it can lead to complete cell lysis, 
and cell death, by autolysin.   
LytA mutants have reduced virulence in murine models of pneumonia and 
bacteraemia, and rabbit model of meningitis, compared to isogenic parent 
strains of pneumococci (Berry et al., 1989a; Berry et al., 1992; Canvin et al., 
1995; Orihuela et al., 2004a; Hirst et al., 2008).  Pre-immunisation of mice with 
autolysin antigen protects mice from subsequent pneumococcal challenge, to a 
level comparable with Ply, but no additive effect is seen when both antigens 
were administered (Lock et al., 1992).  This indicates that the main role of LytA 
in pneumococcal virulence is to induce cell lysis for the release of Ply, and other 
immunogenic factors, into the external milieu.  The contribution of Ply to the 
virulence of pneumococci with different capsular types was investigated, and 
this study discovered that in vitro haemolytic titres of Ply are first detected 
intracellularly at late exponential phase in the majority of strains.  An 
extracellular pool of Ply could be detected before stationary phase in a select 
number of strains, including serotype 3 strain WU2 (Benton et al., 1997b).  The 
release of Ply in this strain was investigated further and, using defined mutants 
of LytA and in vitro growth in the presence of choline, it was shown that this 
release was autolysin-independent (Balachandran et al., 2001).  The authors 
hypothesise that Ply is not secreted in vitro by other strains of S. pneumoniae, 
such as D39, due to the lack an unknown stimulus in the growth conditions 
tested.  This report of autolysin-independent transport of Ply by the 
pneumococcus was further supported by results from Andrew Camilli’s group.  
The authors report that Ply can localise to the pneumococcal cell wall and that 
this phenomenon was not dependent upon capsular serotype or LytA (Price & 
Camilli, 2009).  The results from these three studies suggest that Ply can 
transverse the cytoplasmic membrane in all pneumococcal strains, by an as yet 
uncharacterised mechanism, but secretion of Ply from the cell wall may only 
occur in certain strains or in certain conditions.  These reports raise the 
questions: how is Ply secreted?; how it is sequestered to and released from the 
cell wall?; what controls Ply secretion, i.e. are there particular genes involved?; 
and what implications does Ply secretion have upon pneumococcal colonisation 
and pathogenesis?. 
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1.4 Aims of the project 
The aims of this project were to assess the regulation, expression and function 
of two non-LEE encoded Type III secretion system effectors of E. coli O157:H7, 
NleH1 and NleH2.  Fluorescent proteins are commonly used as reporters of gene 
expression and protein localisation, and were employed in the characterisation 
of NleH.  Conversely, fluorescent proteins have not been utilised extensively in 
pneumococcal research.  To address this, fluorescent proteins with the codon 
usage optimised for expression in S. pneumoniae were developed as reagents for 
future research.  These reagents were characterised in the pneumococcus, using 
parallel techniques from NleH experiments, and used to assess the localisation of 
pneumolysin.  Determining the localisation and distribution of Ply on the 
pneumococcal cell can offer further insight into how this toxin contributes to 
pneumococcal pathogenesis.
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2 Materials and Methods 
2.1 Bacterial strains, growth conditions & storage 
Strains used in this study are listed in Table 1.  E. coli were grown from a single 
colony in Luria-Bertani (LB) broth, M9 minimal media (M9), Minimal Essential 
Media with HEPES modification (MEM; Sigma M7278), or Dulbelcco’s Minimal 
Essential Media (DMEM; Sigma D5671).  Glucose was added to MEM to give a final 
concentration of 0.2%.  Antibiotics were included where necessary at the 
following concentrations: 50 µg/ml kanamycin (Kan), 12.5 µg/ml 
chloramphenicol (Chl), 100 µg/ml ampicillin (Amp), 1 mg/ml erythromycin (Ery), 
15 µg/ml gentamycin (Gent). 
S. pneumoniae were initially grown on BAB (Blood Agar Base No.2; Oxoid, UK) 
supplemented with 5% horse blood (E&O Laboratories, Bonnybridge, UK).  BHI 
(Blood-Heart Infusion broth; Oxoid, UK) was inoculated with a single colony and 
grown statically at 37°C until mid-log phase (OD600nm = 0.6) was reached.  Strain 
purity and optochin sensitivity was tested by streaking onto BAB with an 
optochin disc (Mast, UK).  Antibiotics were included where necessary at the 
following concentrations: 12.5 µg/ml Chl; 1 µg/ml Ery.  
For frozen bacterial stocks, sterile glycerol was added to an overnight LB culture 
of E. coli or mid-log (OD600nm = ~0.6) BHI culture of S. pneumoniae to 15% (v/v) 
and stored at -80°C in 1ml aliquots.   
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Table 2-1  Strains used in study 
Strain Description 
E. coli  
TUV 93-0 Shiga toxin negative (stx-) derivative (Campellone et 
al., 2004) of EHEC O157:H7 strain EDL933 [sequenced 
strain (Perna et al., 2001)]  
ZAP193 EHEC O157:H7 strain NCTC 12900 stx- 
ZAP193Fler Clean deletion of ler gene.  Received from Sean 
McAteer, ZAP Laboratories, University of Edinburgh. 
ZAP193FgrlA-
Tn-Kan 
Transposon insertion in grlA gene; received from 
Sean McAteer, ZAP Laboratories, University of 
Edinburgh. 




BW25113 Keio mutant of rpoS (Baba et al., 2006). 
Received from Dr Gail Ferguson. 
85-170 Spontaneous Stx1_ and Stx2_ EHEC O157:H7 strain 




Received from Prof Gad Frankel. Mutants generated 
by one-step PCR λ-Red-mediated mutagenesis KanR 
AmpR 
85-170FnleH1 Generated by allelic exchange with pKO3bH1 by AH 
MC1000 araD139 Δ(araABC-leu)7679 galU galK Δ(lac)X74 rpsL 
thi (Casadaban & Cohen, 1980). Received from Dr 
Vanessa Sperandio. 
VS184 MC1000FqseC (Sperandio et al., 2002b). Received 
from Dr Vanessa Sperandio. 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZFM15 Tn10 (Tetr)]  
(www.stratagene.com) 
S. pneumoniae  
D39 Avery’s type 2 strain NCTC 7466 (Avery et al., 1944) 
sequenced strain (Lanie et al., 2007) 
TIGR4NO1 Serotype 4 sequenced strain (Aaberge et al., 1995; 
Tettelin et al., 2001) 
R6 Unencapsulated derivative of D39 (Hoskins et al., 
2001) 
A45 Serotype 3 strain isolated from a horse (Whatmore et 
al., 1999) 
D39FPlySTOP Created by Dr Calum Johnston, Janus mutagenesis of 
D39 to introduce early stop codon in Ply sequence. 




Generated by allelic exchange with pUCLytA27R::Chl 
into TIGR4 by AH 
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2.2 Preparation of genomic DNA 
2.2.1 E. coli 
Cells were pelleted from 1ml overnight LB culture and genomic DNA (gDNA) was 
extracted using ChargeSwitchTM gDNA Mini Bacteria kit (Invitrogen; Scotland), as 
per manufacturer’s protocol.  DNA was resuspended in 200 µl molecular grade 
water (dH2O) (Sigma, UK) and stored at 4°C until required. 
2.2.2 S. pneumoniae 
Genomic DNA (gDNA) was extracted from S. pneumoniae cultures using a method 
previously described (Blue et al., 2003), with modifications.  Typically, strains 
were grown overnight in 20ml BHI at 37°C, and a BAB plate aseptically streaked 
to test for purity, and an optochin disc added to confirm identity.  The culture 
was centrifuged in a 4K15 centrifuge (Sigma, UK) at 4,000xg for 15 minutes at 
4°C, and the supernatant carefully removed.  The pellet was resuspended in 1ml 
lysis buffer (10mM Tris, 100mM EDTA and 0.5% SDS) and subsequently incubated 
at 37°C for 1 hour.  Proteinase K (Invitrogen, Scotland) was then added to a final 
concentration of 100 µg/ml and incubated at 50°C for 3 hours. Next, RNAse 
(Invitrogen, Scotland) was added to the mixture to a final concentration of 20 
µg/ml and incubated at 37°C for 30 minutes before adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma, UK).  The tubes were then 
inverted sharply several times to mix the samples, and centrifuged at 12,000xg 
for 3 min. The upper phase of the solution was then removed and placed into a 
fresh 1.5ml tube, before addition of 0.2 volumes of 10M ammonium acetate 
(Sigma-Aldrich, UK) and ~700 µl absolute ethanol (Fisher Scientific, UK, 
analytical reagent grade). The tubes were then gently inverted, and centrifuged 
at 12,000xg for 30 min in a benchtop centrifuge (Centrifuge 5417C, Eppendorf, 
UK) to pellet the DNA, before careful removal of the supernatant. The pellets 
were then air dried for 30 minutes to remove any remaining ethanol, before 
being resuspended in ~200 µl molecular grade dH2O (Sigma, UK). The samples 
were then stored at 4°C until required. 
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2.3 Molecular cloning 
2.3.1 Plasmid DNA preparation 
Plasmid DNA was prepared from 3ml overnight E. coli LB culture using Qiaprep 
Spin Miniprep Kit (QIAGEN) as per manufacturer’s instructions, except DNA was 
eluted in molecular grade water (dH2O) for downstream applications.    
2.3.2 PCR amplification 
Polymerase chain reaction (PCR) was used for two purposes: to amplify DNA for 
molecular cloning or for bacterial colony screening.  For molecular cloning and 
sequencing, a high fidelity DNA polymerase, Phusion DNA polymerase 
(Finnzymes/NEB, UK), was used.  For bacterial colony screening, GoTaq DNA 
polymerase (Promega, UK) with Green buffer was used.  Both DNA polymerases 
were used as outlined by the manufacturer guidelines; a typical reaction and 
cycle conditions are outlined in Table 2-2. 
Table 2-2  Typical PCR reaction and cycle conditions 
Colony PCR with GoTaq polymerase PCR for cloning with Phusion 
polymerase 
Reaction Mix: 25 µl 
5 µl GoTaq Green Buffer (x5) 
3 µl 2.5mM dNTPs (Invitrogen, UK) 
0.2 µl Forward Primer (10 µM) 
0.2 µl Reverse Primer (10 µM) 
0.2 µl GoTaq polymerase (10 U/µl) 
16.4 µl dH2O 
 
Reaction Mix: 50 µl 
10 µl Phusion Buffer (x5) 
4 µl 2.5mM dNTPs (Invitrogen, UK) 
2.5 µl Forward Primer (10 µM) 
2.5 µl Reverse Primer (10 µM) 
0.5 µl DNA template (gDNA/plasmid) 
0.5 µl Phusion polymerase (10 U/µl) 
30 µl dH2O 
Cycle conditions: 
1 x 95°C 5 minutes; 
30 x 94°C 50 seconds, 50°C 50 seconds, 
72°C 1 minute/kb product 
1 x 72°C 5 minutes 
Hold at 4°C 
Cycle conditions: 
1 x 98°C 1 minute; 
30 x 98°C 10 seconds, (lowest melting 
temp of primers + 3)°C 20 seconds, 
72°C 20 seconds/kb product 
1 x 72°C 5 minutes 
Hold at 4°C 
 
PCR products were diluted 1:3 in DNA loading buffer before loading, or loaded 
directly if GoTaq Green buffer used, into a 0.8% agarose (Sigma, UK) gel with 
0.05% SYBR safe DNA stain (Invitrogen, Scotland) alongside 1Kb+ DNA ladder 
 68 
(Invitrogen).  The gel was run at 100V for 20 minutes in TAE buffer and viewed 
under ultraviolet light in an UVIpro Gold Gel-doc system (UVItec, UK) to confirm 
successful PCR. 
2.3.3 Restriction enzyme digestion 
Restriction enzymes were supplied by New England Biolabs (NEB, UK) or 
Promega.  Typically 1 µg of plasmid DNA, or a 30 µl PCR product after being 
cleaned by Qiaquick PCR purification kit (QIAGEN, UK) and eluted in dH2O, was 
mixed with 1 µl chosen restriction enzyme, recommended buffers (1x) and 
bovine serum albumin (BSA; 1 mg/ml) in a total volume of 50 µl.  After 
incubation at 37°C for 3 hours, the DNA of interest was either cleaned by 
QIAquick PCR purification kit (QIAGEN, UK) or extracted from an agarose gel 
slice using QIAquick Gel Extraction kit (QIAGEN, UK).  Both kits were used as per 
manufacturer’s instructions, with DNA eluted in dH2O. 
2.3.4 Ligation reaction 
DNA is mixed in an insert:vector molecular ratio of 3:1 in a total of 8 µl, then 1 
µl T4 DNA ligase buffer and 1 µl T4 DNA ligase (NEB, UK) is added.  The reaction 
is incubated either at room temperature for 3 hours or 16°C overnight.  5 µl of 
this mixture is then used for transformation into XL1-Blue E. coli. 
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2.4 Transformation of E. coli 
For molecular cloning, XL1-Blue chemically competent E. coli was used.  Once a 
100 µl frozen aliquot of competent bacteria was thawed on ice, DNA was added 
and incubated on ice for a further 20 minutes.  The sample was heat-shocked at 
42°C for 45 seconds followed immediately by incubation on ice for 2 minutes.  
700 µl of LB broth was added to the heat-shocked sample and incubated at 37°C, 
with shaking at 180 rpm, for 60 minutes.  150 µl culture was plated onto LB 
plates with appropriate antibiotics added and incubated overnight. 
E. coli O157:H7 strains were made electrocompetent by repeated suspension of 
cells in ice-cold 10% glycerol; ½ volumes, ¼ volumes and finally 1/250 volumes.  
Typically ~500ng DNA was mixed with 40 µl competent cells in an 
electroporation cuvette (Bio-Rad) and incubated for 10 minutes on ice prior to 
electroporation using a Bio-Rad GenePulserTM.  Immediately after 
electroporation, 700 µl LB was added and the cells incubated for 1 hour at 37°C, 
180rpm.  150 µl culture was plated onto LB plates with appropriate antibiotics 
added and incubated overnight. 
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2.5 Construction & analysis of NleH translational fusions 
2.5.1 GFP/RFP fusions 
Promoter regions of NleH1 and NleH2, and an indicated number of amino acids 
of coding sequence, were PCR amplified from TUV-930 gDNA using primers 
described in Table 2-3, and cloned into pAJR70 (Roe et al., 2003) for 
translational fusions to GFP.  Figure 2-1 shows the areas of the genome 
amplified to make the constructs pAHE8 and pAHE18-22.  The upstream primers 
had a BamHI restriction enzyme site, the downstream CDS primers a KpnI site, 
introduced into the sequence to allow sub-cloning into the reporter vectors by 
ligation.  All constructs were confirmed with restriction digest analysis prior to 
sequencing at Dundee Sequencing Service (Dundee University, UK) using primers 
PrAJR70F and PrGFPR. 
 
Figure 2-1 Representation of the promoters and coding sequence cloned upstream of GFP 
Arrangement of genes from Vector NTi software (Invitrogen), arrows indicate primers 
labelled with reference to their name, in Table 2-3, and boxes show primer pairs used for 
fragment. 
 71 
Table 2-3  Primers used for NleH-FP translational fusions 
Primer Sequence (5’  3’) 




NleH1 5 120bp CggatccGGAAGGATGAATTAGTTGCC 




NleH2 5 113bp CGggatccGAAGTAACCCGATAGCTTC 




2.5.2 ILOV fusions 
The coding sequences of NleH1 and NleH2 were PCR amplified from TUV93-0 
gDNA using primers detailed in Table 2-4.  The 5’ primer includes an NdeI site at 
the ATG start codon of the ORF and the 3’ primer includes a KpnI site before the 
natural stop codon of NleH.  This PCR product was cloned into pJ284:iLOV to 
create a translational fusion to iLOV, which is under the control of an IPTG 
inducible (ptac) promoter. 
Table 2-4 Primers used for making NleH-iLOV translational fusions 
Primer Sequence (5’  3’) 
INTRODUCED RESTRICTION ENZYME SITES ARE IN LOWER CASE 
NleH1 LOV 5 NdeI GGCcatatgGTATGTTATCGCCATATTC 
NleH1 LOV 3 KpnI CGCggtaccAATTTTACTTAATACCACAC 
NleH2 LOV 5 NdeI  GTTGAAAcatatgTTATCGCCCTC 




2.5.3 Analysis of bacterial fluorescence  
2.5.3.1 Population based assay 
Constructs pAHE8 and 18-22 were assessed by growing ZAP193, and their 
mutants where indicated, transformants overnight in LB+Chl media then the 
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next morning diluted to a final OD600nm of 0.08 into 20ml DMEM+Chl or MEM+Chl 
in 100ml Erlenmeyer flasks.  Flasks were incubated at 180rpm, 37°C.  At hourly 
intervals, 1ml of culture was removed from the flask, an OD600nm measurement 
taken using spectrophotometer, and 200 µl aliquots were analysed in triplicate 
in a clear 96 flat-well microtitre plate (Costar, UK) using FLUOstar plate reader 
(BMG Labtech, UK).  For any combination of strain and medium, cultures 
containing promoterless gfp (pAJR70) acted as a control for background 
fluorescence.  Background fluorescence was plotted against OD600nm using 
Microsoft Excel software and a line of best fit obtained.  Using this method, data 
were corrected for background fluorescence, and the corrected data was plotted 
using GraphPad Prism 5 (GraphPad Software, USA).  
 
2.5.3.2 Single cell analysis 
Expression of gfp in individual bacteria was analysed by fluorescence 
microscopy.  Strains were grown in MEM and at OD600nm 0.8, a 100 µl aliquot was 
removed and diluted 1:1 in 4% paraformaldehyde (PFA; Sigma, UK).  20 µl was 
dried onto a microscope slide and EspA filaments stained as described previously 
(Roe et al., 2003).  Briefly, 20 µl of α-EspA antibody diluted to 1:100 in 
Phosphate Buffered Saline (PBS) + 0.1% BSA was incubated on each spot 
overnight at 4°C in a humidity chamber.  The primary antibody was washed off 
with three 5 minute washes in PBS + 0.1% BSA; 20 µl α-rabbit AlexaFluor-555 
conjugated secondary antibody (1:1000; Invitrogen, UK) was then incubated on 
each spot for 45 minutes at room temperature in the dark.  After four 5 minute 
washes with PBS + 0.1% BSA, the spots were dried before a coverslip was 
mounted with fluorescence mounting media (Dako, USA). 
The slides were examined on a Zeiss M1 Axioskopp microscope, using the 
appropriate filter sets and x100 objective, a Z-stack of 16 images was captured 
at a spacing of 0.15 µm using Volocity software (PerkinElmer, UK). These images 
were used to create a composite image that reduces the spatial effects of 
bacteria in different focal planes.  The average gfp units per voxel (cubic pixel) 
was quantified, for at least 100 bacteria with a minimum volume of 4 µm3, using 
Volocity Quantification software.  These values were exported and plotted in 
GraphPad Prism 5 (GraphPad Software, USA). 
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2.5.3.3 Upon contact with host cells 
Embryonic bovine cells (German Collection of Microorganisms and Cell Cultures, 
no. ACC192) were prepared and cultured as described previously (Roe et al., 
2004).  Typically, cells were cultured in MEM (M2279; Sigma, UK) supplemented 
with 1mM L-Glutamine, 10% Foetal Calf Serum (FCS; Invitrogen), 100 U/ml 
penicillin and 100 µg/ml streptomycin.  Cells were seeded at a density of 1x105 
into an 8-chamber microscope slide (Nunc/ThermoScientific, UK) and incubated 
at 37°C, 5% CO2 for at least 24 hours before bacterial co-culture. 
ZAP193 transformed with the appropriate GFP reporter plasmids were cultured 
in MEM-HEPES to OD600nm = 0.8 at 37 °C, added to the multichamber slide at a 
multiplicity of infection (MOI) of 100:1, and centrifuged onto the EBL cells 
(1000xg) for 5 min, to begin the infection. Time points analysed were 0, 5, 30 
and 180 min after infection.  ZAP193 strain transformed with the appropriate 
iLOV reporter plasmids were cultured in MEM-HEPES + IPTG to OD600nm = 0.6 at 
37°C, before addition to the EBL cells.  The cells were stained at intervals by 
removal of the culture and addition of CellMaskTM Deep Red plasma membrane 
stain (5 µg/ml; Invitrogen), incubated for 5 minutes at 37°C/5% CO2, washed in 
PBS three times, before addition of 4% PFA to fix the cells.  After 20 minutes, 
the slide was washed with PBS two times and a coverslip applied with 
fluorescence mounting media (Dako, USA). 
Images were acquired on a Zeiss M1 Axioskopp at x100 magnification; z-stacks 
are acquired using Volocity software (PerkinElmer, UK) with 0.15 µm spacing 
between images for 4 µm.  Z-stack images were used to create a composite 
image where background and refractive light fluorescence is reduced.  Volocity 
software allows 3D restoration and the ability to manipulate the composite 




2.6 Quantitative PCR (Q-PCR) 
Triplicate ZAP193, ZAP193FgrlA and ZAP193Fler were cultured in MEM-HEPES 
media to an OD600nm = 1.2.  Bacterial pellets were suspended in RNAProtect 
Bacteria Reagent (QIAGEN, UK).  Total RNA was extracted using RNeasy Mini kit 
(QIAGEN, UK) and cDNA synthesis was carried out using a QuantiTect™ Reverse 
Transcription kit (QIAGEN, UK).  Duplicate Q-PCRs were carried out using a 
Quantifast™ SYBR® green PCR kit (QIAGEN, UK) and Stratagene MX3000 and 
primers listed in Table 2-5.  All the experiments were performed according to 
manufacturer’s instructions.  The RNA extraction, cDNA synthesis and Q-PCR 
were carried out by Dr Dai Wang. 
Table 2-5 Q-PCR primers 
Primer Sequence 5’ 3’ 
H1 RT F   CCGAGTGTGGACTATAACAGGTTG 
H1 RT R   TCGTTGTCACCTCTTCATTGC  
H2 RT F     GCCGAGGGTTAGCAACAATA 




2.7 Construction of NleH knockouts 
There are two methods developed for gene deletions and gene replacements in 
pathogenic E. coli; Lambda Red-mediated recombination and allelic exchange 
with a suicide vector. 
2.7.1 Rationale of Lambda Red-mediated recombination 
This technique uses the Red recombinase enzyme from bacteriophage Lambda 
(λ) to recombine linear fragments of DNA into the bacterial chromosome.  This 
enzyme and Gam, an α-RecBCD exonuclease, is provided to the E. coli strain to 
be mutated in a low copy temperature sensitive plasmid, named pKM201 
(Murphy & Campellone, 2003).  Homologous DNA sequence which flanks the gene 
of interest is added to a chosen antibiotic resistance cassette by PCR.  Gene 
deletions can be made with only 50bp of homologous sequence in E. coli K-12 
strains (Datsenko & Wanner, 2000), however due to the lower efficiency of 
recombination in E. coli O157:H7 strains, the homologous sequence flanking the 
Kan cassette was increased to 500bp.   
Once the PCR product for recombination has been constructed, an E. coli 
O157:H7 strain which has previously been transformed with pKM201 is made 
electrocompetent as follows.  20ml of pre-warmed (30°C) LB+Amp is inoculated 
with four colonies of E. coli O157:H7 pKM201 and incubated at 30°C, 180rpm 
until OD600nm = 0.4.  Red recombinase and Gam endonuclease production is 
induced by addition of IPTG (1mM) for 75 minutes at 30°C.  The cells are heat 
shocked for 15 minutes at 42°C before chilling on ice for 10 minutes.  The 
culture is centrifuged at 4,000rpm for 10 minutes, 4°C.  The cell pellet is 
resuspended in 2ml ice-cold 20% glycerol, and centrifuged again as before but 
only for 3 minutes.  The cell pellet was resuspended in 1ml ice-cold 20% glycerol 
and transferred to a 1.5ml centrifuge tube.  The mixture was centrifuged in at 
8,000rpm for 1 minute, 4°C, and the pellet resuspended in 400 µl ice-cold 20% 
glycerol.  To an 80 µl aliquot of competent cells, 50-1000 ng PCR product (in a 
maximum volume of 15 µl) was added prior to transfer to a pre-chilled 
electroporation cuvette (Bio-Rad, UK).  The sample was electroporated as 
described in Section 1.1.   
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2.7.2 Rationale of allelic exchange 
The technique uses Chl, Kan and levansucrase (SacB) as positive selection 
markers on a temperature sensitive plasmid (Emmerson et al., 2006).  The 
plasmid is first transformed into the strain of choice at 28°C (Figure 2-2, A).  
Positive colonies are then subjected to periods of high temperatures (42°C) and 
antibiotic selection (Chl), to promote a recombination event in the homologous 
sequence adjacent to the gene of interest (Figure 2-2, B), integrating the 
plasmid into the chromosome.  The culture is then returned to low temperature 
(28°C) and antibiotic selection (Kan) and this selects bacteria where a second 
homologous recombination event has occurred, thereby excising the plasmid 
from the chromosome (Figure 2-2, C).  After overnight culture in LB to promote 
plasmid loss, successful recombinants are selected for the KanRChlS phenotype, 
by replica plating on LB+Kan and LB+Chl plates (Figure 2-2, D).  To inhibit 
selection of bacteria which have not resolved the plasmid, replica plating can 
also be carried out on 6% sucrose agar without sodium chloride.  This media 
inhibits growth of strains which have retained the SacB cassette as levansucrase 
cleaves sucrose resulting in toxic levels of levans.  The kanamycin cassette can 
be excised from the chromosome by transforming the plasmid pCP20 into 
successful recombinants; this temperature sensitive plasmid expresses FLP 
recombinase which catalyses the recombination between two neighbouring FRT 
sites, flanking the Kan gene, generating a clean deletion (Figure 2-2, E).   
Although suicide-driven allelic exchange vectors provide a method of targeted 
gene manipulation, it should be noted that inadvertent secondary mutations in 
the neighbouring sequence to the gene manipulated has been previously 
reported. 
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Figure 2-2 Allelic exchange gene replacement and deletion. 
The figure was adapted from (Emmerson et al., 2006).         
A.  The allelic exchange vector carries a temperature 
sensitive system of replication (rep
TS
), the chloramphenicol 
transferase (cat) gene to confer chloramphenicol 
resistance, the levan sucrase (sacB) gene which is toxic to 
E. coli in the presence of sucrose and a kanamycin (Kan) 
gene to confer kanamycin resistance, flanked by the 
homologous upstream (5’) and downstream (3’) sequence 
to the chromosomal gene to be replaced (ORF).  This 
plasmid is transformed into the strain and transformants 
selected on LB+Chl plates at 28°C.  B.  The transformant is 
then grown at 42°C in LB+Chl, which is not permissible for 
plasmid replication, and the plasmid integrates into the 
chromosome, generating two possible primary integrants (i 
and ii).  C.  Primary integrant i is grown at 28°C in LB+Kan, 
which allows the plasmid to replicate so a second 
recombination event (a or b) occurs, excising it from the 
chromosome.  This can result in the original plasmid 
excising from the chromosome, leaving the ORF in the 
chromosome (a) or replacing the ORF with the Kan cassette 
(b).  D.  The recombinants are grown in LB to promote 
plasmid loss, then replica plated on LB+Kan and LB+Chl 





.  The addition of sucrose to media 
inhibits the growth of strains which retain the SacB 
cassette.  E.  Transformation of pCP20 into the recombinant 
can generate a clean deletion by excising the kanamycin 
cassette through recombination of the flanking FRT sites    
catalysed by FLP recombinase expressed by the plasmid.   
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2.7.3 Creation of DNA products for knockouts 
2.7.3.1 In-Fusion cloning 
This cloning method uses a Vaccinia virus DNA polymerase which has 3’  5’ 
exonuclease activity which exposes a 15bp fragment of single stranded DNA 
allowing it to anneal to complementary sequence (Hamilton et al., 2007).  
Transformation of the construct into E. coli then repairs any gaps or nicks in the 
DNA sequence (Zhu et al., 2007). This allows not just the cloning of one 
sequence into any vector of choice, but the possibility to clone multiple 
fragments into the same vector.  First, the three PCR sequences are amplified, 
5’ NleH flank, Kan cassette and 3’ NleH flank using primers listed in Table 2-6, 
with the homologous sequences introduced for complementary base-pairing 
when exposed by the In-Fusion enzyme.  The vector of choice, in this case 
pUC18, linearised with EcoRI and HindIII, and all the fragments are mixed 
together with the In-Fusion reaction mix, Figure 2-3 A.  This is then transformed 
into XL1-Blue competent E. coli as described in Section 1.1, and selection is 
through blue-white screening. 
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P1 cassette 5 GTGTAGGCTGGAGCTGCTTC 
P2 cassette 3 ATGGGAATTAGCCATGGTCC 
 
 
Figure 2-3 In-Fusion cloning of multiple fragments into a single vector 
The method used to genetically fuse multiple DNA fragments together in a single reaction.  
First, the DNA fragments are amplified using primers that add 15bp of homologous 
sequence to the ends of each fragment (A).  The PCR products and linearised pUC18 vector 
were mixed together with the In-Fusion mix, which contains In-Fusion enzyme.  The In-
Fusion enzyme binds to double stranded DNA ends (Bi) and with its 3’5’ exonuclease 
activity exposes single strand DNA (Bii) allowing it to pair with homologous sequence (Biii).  
Transformation of the mixture into E. coli results in antibiotic resistant clones (C), where 
blue colonies are pUC18 plasmid parent and white colonies contain the insert, interrupting 
the β-galactosidase gene.  The figure was adapted from (Zhu et al., 2007). 
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2.7.3.2 Splice overlap extension PCR 
In-Fusion cloning was unsuccessful for NleH2 after three attempts, so the 
homologous sequence introduced into each PCR product was utilised for splice 
overlap extension, whereby during the PCR reaction, the single strands of DNA 
can complementary base-pair over the homologous region, allowing a PCR 
product to be amplified across using a forward primer that binds to one product 
and the reverse primer binds to the other.  Constructing one PCR product from 
three individual PCR products in a single reaction was difficult therefore it was 
approached in a step-by-step process as follows.  The 5’ NleH flank, Kan cassette 
and 3’ NleH flank were amplified and the PCR products cleaned of dNTPs and 
buffers using QIAGEN PCR purification kit.  The 5’ NleH flank and Kan cassette 
PCR products were mixed (3:1 ratio) to provide template for a PCR reaction with 
NleH 5 primer and Kan cassette R (P2) primer.  Similarly, 3’ NleH flank and Kan 
cassette PCR products mixed with NleH 3 primer and Kan cassette F (P1) primer.  
These doublet PCR products were cleaned again and mixed together to construct 
the final product of Kan cassette flanked with NleH 5’ and 3’ flanking sequence. 
2.7.3.3 Allelic exchange vectors 
As constructs had been made previously with the Kan cassette flanked with the 
NleH 5’ and 3’ UTR sequence (NleHKanflank), this was sub-cloned into a 
temperature sensitive plasmid with a Sac cassette alone.  The Kan cassette from 
pTOF24 (KanRChlR) was excised by PstI digest and religated to create pKO3b 
(KanSChlR; named as not original pKO3 (Link et al., 1997)).  The NleHKanflank 
sequence was amplified using the nest primers that sit within the flanking 
sequence, phosphates added to the ends using T4 polynucleotide kinase (NEB, 
UK) and sub-cloned into PstI digested pKO3b that had its overhang ends blunted 
using T4 Klenow (large) fragment (NEB, UK).  This resulted in KanR, ChlR and 
sucrose sensitive allelic exchange vectors: pKO3bH1 and pKO3bH2.  These 
constructs were then transformed into the indicated E. coli O157:H7 strains and 
allelic replacement performed as described in Section 2.7.2. 
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2.8 Transfection of HEK293T cells 
HEK293T cells were cultured in DMEM (21989-0342; GIBCO/Invitrogen, UK) 
supplemented with 2mM L-Glutamine, 10% foetal calf serum (FCS), 100 U/ml 
penicillin and 100 µg/ml streptomycin.  Per well in 24 well plates, cells were 
seeded at a density of 5 x 104, incubated at 37°C/5% CO2 for 24 hours to reach 
70-90% confluence, and transfected with 0.4 µg of control/expression plasmid 
(Table 2-7), 0.4 µg NF-κB luciferase plasmid and 0.1 µg β-galactosidase plasmid.  
GeneJuice (Merck, UK) transfection reagent was used as per manufacturer’s 
instructions for transfecting 1 µg DNA.  40 hours after transfection, one half of 
the plate was stimulated by adding TNF-α (25 ng/ml).  Following 24 hours 
stimulation, cells were washed twice with PBS before adding 250 µl lysis buffer 
from Dual-Light® System (Applied Biosystems).   20 µl of lysate from each well 
was assayed in duplicate for luciferase and, 60 minutes later, β galactosidase 
using a Lumat single tube Luminometer LB9507 (Titertek-berthold, Germany).  
Luciferase activity was determined and normalized to β galactosidase activity as 
described (Philpott et al., 2000).  Each experimental condition was performed in 
triplicate, and repeated three times. 
Table 2-7 Plasmids used for NF-κB assay in HEK293T cells 
Plasmid Description Source 
placZ Β-galactosidase enzyme constitutively 
produced by mammalian expression 
vector 
Stratagene 
NF-κB luc Firefly luciferase gene under the 
control of canonical NF-κB promoter 
Stratagene 
pCMVTag3A N-terminal myc tagging mammalian 
expression vector 
Stratagene 
pCMV-NleH1 NleH1 ORF cloned into PstI + HindIII 
digested pCMVTag3A 
Prof Tom Evans 
pCMV-NleH2 NleH2 ORF cloned into PstI + HindIII 
digested pCMVTag3A 
Prof Tom Evans 
pCMV-NleH1(D258) Site directed mutant (SDM) of NleH1 
residue D258 to alanine (A) 
Prof Tom Evans 
pCMV-NleH1(E173) SDM of NleH1 residue E173 to alanine 
(A) 
Prof Tom Evans 
pCMV-NleH1(K159A) SDM of NleH1 residue K159 to alanine 
(A) 
Prof Tom Evans 
pJ201-OspG OspG ORF with PstI + HindIII sites DNA2.0 
pCMV-OspG OspG ORF cloned into PstI + HindIII 
digested pCMVTag3A. 
AH This study 
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2.9 2-D Fluorescence Difference Gel Electrophoresis (2-D 
DIGE) 
2-D DiGE was carried out in collaboration with Professor Richard Burchmore and 
Mr Alan Scott at the Sir Henry Wellcome Functional Genomics Facility (SHWFGF) 
in order to try and elucidate the human protein target of NleH1 kinase activity.   
HEK193T cells were seeded into four 6-well tissue culture plates (Costar, UK) at 
a density of 1x106 cells/well.   After 24 hours incubation, each well of cells were 
transfected with GeneJuice (Merck, UK) and 4 µg DNA; 12 wells with pCMV-NleH1 
and the other with kinase dead mutant, pCMV-NleH1(K159A).  After 16 hours 
incubation at 37°C, 5% CO2, cells were stimulated with 1.5ml TNF-α (25 ng/ml) 
for 20 minutes prior to harvesting.  Cells were washed gently in pre-warmed 
PBS, 0.5ml trypsin added to each well, the plate incubated at 37°C for 5 minutes 
to allow the cells to detach.   The cells were transferred to a 15ml falcon tube 
(Corning) including a PBS wash of the wells to ensure all cells were harvested.  
The cells were centrifuged (1500xg, 3 minutes) and resuspended in culture 
media to inactivate the trypsin.  The cells were washed in pre-warmed PBS 3 
times, with as much of the PBS removed as possible for the cell pellet to be then 
frozen at -80°C for DiGE sample preparation.   
The DiGE sample preparation, gel casting, electrophoresis and scanning were all 
carried out with Alan Scott.  The cell samples were defrosted on ice, 
resuspended in 1ml ice-cold lysis buffer (6M urea, 2M thiourea, 4% CHAPS, 25mM 
tris base) supplemented with 100  µg/ml Dnase, 5 mM MgCl2 and protease 
inhibitor cocktail (P9599; Sigma, UK), sonicated briefly for 1-2 seconds on, 1 
minute off; for 3 cycles on ice.  After 10 minute incubation at room temperature 
with gentle mixing, the sample was centrifuged at 13,000xg for 10 minutes to 
pellet any insoluble material.  The proteins from the supernatant were acetone 
precipitated at -20°C overnight.  The precipitated proteins were then washed in 
80% acetone and dried before resuspending in DiGE lysis buffer.  The proteins 
were then CyTM labelled; 10 µl NleH sample (50 µg) was labelled with Cy3 and 10 
µl K159A sample (50 µg) with Cy5.  Once the two samples are thoroughly mixed 
together, 500 µl rehydration buffer (6M urea, 2M thiourea, 4% CHAPS, 0.5% IPG 
buffer, 65 mM dithiothreitol (DTT), trace bromophenol blue) was added before 
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being applied to an IPG strip, pH4-7.  Isoelectric focusing is performed by 
applying the IPG strip with sample on an IPGphor system (Amersham, UK) and 
proteins separated at 8000V applied in a stepwise manner; 10-15 hours at 30 V 
(IPG strip rehydration step), 2 hours at 300 V, 2 hours gradient to 600 V, 2 hours 
gradient to 1000 V, 3 hours gradient to 8000 V, 8 hours at 8000 V.  The strip 
equilibrated with SDS and is then applied to the top of a 12% SDS-PAGE gel and 
run overnight to separate the proteins based on their molecular weight.  The 2D-
gel is scanned on Typhoon 9400 (GE Healthcare Life Sciences, UK) which exposes 
the gel to the appropriate wavelengths to excite each of the CyDye labels and an 
image captured.  These images were first cropped by Imagequant software and 
then loaded into DeCyder 5 software (GE Healthcare Life Sciences, UK) for 
analysis, and this DIGE analysis was carried out with Prof Richard Burchmore. 
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2.10 Yeast-two hybrid analysis 
Yeast-two hybrid (Y2H) was first described as a method to detect protein-protein 
interactions in 1989 (Fields & Song, 1989).  This system takes advantage of the 
Gal4 transcription factor from Saccharomyces cerevisiae which consists of two 
separate but equally essential functional domains; the DNA binding domain 
(DBD) which binds the promoter and an activation domain (AD) which recruits 
the transcription complex.  By genetically fusing protein X to the DBD (bait) and 
protein Y to the AD (prey), protein-protein interaction can be determined by the 
transcription of a reporter gene which can only occur when the DBD and AD are 
restored to close proximity. 
 
Figure 2-4  The yeast-two hybrid system 
A.  Transcription factors consist of two functional domains, the DNA binding domain (DBD) 
and activation domain (AD), which act together to activate transcription of genes, B. as 
individual protein hybrids (X:DBD or Y:AD) these domains cannot induce transcription.  C. 
When the domains are brought to close proximity through hybrid (X+Y) protein-protein 
interactions, transcriptional activity is restored.  Figure is based upon (Fields & Song, 1989). 
To identify the eukaryotic protein(s) which interact with NleH1 or NleH2, yeast-
two hybrid analysis was carried out in collaboration with Prof Jurgen Haas, 
University of Edinburgh, Dr Peter Uetz and Dr Thorsten Stellberger at the 
Institute of Toxicology and Genetics, Karlsruhe, Germany, where they have a 
high-throughput robot-assisted Y2H assay in 96- well plate format (Uetz et al., 
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2000; Rajagopala et al., 2007; Stellberger et al., 2010).  The system uses the 
Gateway® cloning system to create expression vectors of either bait (DBD) or 
prey (AD) (Stellberger et al., 2010).  Gateway® entry clones of E. coli O157:H7 
NleH1 and NleH2 were constructed as follows.  NleH1 and NleH2 ORF were PCR 
amplified from pAHE27 and pAHE28 respectively and then a second round of PCR 
was carried out to add the full attB recombination sites to 5’ and 3’ of the PCR 
sequence.  The primers used are detailed in Table 2-8.  The NleH-attB flanked 
PCR product was then cloned into pDONR207 using BP Clonase IITM as per 
manufacturer instructions (Invitrogen, Scotland).  This Gateway®-NleH entry 
clone was then electroporated into DH10B E. coli and 250 µl SOC media added for 
recovery at 37°C for 1 hour, shaking at 180rpm.  25 µl and 100 µl of culture was 
plated on LB+Gent plates and incubated at 37°C overnight.  Gentamycin 
resistant colonies were picked and plasmid DNA purified as described previously, 
and plasmid confirmed for presence of correct insert by restriction digest 
analysis.  The NleH entry clones were then sent to University of Edinburgh, to 
introduce the NleH1 and NleH2 genes into the yeast-two hybrid Gateway® 
expression clone pGBKT7-DEST (bait), via an LR recombination reaction 
(Stellberger et al., 2010).  The bait clones are transformed into yeast strain 
AH109 and screened against an array of yeast strain Y187 transformed with 
human cDNA prey (pGADT7-DEST) clones, in a high throughput approach 
previously described (Uetz et al., 2000). 
Table 2-8 Primers used to create Y2H entry clones 
Primer Sequence (5’  3’) 
NleH1 Y2H F AAAAAGCAGGCTCCGCCATGTTATCGCCATATTC 
NleH1 Y2H R AGAAAGCTGGGTCTTACTTAATACCACAC 
NleH2 Y2H F AAAAAGCAGGCTCCGCCATGTTATCGCCCTC 
NleH2 Y2H R A GAA AGC TGG GTC TTA 
attB1 F GGGGACAAGTTTGTACAAAAAAGCAGGCT 




2.11 S. pneumoniae codon-optimised constructs 
2.11.1 Fluorescent proteins and pneumolysin 
The coding sequences of monomeric GFP, YFP and RFP from Evrogen and 
pneumolysin from TIGR4 were codon-optimised and synthesised by DNA2.0 into 
pUC-based vectors.  Also included in the design was the introduction of His, 
FLAG and Lumio (FlAsH) tags at the N-terminus of the sequence, an NdeI 
restriction site at the ATG start codon and an AgeI restriction site before the 
stop codon of the fluorescent proteins or the start methionine of pneumolysin.  
The pneumococcal ami promoter was chosen to control transcription of the 
codon-optimised protein as it has been shown to be constitutive in the 
pneumococcus (Claverys et al., 1995).  The constructs received from DNA2.0 are 
listed in Table 2-9.  As the constructs could only be propagated in E. coli, the 
designed inserts were subcloned into an E. coli-Streptococci shuttle vector, 
pAL2YI.  The inserts from pAHE1-5 were liberated by AvaI digest, and pAHE6 by 
NcoI and AclI digest, then subcloned into pAL2YI.  The NdeI and AgeI sites were 
used to create a construct with rfp gene alone, whereby the rfp gene was 
digested out of pAHE6, subcloned into the backbone of pAHE5 to provide the 
stop codon before a final subclone step into the shuttle vector.  This strategy 
was repeated to create a number of constructs with pneumolysin genetically 
fused to a fluorescent protein at its N-terminus, Table 2-9. 
Table 2-9 Pneumolysin and fluorescent protein constructs 
Construct Description (3 tags = His, FLAG, Lumio) Source 
pAHE1 3 tags: Domains 1, 2 and 3 pneumolysin (TIGR4)  DNA2.0 
pAHE2 3 tags: Domain 4 pneumolysin (TIGR4) DNA2.0 
pAHE3 3 tags: Pneumolysin (TIGR4) DNA2.0 
pAHE4 3 tags: Green Fluorescent Protein DNA2.0 
pAHE5 3 tags: Yellow Fluorescent Protein DNA2.0 
pAHE6 3 tags: Red Fluorescent Protein: Pneumolysin (TIGR4) DNA2.0 





pAHE11 3tags: GFP-Ply [AgeI+NotI digest pAHE4 to give 
GFP:3tags insert, ligated into pAHE3 to tag Ply] 
AH 
pAHE12 3 tags: YFP-Ply[AgeI+NotI digest pAHE5 to give 
YFP:3tags insert, ligated into pAHE3 to tag Ply] 
AH 
pAHE13 3 tags: Red Fluorescent Protein [AgeI+NotI digest pAHE6 
to give RFP:3tags insert, ligated into pAHE5] 
AH 
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pAHE14 3 tags: GFP-Domain4 [AgeI+NotI digest pAHE4 to give 
GFP:3tags insert, ligated into pAHE2 to tag Ply Domain 
4] 
AH 
pAHE15 3 tags: YFP-Domain4 [AgeI+NotI digest pAHE5 to give 
YFP:3tags insert, ligated into pAHE2 to tag Ply Domain 
4] 
AH 
pAHE16 3 tags: RFP-Domain4 [AgeI+NotI digest pAHE6 to give 
RFP:3tags insert, ligated into pAHE2 to tag Ply Domain 
4] 
AH 
pAHE24 3tags: GFP-Domains123 [AgeI+NotI digest pAHE4 to give 
GFP:3tags insert, ligated into pAHE1 to tag Ply Domain 
123] 
AH 
pAHE25 3 tags: YFP-Domains123 [AgeI+NotI digest pAHE5 to give 
YFP:3tags insert, ligated into pAHE1 to tag Ply Domain 
123] 
AH 
pAHE26 3 tags: RFP-Domains123 [AgeI+NotI digest pAHE6 to give 
RFP:3tags insert, ligated into pAHE1 to tag Ply Domain 
123] 
AH 
   
pAHS1 Ply Domain 1-3; 3 tags [AvaI digest from pAHE1 cloned 
into pAL2YI] 
AH 
pAHS2 Ply Domain 4; 3 tags [AvaI digest from pAHE2 cloned 
into pAL2YI] 
AH 
pAHS3 Ply; 3 tags [AvaI digest from pAHE3 cloned into pAL2YI] AH 
pAHS4 gfp++; 3 tags [AvaI digest from pAHE4 cloned into 
pAL2YI] 
AH 
pAHS5 yfp++; 3 tags [AvaI digest from pAHE5 cloned into 
pAL2YI] 
AH 
pAHS6 rfp-Ply; 3 tags [AclI + NcoI digest from pAHE6 cloned 
into pAL2YI] 
AH 
pAHS7 gfp-Ply Domain 4; 3 tags [AvaI digest from pAHE14 
cloned into pAL2YI] 
AH 
pAHS8 rfp++; 3 tags [AvaI digest from pAHE13 cloned into 
pAL2YI] 
AH 
pAHS9 YFP-Ply Domain 4; 3 tags [AvaI digest from pAHE15 
cloned into pAL2YI] 
AH 
pAHS11 GFP-Ply Domain 1-3; 3 tags [AvaI digest from pAHE24 




2.11.2 Transcriptional reporter construct 
To assess the application of the fluorescent proteins as a transcriptional 
reporter, a shuttle vector had to first be constructed with a promoterless YFP 
gene.  The cloning strategy was designed to PCR amplify YFP introducing 
restriction enzyme sites at its 5’ and 3’ ends to subclone into pAL2YI in a 
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suitable position where there was an additional restriction site available 
upstream to enable subsequent subcloning of putative promoters for testing.  
pAL2YI has StuI, NcoI and AclI sites in close proximity to allow the strategy, 
Figure 2-5.   
 
Figure 2-5 Promoterless YFP construct pAHS12 
 
The molecular biology to create pAHS12 was carried out by Sultan Al-Sharif, a 
Masters student at the time.  To assess the efficacy of the expression vector, 
three putative promoters of NanA (Camara et al., 1994) were cloned into 
pAHS12, Figure 2-6, to control expression of YFP.  Primers used are detailed in 
Table 2-10. 
Table 2-10 Primers used for transcriptional reporter constructs 
Primer Sequence Construct 
YFP NcoI 5’ CGCCCTTGAACGTTTTAACCGG pAHS12 
YFP AclI 3’ GGATAACCCATGGCTAATAAACATC pAHS12 




-246NanA NcoI 3’ GAAATAAGCCATGGACTCCAGAAAATGC -246 NanA pAHS12 
-291NanA NcoI 3’ CTCCGATCCATGGTGATCCTCTC -291 NanA pAHS12 
-405NanA NcoI 3’ GCCCCTTCCATGGCTAAAACAGGAG -405 NanA pAHS12 
 
 
Figure 2-6 Putative promoter sequences of NanA cloned upstream of YFP 
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2.12 Transformation of S. pneumoniae 
S. pneumoniae were grown in 10ml BHI with 1mM CaCl2 until an OD600nm of 0.1 
was reached. Aliquots of 1ml of the culture were prepared, and 100 ng/ml 
competence stimulating peptide 1 (CSP-1, Sigma-Aldrich, UK) for type 2 
pneumococci, or CSP-2 for type 4, was added to induce uptake of extracellular 
DNA. Samples were then incubated at 37°C for 15 min before addition of 500ng 
DNA and a further incubation at 37°C for 75 min. Samples were then plated on 
BAB + 5% horse blood and Ery or Chl where required. 
 
2.13 Characterisation of codon-optimised proteins 
2.13.1 Preparation of samples 
Strains were grown statically at 37°C in 15ml BHI until OD600nm = 0.6, centrifuged 
at 4,000xg for 15 minutes, 4°C in a 4K15 centrifuge (Sigma, UK).  The 
supernatant was discarded and the pellet resuspended in 1ml PBS, and the 
sample sonicated at 10 microns for 30sec with 30sec rest on ice, for 3 cycles, 
using a Soniprep 150 sonicator (MSE, UK).  The sonicated pellet was centrifuged 
at 13,000rpm for 1 min to pellet membranes and insoluble proteins. 
The protein concentration of pneumococcal lysates was measured using Qubit® 
Protein Assay kit and fluorimeter (Invitrogen, Scotland) as per manufacturer’s 
instructions. 
2.13.2  SDS-PAGE and western blotting 
Samples were mixed 3:1 in NuPAGE sample buffer (x4; Invitrogen) and boiled at 
72°C for 12 minutes before loading 10 µl onto gel.  Gels used were either a 
NuPAGE 4-12% Bis-Tris pre-cast SDS-PAGE gel (Invitrogen) or 10% polyacrylamide 
gel, where indicated.  SeeBlue+2 (Invitrogen, UK) marker was used throughout.  
SDS-PAGE gels were stained overnight in Coomassie stain (500ml dH2O, 400ml 
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methanol, 100ml acetic acid, 0.5g Coomassie blue R250), and destained with 
destain solution (500ml dH2O, 400ml methanol, 100ml acetic acid) until clear. 
For western blot, proteins were transferred using Sure-Lock Cell Blotting Module 
(Invitrogen) onto PVDF membrane at 30V for 75 minutes, then blocked in 3% 
skimmed milk (Marvel, UK) in Tris NaCl, pH 7.4 (10mM Tris, 150mM NaCl, 8mM 
HCl).  Primary antibody was applied for 2-3 hours at 37°C diluted in 3% skimmed 
milk in Tris NaCl, pH7.4; α-FLAG® (#200471; Stratagene, UK) at 1:5000 dilution, 
α-Ply at 1:1000 dilution, α-GroEL (ADI-SPS-875; Enzo Life Sciences, UK) at 1:2000 
dilution.  After washing the membrane four times for 5 minutes in 100ml Tris 
NaCl, pH7.4 + 0.08% (v/v) Tween-20 (Sigma, UK), secondary horseradish-
peroxidase (HRP) conjugate antibody, donkey α-rabbit IgG (Amersham 
Biosciences, UK) or goat α-mouse IgG (Promega, UK), was added to the 
membrane at 1:40000 dilution and incubated for 45 minutes, 37°C.  After four 
10 minute washes, the membrane was developed with Immobilion® Western HRP 
Chemiluminescent substrate (Millipore, UK).   
2.13.3 Haemolytic assay 
The haemolytic activity of Ply in culture lysates was measured using a 
haemolytic assay previously described (Walker et al., 1987), with modifications.  
Briefly, doubling dilutions of 50 µl culture lysates were made in PBS in duplicate 
in a round-bottomed 96-well plate (Costar, UK). A control double dilution of a 
1:1000 dilution of purified Ply (0.7 mg/ml) (Mitchell et al., 1989) was included in 
duplicate. PBS was included as a negative control. 50 µl of 10mM DTT (Sigma-
Aldrich, UK) was added to each well, to act as a reducing agent for any Ply 
oxidised in the lysate. The plate was then incubated at 37°C for 15 min with a 
lid to prevent evaporation.  A 2% (vol/vol) solution of sheep erythrocytes (E&O 
Laboratories, Scotland) was prepared and 50 µl was added to each well.  The 
plate was then incubated at 37°C for 30 min before addition of a further 50 µl 
PBS, and centrifugation at 500xg for 1 minute in a 4K15 centrifuge (Sigma-
Aldrich, UK) to pellet the intact erythrocytes. 
The haemolytic titre of a sample was calculated from the reciprocal of the last 
dilution to give 100% lysis as described previously (Benton et al., 1997b). 
 91 
2.13.4 Analysis of S. pneumoniae fluorescence 
2.13.4.1 Population based assay 
20ml of prewarmed BHI with Ery where appropriate, was inoculated with 5x105 
cfu/ml S. pneumoniae.  At regular time points, 1ml of culture was removed, 
OD600nm measured, and centrifuged at 5,000 rpm for 2 minutes.  The BHI 
supernatant was removed and the pellet resuspended in sterile PBS.  200 µl of 
this suspension was aliquoted in triplicate in a 96 well flat bottom plate (Costar, 
UK) then analysed in a FLUOstar Optima plate reader (BMG Labtech, UK).  20 µl 
of the suspension was also used for viable count. Untransformed S. pneumoniae 
or strain transformed with pAHS12 provided background fluorescence levels.  
Data was normalised and analysed as described previously in Section 2.5.3. 
2.13.4.2 Single cell analysis 
Pneumococcal cells expressing fluorescent proteins were grown to OD600nm = 0.6, 
washed in PBS three times prior to mixing 1:1 (v/v) with 4% paraformaldehyde to 
fix the cells.  After 20 minutes incubation at room temperature, 20 µl of fixed 
cells were spotted onto a microscope slide and dried.  A coverslip was mounted 
after the application of fluorescence mounting media (Dako, USA). 
Images were captured on a Zeiss M1 Axioskopp microscope as described 
previously in Section 2.5.3.2. 
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2.14 Fluorescence microscopy of pneumococci 
2.14.1 Immunofluorescence 
S. pneumoniae strains were grown in BHI at 37°C until OD600nm = 0.6, and 1ml of 
culture was centrifuged for 2 minutes at 13,000rpm.  The cell pellet was washed 
three times and suspended in 1ml sterile PBS and 100 µl mixed 1:1 with 4% (w/v) 
paraformaldehyde.  After 20 minutes incubation at room temperature, 1 µl of 
the fixed cells were spotted with 20 µl PBS onto a 12 spot microscope slide.  
Once the spots dried, the slide was washed twice with PBS.  20 µl of primary 
antibody was added per spot, α-Ply (1:500), α-FLAG (1:500) or α-capsule 
(1:1000), and incubated for an hour at room temperature. The slide is washed 
three times with PBS + 0.1% BSA before the application of secondary antibody, α-
rabbit IgG AlexaFluor conjugate (Invitrogen) or α-mouse IgG Northern Lights at 
1:1000 dilution.  After 45 minutes incubation in the dark, the slide is washed 
four times with PBS + 0.1% BSA, dried and a cover slip mounted with Dako 
fluorescent mounting media. Images were captured on a Zeiss M1 Axioskopp 
microscope as described previously in Section 2.5.3.3. 
2.14.2 LumioTM fluorescence 
S. pneumoniae strains were grown in BHI at 37°C until OD600nm = 0.6-0.7, and 1ml 
of culture was centrifuged for 2 minutes at 13,000rpm.  The cell pellet was 
washed three times with sterile PBS and finally suspended in 100 µl PBS + 0.15 µl 
LumioTM Green reagent (Invitrogen).  After 15 minutes incubation in the dark, 
the cells were washed with PBS to remove any excess reagent and 2 µl of cells 
spotted onto a microscope slide and a coverslip applied; the wet mounts were 
immediately viewed using a Zeiss AxioImager M1 microscope.  Images were 
captured as described previously in Section 2.5.3.3. 
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2.15 Construction of LytA-Ply fusion in TIGR4NO1 
The A45 LytA-Ply fusion was introduced into TIGR4 through homologous 
recombination.  The LytA-Ply fusion gene with 1kb of upstream and downstream 
sequence was amplified from A45 using LytA forward and 27R primers.  This PCR 
product had phosphates added to its ends using T4 polynucleotide kinase to 
allow it to be ligated into a Klenow treated EcoRI linearised pUC18, to create 
pUCLytA27R.  There is a natural BamHI restriction enzyme recognition site within 
the fusion gene and this was exploited to introduce a Cat cassette to allow 
selection of successful recombinants.  The Cat cassette, with ami promoter 
(Iannelli et al., 2004), was amplified from FP28 gDNA using CatF and CatR 
primers and this was treated with T4 polynucleotide kinase and ligated into 
Klenow treated BamHI linearised pUCLytA27R, to create pUCLytA27R::Chl.  This 
final construct was transformed into S. pneumoniae strain TIGR4NO1, as 
described in Section 2.12.  The plasmid cannot replicate in the pneumococcus as 
it has an E. coli origin of replication, therefore TIGR4 transformants which are 
Chl resistant can only arise from a recombination event. 
Table 2-11 Primers for LytA-Ply fusion 
Primer Sequence 
27R CTTGGCTACGATATTGGC 
LytA upstream CCATTTCCTCTAGTGAACATCG 
Cat F CTGAAAATTTGTTTGATTTTTAATGG 








2.16 Characterisation of TIGR4NO1∆LytA-Ply::Chl 
2.16.1 Confirmation of successful mutation 
The successful introduction of the autolysin-pneumolysin fusion (LytA-Ply) in 
TIGR4NO1, resulting in no production of pneumolysin or autolysin, was confirmed 
by PCR, sequencing, haemolytic assay, western blotting, all as described 
previously, and Gram staining. 
2.16.1.1 Gram staining of bacteria 
For Gram stain, 5 µl of broth culture was smeared onto a microscope slide and 
passed through a Bunsen flame to heat-fix; an E. coli sample was included on 
each slide as a Gram negative control.  The slide was flooded with crystal violet 
for 1 minute, rinsed with water before flooding with iodine solution for 30 
seconds.  This forms an insoluble complex within the bacterial cells, staining 
them all purple.  After rinsing with water, alcohol/acetone was added for 2-3 
seconds to dehydrate the cells, which traps the crystal violet stain in the Gram 
positive cells due to the thick peptidoglycan cell wall and decolorises the thin-
walled Gram negative cells as the stain complex can escape.  The slide was 
flushed with water and flooded finally with safranin for 1 minute to counterstain 
the decolorised cells pink.  When Gram staining S. pneumoniae, a smear of E. 
coli is always included as a staining control to ensure efficient counterstaining, 
thus a differential stain. 
 
2.17 Fractionation of S. pneumoniae 
Pneumococcal cells were separated into cellular fractions using a fractionation 
protocol previously described (Price & Camilli, 2009), with modifications. 
In short, strains were grown statically at 37°C in 35-50ml BHI, until OD600nm = 
0.6, then 24-25ml of culture was transferred to a centrifuge tube (Beckman 
Instruments, CA, USA) and centrifuged at 14,100xg for 6 minutes at 4°C in 4K15 
centrifuge (Sigma-Aldrich, UK) with a 12172 rotor.  The broth supernatant was 
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carefully removed, where indicated passed through a 0.2 µm syringe filter 
(Sartorius Stedim Biotech, Germany), and 6% (v/v) trichloracetic acid and  4 
µg/ml BSA (Sigma, UK) added, to precipitate proteins overnight at 4°C.  BSA acts 
as a co-precipitate and can provide an indication of equivalent preparation and 
loading between samples.  This was then centrifuged at 4,000xg for 30 minutes 
at 4°C to pellet the precipitated proteins and resuspended in 70 µl 50mM Tris-
HCl, pH 7.5; giving the supernatant fraction.  The pneumococcal cell pellet was 
washed once in sterile PBS before being resuspended in 70 µl cell wall digestion 
buffer (10mM Tris-HCl, 30% sucrose, 1 x protease inhibitor cocktail (Roche), 1 
mg/ml lysozyme, 300U mutanolysin) and incubated at 37°C for 3 hours with 
gentle rocking.  The sample was then centrifuged 14,100xg for 10 minutes at 
4°C.  If the sample did not pellet well, it was transferred to a 1.5ml Eppendorf 
tube and centrifuged in a 1K15 centrifuge (Sigma, UK) at 14,100xg for 10minutes 
at 4°C.  The supernatant was removed, giving the digested cell wall fraction; 
and the pellet was resuspended in 70 µl 50mM Tris-HCl, pH 7.5, giving the 
protoplast fraction. 
2.17.1 Cell wall digestion buffer 
It was first reported in 1975 that pneumococcal cells spontaneously form 
protoplasts when incubated in hypertonic solutions (Lacks & Neuberger, 1975).  
This technique has been used in other studies (Vijayakumar & Morrison, 1986; 
Neef et al., 2011) but incubation temperatures and times vary.  S. pneumoniae 
D39 cells were resuspended in protoplast inducing buffer (100mM Tris-HCl pH7.5, 
2mM MgCl2, 1 x protease inhibitor (Roche) and 30% sucrose) and separated into 3 
aliquots to test different incubation times and temperatures; 25°C for 30 
minutes, 37°C for 30 minutes and 30°C for 60 minutes.  After incubation, 2 µl of 
pneumococcal cells, treated and untreated, and 2 µl of an overnight culture of 
E. coli were heat fixed onto a microscope slide and Gram stained to detect 
pneumococcal cells with reduced cell wall thickness. 
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3 Expression and regulation of Non-LEE encoded 
effectors (Nle) H1 and H2 
3.1 Summary 
Non-LEE encoded effectors H1 and H2 were identified through a bioinformatic 
screen searching for homologues to over 300 known T3SS effectors in animal and 
plant pathogens and symbionts; shown to be secreted into the extracellular 
media by a sepL hypersecretor mutant in EHEC O157:H7, and translocated into 
eukaryotic cells under inducing conditions (Tobe et al., 2006).  The aim of this 
chapter was to determine whether both E. coli O157:H7 NleH1 and NleH2 were 
expressed under T3SS secretion permissive conditions when under the control of 
their native promoters, and if this expression was in co-ordination with the LEE.  
LEE expression in EHEC O157 is complex as expression of the translocon of the 
T3SS (EspABD) has been shown to be heterogenous and regulated at the post-
transcriptional level (Roe et al., 2003; Roe et al., 2004).  Translational fusions to 
gfp were used to assess NleH expression in the population, at the single-cell 
level in co-ordination with the production of EspA filaments and upon contact 
with host cells.  The translational fusions were also tested in LEE-encoded or 
endogenous regulator knockout strains to assess their impact upon NleH-GFP 
expression. 
 
3.2 Expression of NleH in different media types 
Previous work has shown that the media that E. coli O157:H7 is grown in can 
affect the expression of the LEE and genes which are co-regulated with the PAI.  
It has been reported that T3SS proteins EspD and Tir are secreted 5-10 fold 
higher in MEM media compared to DMEM (Roe et al., 2007).  These conditions 
were used to identify differentially regulated genes in E. coli O157:H7 and genes 
regulated in coordination with the O157 LEE PAI.  From these data (GEO 
accession no. GSE6296), NleH expression was shown to be differentially 
expressed when grown in MEM compared to DMEM, indicating it was indeed 
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expressed and also that it was subject to regulation.  In order to determine how 
the two alleles are expressed and regulated, translational fusions of NleH1 and 
NleH2 to GFP were constructed and their expression measured under different 
conditions. 
 
3.2.1 Expression of GFP translational fusions 
Upon closer assessment of the sequence of NleH1 and NleH2 5’ untranslated 
regions (5’ UTR) from E. coli O157:H7 strain EDL933, it was evident that the 
sequences became more divergent further upstream from the ATG start codon.  
The upstream sequences share 70% identity to -120bp which decreases to 60% for 
290bp and finally to 53% for 655bp, when the sequences are aligned using 
ClustalW, Figure 3-1.  The length of 5’ UTR cloned upstream of the translational 
fusion nleH1/2::gfp was varied to investigate if this had any effect upon NleH-
GFP expression.   
The constructs (pAHE8, pAHE18-22) were transformed into E. coli O157:H7 strain 
ZAP193 and the expression of NleH-GFP assessed during growth in MEM and DMEM 
as described.  ZAP193 is a Shiga-like toxin-negative strain and there is a panel of 
mutants available in this background.  The trend of expression of NleH1 and 
NleH2 in MEM media is that expression increases as the population increases.  
The trend seen in DMEM differs in that once the population reaches OD600nm = 
1.2, expression begins to decline and does not reach the same levels as seen in 
MEM.  Expression of NleH1 and NleH2 at OD600 = 1.2, is ~4-fold greater in MEM 
compared to DMEM (Figure 3-2) which correlates with a previous report showing 
greater expression of NleA and NleB in this media (Roe et al., 2007).   
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Figure 3-1:  Sequence alignment of the 5’ UTR of E. coli O157:H7 NleH1 and NleH2 
The 655 nucleotides upstream from the ATG start codon of E. coli O157:H7 EDL933 NleH1 
and NleH2 were aligned using ClustalW.  Primers designed for translational fusions to gfp 
are labelled; green for NleH1 and blue for NleH2. 
 
Upon analysis of the 5’ UTR lengths in MEM, the length of 5’ UTR cloned 
upstream of NleH2-GFP does not greatly affect its expression, as 291bp 5’ UTR 
(pAHE21) expresses to ~90%, and 113bp 5’ UTR (pAHE18) equivalent, levels of 
655bp 5’ UTR (pAHE22).  There is no significant difference in NleH2-GFP 
fluorescence from the different vectors at OD600 = 1.2 (One-way ANOVA with 
Bonferroni’s multiple comparison test).  However, after OD600nm = 0.8, NleH1 
expression is reduced in a step-wise manner with the decrease in 5’ UTR length 
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controlling expression.  NleH1-GFP with 283bp 5’ UTR (pAHE19) expression is 
70%, and 120bp 5’ UTR (pAHE18) expression is 30%, relative fluorescence units 
(RFU) of 531bp 5’ UTR (pAHE8), at OD600 = 1.2.  The difference in NleH1-GFP 
fluorescence from 531bp 5’UTR compared to 120bp 5’ UTR is significant (One-
way ANOVA with Bonferroni’s multiple comparison test, p<0.0001), but not 
compared to 283bp 5’ UTR (Student’s t test, p=0.063).   These trends in NleH1-
GFP expression is not observed in DMEM, likely due to the largely reduced levels 
of expression of the GFP fusions in this media.  Similarly, previous work has 
shown that expression of the LEE and non-LEE encoded effectors NleA-E is 
induced to greater levels in MEM compared to DMEM (Roe et al., 2007).  
Comparing the formulations of MEM (M7278) with DMEM (D5671), they are both 
based upon Eagle’s Basal Medium (EBM) but have the following differences.  
DMEM has no HEPES buffer; four times the concentration of vitamins; double the 
concentration of amino acids; and double the concentration of glucose compared 
with MEM+0.1% glucose.  The greater LEE induction observed when E. coli 
O157:H7 are cultured in MEM cannot be attributed to a particular component 
present in the media (Dr Andrew Roe; personal communication) and therefore 
remains to be elucidated.  
This stepwise increase in NleH1-GFP expression during the stationary phase of 
growth in MEM with increase in 5’ UTR length indicates that an activator of 
transcription may bind between -283bp and -531bp; the secondary structure of 
the upstream DNA may influence transcription of NleH1; there may be 
competition between a repressor that binds close to the ORF of NleH1 and an 
activator that competes for a similar site but also requires an upstream 
sequence for binding.  Expression of NleH2-GFP is dependent upon the 113 
nucleotides upstream of the start of the open reading frame.  
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Figure 3-2 Expression of NleH-GFP constructs in E. coli O157:H7 grown in minimal media 
Constructs NleH1 with 120bp (pAHE18), 283bp (pAHE19) or 531 bp (pAHE8), and NleH2 with 
113bp (pAHE20), 291bp (pAHE21) or 655bp (pAHE22), 5’ UTR cloned upstream of gfp were 
transformed into ZAP193 and grown in MEM (A) or DMEM (B) and fluorescence measured 
during growth as described in Materials and Methods.  All values were corrected for 
background by subtracting the value of a promoterless gfp (pAJR70) control measured at 
the same optical density, with the mean+SEM plotted.  Graphs represent the measurements 
from three biological repeats performed on different days. 
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3.3 Expression of NleH in defined regulatory deletions 
In order to try to ascertain what influences NleH expression in E. coli O157:H7, 
the translational fusions (pAHE8 and pAHE22) were assessed in a number of gene 
knockouts to test their affect on NleH expression.  NleH-GFP expression in a K-12 
E. coli background was investigated to determine whether expression is 
dependent upon endogenous or EHEC specific factors. 
3.3.1 Expression in stationary phase regulator knockouts 
As expression of NleH-GFP is greatest towards the stationary phase of growth 
and therefore high population density, this raised the question whether quorum 
sensing or alternative sigma factors affect nleH gene transcription.  Quorum 
sensing has been shown to regulate T3SS expression (Sperandio et al., 1999) and 
QseC is the sensor kinase in the signalling pathway (Clarke & Sperandio, 2005a).  
The alternative sigma factor RpoS has also been shown to have an effect on the 
regulation of horizontally acquired elements, such as the LEE (Sperandio et al., 
1999; Dong & Schellhorn, 2009). 
To test this, pAHE8 (-531bp_nleH1::gfp) and pAHE22 (-655bp_nleH2::gfp) were 
transformed into an E. coli K-12FqseC and FrpoS mutants, alongside their 
isogenic parent strain and expression monitored during growth in MEM.  The 
construct pAJR132 (tir::gfp) was included to act as a LEE encoded effector 
control in the expression assay.  The expression profiles of NleH-GFP differ 
between K-12 strains, which may be attributed to the transformation of data 
from subtracting the background fluorescence from strains containing 
promoterless gfp plasmid pAJR70.  NleH-GFP expression is negligible in E. coli K-
12 strain BW25113 and reduced at least 8-fold in strain MC1000 (Figure 3-3 A and 
C).  NleH1-GFP fusion protein expression slightly greater than NleH2-GFP, 
opposite to what was observed from the same constructs in E. coli O157:H7 
ZAP193; Tir-GFP fusion protein expression is reduced ~60-fold in BW25113 and 
~120-fold in MC1000.  In BW25113FrpoS (Figure 3-3 B), NleH-GFP is only 
detected in the lag phase of growth, H1 until OD600 = 0.15 and H2 until OD600 = 
0.3.  Expression of NleH1-GFP fusion protein in VS184 (MC1000FqseC; Figure 3-3 
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D) is only detected between OD600 = 0.35 and 0.95, and NleH2-GFP fusion protein 
expression is not detected in this strain.   
 
Figure 3-3 Expression of NleH-GFP and Tir-GFP in E. coli K-12, ∆rpoS and ∆qseC mutants 
NleH1-GFP (pAHE8), NleH2-GFP (pAHE22) and Tir-GFP (pAJR132) expression was analysed 
when transformed into E. coli K-12 strain BW25113 (A), BW25113∆rpoS (B), MC1000 (C) and 
VS184 (D) as described in Materials and Methods.  Lines represent the average of two 
biological repeats. 
These results therefore indicate that the presence of E. coli O157:H7 specific 
factors are central to nleH expression.  Tir expression is also reduced in an E. 
coli K-12 background and these effectors are all upregulated in LEE inducing 
conditions.  Owing to this, nleH::gfp expression was tested in LEE regulator 
knockouts. 
 
3.3.2 Expression in LEE regulator knockouts 
As it has been indicated from previous experiments that the expression of nleH is 
dependent on E. coli O157:H7 specific regulators and upregulated alongside the 
LEE; pAHE8 and pAHE22 were transformed into E. coli O157:H7 ZAP193 isogenic 
mutants of ler and grlA, two characterised LEE encoded regulators.  Ler has 
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been shown not only to positively regulate the transcription of LEE encoded 
effectors, but also non-LEE encoded effectors, such as nleA (Elliott et al., 2000; 
Roe et al., 2007; Schwidder et al., 2011) and tccP/espFu (Abe et al., 2008).  
Transcription of the ler gene can be self-regulated (Berdichevsky et al., 2005) 
and positively regulated by GrlA (Deng et al., 2004; Huang & Syu, 2008).  
Transcription of the grlA gene is regulated by Ler, through its ability to alleviate 
H-NS repression, thereby forming a positive feedback loop (Barba et al., 2005); 
indirectly and positively regulated by QseA (Russell et al., 2007); indirectly and 
negatively regulated by RpoS (Dong & Schellhorn, 2009); and post-
transcriptionally regulated by Hfq (Hansen & Kaper, 2009; Shakhnovich et al., 
2009).  GrlA protein activity is regulated through binding with GrlR (Jobichen et 
al., 2007).  GrlA can also exert an effect of transcription of genes outwith the 
LEE, such as the flagellar genes (Iyoda et al., 2006) and the enterohaemolysin 
operon (Saitoh et al., 2008). 
NleH1-GFP expression, at OD600 = 1.2 (intermediate level of expression), is 
reduced in ZAP193Fler and ZAP193FgrlA by ~45% and ~65% respectively, Figure 
3-4 A; NleH2-GFP expression is reduced in Fler and Fgrla by ~40% and ~75% 
respectively, Figure 3-4 B.  Tir-GFP (pAJR132) was included as a control as its 
expression has been shown to be dependent upon both Ler and GrlA (Elliott et 
al., 2000; Deng et al., 2004), which is reflected in the results, Figure 3-4 C.  Tir-
GFP expression at OD600 = 1.0 (near maximum level of expression), is reduced by 
~85% in the absence of Ler and by ~50% in the absence of GrlA.  Tir expression is 
15-fold that of NleH.  Ler has a more significant effect on the expression of Tir-
GFP compared to GrlA, as Ler has been shown to directly bind the promoter 
region of tir.  This suggests that the result seen for ZAP193FgrlA/pAJR132 is 
likely to be an indirect effect due to the reduction in the transcription of ler in 
the absence of GrlA.  An opposite trend is seen with NleH-GFP expression in 
these regulator mutants, with the expression of NleH-GFP reduced more in the 
absence of GrlA than in the absence of Ler.   This also implies that these 
regulators have an indirect effect upon nleH gene transcription. 
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Figure 3-4 Expression of NleH-GFP and Tir-GFP in E. coli O157:H7 defined LEE regulator 
mutants 
E. coli O157:H7 ZAP193, ZAP193∆ler and ZAP193∆grlA were transformed with constructs 
expressing NleH1-GFP (pAHE8; A), NleH2-GFP (pAHE22; B) and Tir-GFP (pAJR132; C).  GFP 
expression was monitored during growth of the transformants in MEM media, with a 
promoterless gfp construct (pAJR70) as a background control.  Lines represent the average 
of three biological repeats. 
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Although reporter plasmids are frequently used to assess gene transcription and 
translation in bacteria, often the results observed should be supported by other 
techniques, such as RT-PCR or single chromosomal insertions.  This is due to the 
possible implications from the use of plasmid reporter systems, such as 
difference in DNA topology compared to the chromosome (Parsot & Mekalanos, 
1992); the fitness cost of heterologous (GFP) expression (Knodler et al., 2005) 
and/or plasmid maintenance (Clark et al., 2009); and amplification of expression 
levels due to the presence of multiple copies of the gene/promoter of interest.  
Therefore, to further quantify the effects of Ler and GrlA on the transcription of 
NleH1 and NleH2, quantitative PCR (Q-PCR) was performed on RNA harvested 
from strains grown in MEM to OD600 = 1.2, as described in Materials and Methods.  
The nleH transcripts were normalised between samples using 16S RNA as a 
control.  Transcription of nleH in the mutants was compared to wild-type 
expression to give a fold-change. The Q-PCR results show that the NleH 
transcripts are reduced in the Fler and FgrlA strains, Figure 3-5.  NleH1 
transcript levels are reduced 13- and 14-fold in ZAP193Fler and ZAP193FgrlA, 
respectively.  Similarly, NleH2 is reduced 22- and 17-fold in the same mutants.  
These results indicate a strong influence of Ler and GrlA in NleH transcription, 
confirming the results obtained with the translational fusions to gfp. 
 
Figure 3-5 Quantitative PCR of NleH transcripts in LEE regulator knockouts 
RNA was collected from ZAP193 strains WT, ∆ler and ∆grlA grown to OD600 = 1.2 in MEM 
and cDNA prepared.  NleH1, NleH2 and 16S RNA transcript was then quantified by q-PCR, 
NleH values normalised to that of 16S RNA, and the fold change calculated comparing 
mutant to wild-type.  Bars represent the average of three biological samples. 
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Expression of the T3SS apparatus, specifically the EspA filaments, has been 
shown to be heterogenous in a population as LEE4 is posttranscriptionally 
regulated (Roe et al., 2003; Roe et al., 2004).  NleH has been shown to be 
secreted via the T3SS (Tobe et al., 2006; Garcia-Angulo et al., 2008; Gao et al., 
2009), the GFP translational fusions were assessed by fluorescence microscopy to 
ascertain whether expression of NleH in a population is homo- or heterogenous 
in ZAP193, its isogenic ler and grlA mutants, and whether this expression is co-
ordinated with the T3S apparatus.  Maximal expression of EspA occurs at OD600nm 
= 0.8 (Roe et al., 2004), therefore this optical density was chosen to investigate 
if NleH expression is co-ordinated with the LEE translocon. 
NleH is not strictly co-ordinately expressed with EspA filaments, as there is 
approximately 18-20% of the population expressing NleH-GFP without EspA 
filaments, and therefore T3SS apparatus, Figure 3-6 A.  Quantification of the 
mean GFP fluorescence (RFU) per voxel, in at least 100 individual bacteria from 
3 separate fields shows that NleH2 is expressed at ~2 fold greater levels than 
NleH1, Figure 3-6 D and E, correlating with the results from the population 
studies at the same optical density.  NleH2-GFP expression is also heterogenous 
as there is a sub-population (14%) which are ‘hyperexpressors’, where they are 
expressing GFP approximately 5-fold greater levels (average RFU = 234 units) 
than the rest of the population (RFU = 49 units), Figure 3-6 A and E.  Analysis of 
these ‘hyperexpressors’ separate from the rest of the population show that they 
maintain the same percentage (18-20%) of cells not expressing EspA filaments, 
therefore there is no correlation between the hyperexpression of NleH2-GFP 




Figure 3-6  Fluorescence microscopy of NleH-GFP  
pAHE8 (NleH1-GFP) and pAHE22 (NleH2-GFP) were transformed in ZAP193 (A), ZAP193∆ler 
(B) and ZAP193∆grlA (C) and at OD600 = 0.8 fixed onto a microscope slide, stained for EspA 
filaments and z-stacks taken as described in Materials and Methods.  Using Volocity 
quantification software, the average GFP fluorescence per voxel of 100 individual bacteria 
of each strain was measured and plotted for NleH1 (D) and NleH2 (E).  Error bars represent 
the standard deviation. 
 
EspA filaments are not detected in a ler negative background and are reduced in 
the grlA mutant.  The expression of NleH-GFP in both mutants is reduced, and 
the heterogeneity seen with NleH2-GFP is lost.  NleH1-GFP expression is reduced 
from a mean RFU value of 29 in wildtype to 24 and 26 RFU in a Fler and FgrlA 
mutant respectively; NleH2-GFP from an overall average of 78 RFU to 25 and 27 
RFU.  The difference in NleH-GFP expression between the two mutants is not 
great at this optical density; the difference may be more apparent if the sample 
was taken from a later point as it can be seen from the population analysis that 
the difference increases during the stationary phase of growth, Figure 3-4.  
However, assessment of the presence of EspA filaments cannot occur at OD600nm 
= 1.2 as EspA expression is rapidly reduced upon entry into stationary phase (Roe 
et al., 2003). 
 
3.3.3 Expression in nleH knockouts 
3.3.3.1 Construction of E. coli O157:H7∆nleH mutants 
E. coli O157:H7 strain TUV93-0 is a non Shiga-like toxin-producing derivative of 
the genome sequenced strain EDL933 (Perna et al., 2001), with the sequence 
publically available on coliBASE (http://www.xbase.ac.uk/genome/escherichia-
coli-o157h7-edl933).  The availability of the sequence allows confident primer 
design and to create defined nleH deletions in this strain.  The first approach to 
generate mutants was to use lambda red-mediated gene replacement and this 
technique was chosen because it is a one-step process.  First, In-Fusion cloning 
was used to construct a plasmid containing a Kan cassette flanked with 500bp of 
sequence homologous to NleH1 5’ and 3’ UTRs (pAHE17).  This product was PCR 
amplified and purified for recombination into the chromosome.  Three separate 
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Lambda Red-mediated recombination events were attempted to replace the 
NleH1 gene with the Kan cassette in the TUV93-0 chromosome.  Although 
possible recombinants with the kanamycin resistant phenotype were generated, 
the replacement of NleH1 by the Kan cassette could not be confirmed by PCR.  
On other occasions, the recombinants would remain ampicillin resistant 
indicating that pKM201 had not been lost.  Overexpression of the red and gam 
genes, present on pKM201, are mutagenic to E.coli O157:H7 therefore 
recombinants must not retain this plasmid in order to ensure that any phenotype 
seen is solely due to the engineered deletion (Murphy & Campellone, 2003).  
Owing to this an alternative strategy, allelic exchange, was undertaken to create 
nleH mutants and allelic exchange vectors pKO3bH1 and pKO3bH2 were 
constructed.  NleH1 was successfully replaced with a kanamycin cassette in 
TUV93-0, and subsequently the cassette excised by Flp recombinase expressed 
from pCP20, which was confirmed by PCR using primers which bind upstream and 
downstream of NleH1, at a position outwith the flanking regions used for allelic 
exchange.  Figure 3-7 shows that the PCR product is increased from 2090bp in 
the TUV wildtype to ~2500bp in TUVFnleH1::Kan due to the replacement of the 
NleH1 gene (882bp) with the kanamycin cassette (1400bp).  The PCR product 
from TUVFnleH1 is 1200bp due to the deletion of nleH1. 
 
Figure 3-7  PCR to confirm replacement or deletion of NleH1 in EHEC strain TUV93-0 
EHEC O157:H7 strain TUV93-0 was transformed with allelic exchange vector pKO3bH1 to 
create TUV∆nleH1::Kan, which was then transformed with pCP20 to excise the antibiotic 
cassette to create TUV∆nleH1.  Genomic DNA was extracted from each variant, with 
numbers denoting different mutant clones, and PCR performed with primers NleH1.ext.F 
and NleH1.ext.R to amplify across the NleH1 gene. 
 
TUV93-0 and TUVFnleH1 were transformed with pKO3bH2 to exchange NleH2 
with a kanamycin cassette; unfortunately a successful recombinant could not be 
resolved after three individual attempts for each strain.  Therefore, due to time 
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constraints, an NleH double mutant and its parent E. coli O157:H7 strain 85-170 
was requested from Prof Gad Frankel (Hemrajani et al., 2008).  Single allele 
mutants were not available therefore 85-170 was transformed with pKO3bH1 or 
pKO3bH2 for allelic exchange.  85-170FnleH1 was successfully made and 
although recombination with pKO3bH2 was unsuccessful, a single allele mutant 
in NleH1 may still provide interesting results.  PCR was performed to amplify 
across the NleH1 or NleH2 genes on 85-170 wild-type, 85-170FnleH1H2 and 85-
170FnleH1 to confirm replacement or deletion.  Wild-type 85-170 nleH1 and 
nleH2 generates a PCR product of 2090bp and 2120bp respectively, Figure 3-8.  
85-170FnleH1H2 produces PCR products greater (~3000bp) and smaller (~1400bp) 
than wild-type for nleH1 and nleH2 respectively; this shows a replacement of 
NleH1 and deletion of NleH2 in this strain.  The PCR product from 85-170FnleH1 
is 1200bp, showing the successful deletion of the nleH1 gene. 
 
Figure 3-8 PCR to confirm NleH1 and NleH2 replacement or deletion in EHEC strain 85-170 
EHEC strain 85-170 and 85-170∆nleH1H2 were received from Prof Gad Frankel; 85-170 was 
transformed with pKO3bH1 and pCP20 to generate single NleH1 mutant.  Genomic DNA was 
extracted from each variant, with numbers denoting different mutant clones, and PCR 
performed with primers H1.ext.F+R or H2.ext.F+R to amplify across the NleH1 or NleH2 gene 
respectively. 
 
3.3.3.2 Expression of NleH-GFP 
Once replacement or deletion of the nleH alleles was confirmed in the mutants, 
all three strains were transformed with pAHE8 and pAHE22 to assess NleH-GFP 
expression in these backgrounds.  NleH-GFP expression is negligible in 85-170 
wild-type (WT) and 85-170FnleH1 (FH1) (Figure 3-9); the expression levels are 
~200-fold less than in ZAP193, Figure 3-2.  Expression of NleH-GFP in the double 
mutant increases as the OD600 increases; NleH1-GFP is ~11-14 times, and NleH2-
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GFP is ~8 times, that of wild-type.  NleH1-GFP expression is double that of 
NleH2-GFP in 85-170FnleH1H2 after OD600 = 0.6.  At OD600 = 1.2, NleH1-GFP 
expression is ~4-fold less in 85-170FnleH1H2 than ZAP193; NleH2-GFP is reduced 
~8-fold.  
 
Figure 3-9 NleH-GFP expression in NleH knockouts 
pAHE8 (A) and pAHE22 (B) were transformed into 85-170, 85-170∆nleH1 and 85-
170∆nleH1H2.  Fluorescence was measured during growth in MEM as described in Materials 
and Methods. 
Also, NleH1-GFP is expressed two times more than NleH2-GFP at OD600 = 0.8; the 
converse is seen in ZAP193 at the same optical density.  Growth of these strains 
in MEM media is comparable to that of ZAP193 as they reached similar optical 
density levels during the timecourse (8 hours maximum).  Therefore, these 
results imply that there may be a different repertoire, or alternative action or 
expression, of regulators in 85-170 compared to ZAP193.  For example, the 
alternative sigma factor rpoS can vary between strains/isolates, affecting 
phenotypes such as the GAD stress response (Bhagwat et al., 2005), both of 
which are involved in LEE regulation, and can impact upon virulence.  Also, it 
has previously been shown that EHEC strains differ in their expression of 
translocon proteins from the LEE (Roe et al., 2003), therefore it can be possible 
to observe heterogeneity in expression of other horizontally acquired genes.  
NleH-GFP expression is greater in an 85-170 nleH double mutant compared to 
parent, and this may be attributed to less competition for binding to the CesT 
chaperone allowing NleH-GFP to be stabilised and protected from 
posttranslational degradation.   
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3.4 Expression of NleH upon host cell contact 
Once the expression of NleH had been assessed in a population, the effect of 
host cell contact was tested by infecting embryonic bovine lung (EBL) epithelium 
cells with ZAP193 transformed with pAHE8, pAHE22 and pAJR145 (rpsm::gfp), a 
transcription reporter plasmid with the rpsM promoter cloned upstream of gfp, 
which constitutively expresses GFP (Roe et al., 2004).  Time 0 is determined as 
immediately after centrifugation of the bacteria upon the host cells at 1,000 xg 
for 5 minutes.  At 5, 10, 30 and 180 minutes post infection, the media was 
removed, membrane stain applied then the cells were fixed in 
paraformaldehyde.  The bacteria were stained by indirect immunofluorescence 
with α-O157 and α-rabbit AlexaFluor-555 conjugate antibodies. 
Upon contact with host cells, the expression of NleH-GFP is reduced to below 
detectable levels at all time points tested, whereas the control, consisting of 
the constitutive rpsM promoter, was detected at all time points.  This indicates 
that there are no experimental factors affecting GFP fluorescence during the 
course of the experiment.  Also, it was previously mentioned that there can be a 
fitness cost inferred from the maintenance of GFP reporter plasmids which may 
result in a reduction in virulence, for example in Salmonella (Knodler et al., 
2005; Clark et al., 2009).  However, E. coli O157:H7 carrying the GFP reporter 
plasmids employed in this study can still form A/E lesions in vitro and within a 




Figure 3-10 Expression of NleH-GFP upon E. coli O157:H7 ZAP193 contact with EBL cells 
ZAP193 transformed with plasmids expressing GFP constitutively (pAJR145; rpsm::gfp) or translational fusions of nleH to gfp under the control of their 
native promoter (pAHE8; NleH1-GFP, pAHE22; NleH2-GFP) were added to EBL cells and incubated for 0, 5, 30 or 180 minutes at 37°C, 5% CO2 before 




Non-LEE encoded effector H is a bacterial effector found in all A/E pathogens 
tested to date, and is translocated by the T3SS.  It was first identified through a 
bioinformatic and proteomic approach, owing to its homology to S. flexneri  
effector OspG (Tobe et al., 2006).  There is only one nleH allele in the mouse 
A/E pathogen C. rodentium but there are two alleles present in E. coli O157:H7; 
each nleH allele is encoded on a prophage which also carries other nle effectors 
previously reported to be expressed and secreted.  NleH1 (z0989) is encoded on 
the same O-Island (OI-36) as nleC (z0986) and nleD (z0990) which are both 
transcribed in secretion permissive conditions, and NleD expression is reduced 
two-fold in a ler negative background (Roe et al., 2007).  NleH2 (z6021) is 
encoded on the same O-Island (OI-71) as nleA (z6024), nleF (z6022) and nleG 
(z6030); nleA has been shown to be transcribed and its expression dependant 
upon Ler (Roe et al., 2007; Schwidder et al., 2011).  NleH was a good candidate 
for further research due to preliminary data showing that its expression was 
upregulated in the same conditions which upregulated the LEE; also the 
presence of two alleles encoded on separate O-Islands raised questions as to 
whether they are each expressed under the same conditions, how their 
expression is regulated and if it is differential. 
Upon comparison of the 5’ UTR sequences of E. coli O157:H7 EDL933 NleH1 and 
NleH2, it was apparent that the further from the ATG start codon of the ORF, 
the more diverse the sequence.  This led to the hypothesis that transcription 
may vary between the two alleles depending upon the length of 5’ UTR cloned 
upstream of a translational fusion of nleH to gfp.  The length of 5’ UTR did not 
vary the expression of NleH2-GFP, indicating a minimum of 113 nucleotides 
upstream of the start of the ORF is required for expression; it would have been 
interesting to test if the coding sequence of NleH2 is also required for its 
expression with this length of 5’ UTR by cloning the NleH2 5’ UTR upstream of 
NleH1-GFP.  However, NleH1-GFP expression in MEM is dependant upon the 5’ 
UTR length, as after OD600nm = 0.8, expression increases with an increase in 5’ 
UTR length cloned.  Research, published during this study, using ChIP-on-chip 
analysis demonstrated that the E. coli O157:H7 Per-C like homologue (Pch) 
regulator directly binds the nleH1 promoter but binds further upstream in the 
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nleH2 prophage in order to exert its control (Abe et al., 2008).  This study also 
determined that Pch does not have a general consensus binding site, as it has 
various numbers and positions of binding sites depending upon the target gene, 
thus regulating a broad range of genes.  Therefore, the increase in NleH1-GFP 
expression with increase in 5’ UTR cloned may be due to a direct effect of Pch 
binding to the area between -283 and -531bp, or an indirect effect of Pch 
modulating the secondary structure of nleH1 and its 5’ UTR, facilitating the 
action of another positive regulator, or displacing a repressor such as H-NS.  
Further experiments would have to be carried out to confirm that Pch binds to 
this region of the NleH1 5’ UTR.  NleH-GFP expression is greatest upon entry into 
stationary phase, nutrient depletion in this stage of growth increases the 
concentration of ppGpp, a signalling molecule which positively regulates the 
transcription of ler and pch via its interaction with RNA polymerase (Nakanishi et 
al., 2006).  Pch regulators are not present in K-12 strains, thus providing some 
explanation to the lack of expression of the NleH-GFP plasmids observed in this 
background.  It can be concluded from the NleH-GFP expression in 
BW25113FrpoS data, Figure 3-3 B, that RpoS is not a direct repressor of nleH 
expression.  It would have been interesting to test NleH-GFP expression in an E. 
coli O157:H7 FrpoS background, as RpoS negatively regulates pch transcription 
(Iyoda & Watanabe, 2005), or to co-express Pch with NleH-GFP in E. coli K-
12FrpoS.   
Previous work has shown that the LEE is upregulated when E. coli O157:H7 is 
cultured in MEM compared to DMEM, as well as non-LEE encoded effectors NleA-E 
(Roe et al., 2007).  Analysis of the expression of translational fusions of nleH1 
and nleH2 to gfp under the control of their native promoters reveals that 
expression of NleH-GFP is 4-fold greater in MEM compared to DMEM, Figure 3-2.  
As discussed previously, it remains to be elucidated which component, or 
combination of nutrients, is responsible for the increased induction of gene 
expression in MEM compared to DMEM.  It may be that the lower concentrations 
of amino acids and vitamins present in MEM provide a better representation of 
the conditions encountered by the bacterium in vivo.  Previous studies have 
reported that EHEC esp::lacZ expression is detected in DMEM+HEPES but not in 
DMEM alone (Beltrametti et al., 1999) and EHEC adherence in vitro is increased 
by the addition of bicarbonate ions, but not HEPES, to LB (Abe et al., 2002).  A 
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recent report has shown that adding butyrate to DMEM increases LEE expression 
and EHEC adherence to cells in vitro (Nakanishi et al., 2009).  It has also been 
reported in other bacterial species that small modifications of culture media can 
affect the expression of the T3SS.  In Yersinia, the translocon of the T3SS is 
secreted in the presence of calcium ions, and when these ions are chelated from 
the media, secretion of the Yop effectors is induced (Nilles et al., 1997; DeBord 
et al., 2003; Edqvist et al., 2003; Torruellas et al., 2005).  Similarly, the 
absence of magnesium in the media induces expression of the second T3SS SPI-2 
in Salmonella enterica serovar typhimurium (Deiwick et al., 1999).  Also the SPI-
1 system of S. Typhimurium is induced when in the presence of increased sodium 
chloride concentrations (Song et al., 2004; Ibarra et al., 2010).  These results 
demonstrate that expression of the T3SS, and its effectors, can vary significantly 
depending upon the in vitro culture conditions. 
Based on the hypothesis that effectors would be co-ordinately expressed with 
the apparatus that secretes them, NleH-GFP expression was assessed in LEE 
encoded regulator negative backgrounds.  GFP expression in vitro from the 
translational fusions was reduced for NleH1 and NleH2 in ler and grlA negative 
strains.  Q-PCR shows that nleH1 and nleH2 transcription, or mRNA stability, is 
dependant upon ler and grlA; however based upon the 5’ UTR assay results and 
other published research, these regulators are likely to have an indirect effect 
on nleH expression.  Pch has been shown to regulate expression of nleH1 and 
nleH2 independent of Ler, through microarray analysis and ChIP-on-chip (Abe et 
al., 2008).  Investigations published during the period of my study reported that 
C. rodentium nleH (CRnleH) transcription is reduced in a ler and grlA mutant 
background, in a similar trend to the results above with E. coli O157:H7 nleH1 
and nleH2, although not significantly in their CAT activity assay (Garcia-Angulo 
et al., 2008).  Further analysis with Fler, FgrlA, FgrlR and FcesT mutants 
transformed with a plasmid expressing CRnleH::HA under the control of an 
inducible promoter demonstrated that CRNleH-HA is regulated 
posttranslationally; with its stability dependant upon the presence of its 
chaperone CesT (Thomas et al., 2005; Thomas et al., 2007) and active secretion, 
its degradation is mediated by Lon, thereby regulating NleH in coordination with 
the LEE.  GrlR was also shown to have a negative posttranscriptional and 
posttranslational effect on CRNleH expression, which may be in concert with the 
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indirect effect of ler and grlA on NleH expression, as they are all involved in the 
same regulatory loop (Barba et al., 2005), with GrlR binding to GrlA thereby 
hindering its regulatory activity (Jobichen et al., 2007; Huang & Syu, 2008).   
Many E. coli O157:H7 virulence factors are expressed heterogeneously, such as 
espA (Roe et al., 2003), tir, map, intimin (Roe et al., 2004) and nleA (Roe et 
al., 2007), in order to co-ordinate expression of the effectors with that of the 
T3S apparatus.  Single cell imaging of NleH-GFP expressing E. coli O157:H7 
showed that NleH-GFP is expressed by all cells, however the RFU of GFP 
measured per cell is homogenous in NleH1 and heterogeneous in NleH2.  When 
cultured in MEM, only 80% of the population co-stained for EspA filaments, 
correlating with previous reports (Roe et al., 2003) showing that only a sub-
population of ZAP193 (40-80%) express EspA filaments when cultured in the same 
media, and this percentage was maintained in the ‘hyperexpressor’ population 
of NleH2.  This shows that although NleH-GFP expression is induced by the same 
conditions as that for the LEE, it is not strictly co-ordinated.  Expression of nleA 
is strictly co-ordinated with the LEE and its transcription has been shown to be 
directly regulated by ler (Roe et al., 2007; Abe et al., 2008; Schwidder et al., 
2011). NleA also plays an important role in the virulence of A/E pathogens 
(Gruenheid et al., 2004; Thanabalasuriar et al., 2010).  These results suggest 
that the contribution of an effector to E. coli O157:H7 pathogenesis may reflect 
how the effector is regulated to be expressed in co-ordination with the LEE.    
NleH-GFP expression cannot be detected upon contact with host cells under the 
conditions tested, and it has previously been reported that host cell contact 
results in a reduction in expression of non LEE genes (Dahan et al., 2004; Roe et 
al., 2007).  The persistence of E. coli O157:H7 on host cells has been shown to 
be mediated through gadE (Tatsuno et al., 2003; Tree et al., 2011).  GadE is a 
transcriptional regulator, part of the GAD acid stress response, which is also able 
to repress LEE2/3 thereby reducing LEE-encoded effector transcription.  This 
induction of the GAD stress response and reciprocal repression of the LEE 
mediated by GadE is controlled by psr genes.  There is a high association 
between non-LEE encoded effectors with psr and/or pch regulator genes 
encoded on the same horizontally acquired element, leading to the hypothesis 
that the Psr mediated induction of gadE transcription and subsequent repression 
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of LEE encoded effectors facilitates non-LEE encoded effector secretion (Tree et 
al., 2011).  It is also interesting to note that many nle effector proteins, 
including NleH, exhibit an important role in colonisation but not for A/E lesion 
production or pathogenesis (Dziva et al., 2004; van Diemen et al., 2005; Kelly et 
al., 2006; Vlisidou et al., 2006b; Wickham et al., 2007; Echtenkamp et al., 2008; 
Garcia-Angulo et al., 2008; Hemrajani et al., 2008).  
In conclusion, NleH1 and NleH2 are expressed in E. coli O157:H7 ZAP193 under 
secretion permissive conditions and their transcription is dependant upon 
regulators specific to E. coli O157:H7.  Although the 120bp sequence upstream 
of NleH1 and NleH2 is 70% homologous, expression of the two alleles is 
differential as this is enough for maximal NleH2 expression but NleH1 requires 
additional upstream sequence.  Therefore, NleH1 expression is under the control 
of a regulator, possibly Pch, which binds between 531 and 283bp upstream of 
the ORF.  LEE encoded regulators Ler and GrlA have an indirect effect on nleH 
transcription as NleH expression is not strictly co-ordinated with that of the T3S 
apparatus.  NleH expression may be alternatively regulated in other E. coli 
O157:H7 strains as expression of the nleH::gfp translational fusions differed 
between two E. coli O157:H7 strains. 
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4 Function of Non-LEE encoded effector H (NleH) 
4.1 Summary 
During the course of this study, other laboratories have been investigating the 
function of NleH, and it has been found to play a role in modulating the host’s 
response to infection through its interaction with ribosomal protein subunit 3 
(RPS3), altering NF-κB activation (Gao et al., 2009), and Bax inhibitor 1 (BI-1), 
inhibiting apoptosis (Hemrajani et al., 2010).  The aim of the work described in 
this chapter was to elucidate the function of E. coli O157:H7 NleH in the host 
cell by independently testing its effects on NF-κB activation, owing to its 
homology with OspG, and trying to determine its host target through 2D 




NleH1 and NleH2 are homologs of the OspG protein, an effector protein of 
Shigella flexneri, identified by a BLASTp query search (Tobe et al., 2006). Using 
a yeast two hybrid screen, OspG was found to interact with E2 ubiquitin-
conjugating enzymes, thereby inhibiting NF-κB activation and interfering with 
the host innate immune response (Kim et al., 2005).  An alignment of E. coli 
O157:H7 EDL933 NleH1, NleH2 and OspG primary sequences, using ClustalW 
(Figure 4-1), reveals that NleH1 and NleH2 share 87% identity and NleH1/2 and 
OspG share 14-15% identity.  This indicates that the homology of NleH with OspG 
is largely because they share the key residues for kinase catalytic motifs (Hanks 
& Hunter, 1995); their C-terminal region shares 48% protein identity (Nobe et 
al., 2009) and both effectors are able to autophosphorylate (Kim et al., 2005; 
Gao et al., 2009; Hemrajani et al., 2010).   
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Figure 4-1 Amino acid sequence alignment of NleH1, NleH2 and OspG 
Alignment performed using ClustalW software (http://www.ebi.ac.uk/Tools/msa/clustalw2/).  
The 10 amino acid indel in NleH2 is highlighted in orange.  Domains I, II, III are conserved 
catalytic motifs found in protein kinases, present in all three effectors.  PDZ and SH3 
binding domains and motifs recognised by SUMO-1 for modification were identified by 
inputting the amino acid sequence into the ELM resource (http://elm.eu.org/links.html).  The 
N-terminal part of NleH has been shown to interact with CesT in EPEC (Thomas et al., 2007).  
The residues, K159, E173, D258, which were mutated to alanine for functional studies are 
indicated by red underscore. 
 
Although T3SS effectors are prokaryotic proteins, they must be able to function, 
tolerate and be stable in eukaryotic environments.  Also, as they exert a 
function in the host cell, they may possess some eukaryotic linear motifs (ELMs), 
which are short amino acid sequences that function as regions of regulation, 
independent of the tertiary structure of the protein (Gould et al., 2010).  
Software which maps ELMs to any of the 153 identified motifs, to a protein of 
interest has been described (http://elm.eu.org/).  Dr Paul Dean (Newcastle 
University) used this software to mine for potential effectors in 
enteropathogenic E. coli (EPEC) using this resource; first all predicted proteins 
in EPEC (~4600) are cross-referenced against the ELM database to give common 
motifs found in the proteome and then all known effectors, to give common 
motifs found in effectors.  By comparing common motifs found in the proteome 
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with those found in effectors, it is possible to highlight motifs specific to 
effectors that are not common in the proteome.  If a non-proteome ELM is found 
within the sequence of a putative effector protein, this suggests that the ELM 
may contribute to the protein’s function outwith the bacterium, i.e. within the 
mammalian cell.  ELMs found in EPEC effectors include KEN box, PDZ_1 ligand, 
SH3_5 ligand, WW_2 ligand and SUMO modification motifs (University of Glasgow 
Microbiology seminar 30/03/10, Dr Paul Dean).  NleH1, NleH2 (from E. coli 
O157:H7 EDL933 sequence) and OspG were screened for the presence of ELMs; 
NleH1 has 36/153, NleH2 has 33/153 and OspG 21/153 possible ELMs.  Three out 
of the five aforementioned ELMs common in EPEC effectors were identified in 
NleH1 and NleH2, Figure 4-1 (PDZ, SH3 and SUMO).   
PDZ (PSD-95/Disk-large/ZO-1) domains have an important role in mediating 
protein-protein interactions within higher organisms and typically interact with 
proteins displaying a consensus sequence of X-S/T-X-H, where X is any amino 
acid and H is hydrophobic, at its C-terminal end.  NleH1 binds Na+/H+ exchanger 
regulatory factor 2 (NHERF2) via its PDZ motif (-SKI) (Martinez et al., 2010); 
NHERF proteins are plasma membrane associated proteins which interact with 
multiple proteins, forming scaffolds, therefore influencing protein trafficking 
and localisation.  NHERF2 binding to NleH1 modulates its trafficking to the 
endoplasmic reticulum and also subdues its anti-apoptotic function (Martinez et 
al., 2010).  The same study shows that the NHERF binding to effector proteins 
Map and NleA also affects their localisation and function within the host cell.  
The authors propose that NHERF binding of bacterial effectors provides an 
additional regulatory function to co-ordinate the localisation and timing of their 
function. 
The SH3_5 motif (PXXDY) is recognised by some Src Homology 3 (SH3) domains 
and SH3_3 (XXXP/VXXP) is a more general SH3 recognition motif.  This motif is 
also involved in protein-protein interactions and although common amongst 
bacterial effectors (Dean, 2011), a role for these motifs in protein function has 
only been described in two effectors, EspF and its homolog EspFU/TccP.  EspF 
contains an SH3 binding motif in each of its proline rich repeats (PRR).  A yeast 
two hybrid screen of EspF against cDNA prepared from HeLa cells determined 
that EspF interacts with sorting nexin 9 (SNX9), which is mediated by SNX9’s SH3 
domain (Marches et al., 2006).  Further studies using a phage library elucidated 
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the SH3 consensus sequence recognised by SNX9 (RXAPXXP), present in the N-
terminal region of the PRRs in EspF (Alto et al., 2007).  EspF’s role in membrane 
remodelling and rearranging the cytoskeleton is dependent upon this 
interaction, as it results in tubule formation by SNX9 allowing recruitment of N-
WASP, another binding partner of EspF, to the tubules and subsequent actin 
polymerisation (Alto et al., 2007). 
SUMOs (Small Ubiquitin-related Modifiers) are ubiquitin-like proteins that can be 
reversibly and covalently conjugated onto lysine residues via E1, E2, E3-based 
system (like that used for NF-κB activation) (Hay, 2005).  SUMO post-
translational modification (aka sumoylation) is most common to nuclear proteins 
and can dramatically alter the subnuclear localisation of a modified protein 
(Wilson & Rangasamy, 2001).  SUMO modification of a bacterial protein has not 
yet been described however this post-translational modification has been 
reported with viral proteins.  The function of papillomavirus E1 protein, a DNA 
helicase, is dependent upon its localisation to the nucleus which is mediated by 
sumoylation (Rangasamy et al., 2000).  Human cytomegalovirus (CMV) protein 
IE1 is sumoylated (Spengler et al., 2002), which promotes viral replication by 
increasing transcription of another CMV protein IE2 (Nevels et al., 2004).  
Sumoylation of vaccinia virus protein A40R makes it soluble and controls its 
localisation, interestingly not to the host nucleus, but to the areas of viral 
replication in the cytoplasm termed by the authors as ‘mini-nuclei’ (Palacios et 
al., 2005). 
 
4.3 Investigating the effects of NleH on NF-κB signalling 
NleH is a predicted Ser/Thr protein kinase, and the C-terminal end of the 
protein shares sequence similarity with that of the S. flexneri effector OspG.  
OspG controls the host innate immune response by interfering with NF-κB 
activation.  Therefore, NF-κB activation in the presence of E. coli O157:H7 
NleH1 or NleH2 was tested in vitro to elucidate if NleH has the same effect as 
OspG.  To facilitate the comparison, the OspG construct (pRK5myc-OspG) used in 
the OspG study (Kim et al., 2005) was requested from the corresponding author, 
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Dr Claude Parsot, but unfortunately the request was refused.  Owing to this, 
pCMV-OspG was constructed as described in Materials and Methods to allow a 
comparison between the effectors with the same assay.  Shortly prior to 
conducting the experiment, it was reported that NleH1 inhibits and NleH2 
stimulates NF-κB activation but they interact with the same host target (RPS3) 
(Gao et al., 2009).  These opposing, and possibly contradictory, results were 
surprising considering the high identity shared between the two proteins and 
consequently provided more reason to independently test the affect of NleH on 
NF-κB activation.   
The impact of NleH on NF-κB activation in host cells was assessed by transfecting 
plasmids which expressed NleH variants, with pCMV (vector only) and OspG as 
controls, into HEK293T cells.  Activation of NF-κB was stimulated by adding TNF-
α (25 ng/ml) and quantified through a luciferase reporter.  This work was carried 
out in collaboration with Prof Tom Evans, who provided the mammalian cell line 
and plasmids.  Three site-directed mutants of NleH (K159A, E173A and D258A), 
Figure 4-1, were included to assess their affect on NF-κB activation.  These 
residues are conserved in kinase domains, where the lysine (K159) residue is 
essential for activity, the glutamate (E173) stabilises ATP docking and the 
aspartate (D258) stabilises the catalytic loop (Hanks & Hunter, 1995).  Prof Tom 
Evans performed an in vitro kinase assay and autoradiography to demonstrate 
autophosphorylation of recombinantly purified NleH1 protein and its kinase dead 
mutant K159A.  This confirmed that NleH1 can autophosphorylate in the 
presence of radioactive labelled ATP and magnesium ions, an action shared with 




Figure 4-2 NF-κB activation in the presence of NleH variants 
HEK293T cells were co-transfected with a luciferase reporter plasmid under the control of 
consensus κB sites, a β-galactosidase and a control, NleH or OspG vector.  After 40 hours, 
cells were stimulated by the addition of TNF-α (25 ng/ml; 24 hours).  Statistical analysis with 
one-way ANOVA shows no significant difference compared with the pCMV control. 
 
The luciferase assay results (Figure 4-2) indicate that NleH1 stimulates NF-κB 
activation by ~45% and this effect is not dependent upon its kinase activity, as 
kinase-dead mutant K159A demonstrates similar levels of NF-κB induction 
compared with the WT NleH1.  NleH1 D258A reduces WT phenotype by ~35% and 
NleH1 E173A appears to abolish the WT phenotype as the NF-κB activity is 
similar to that of the control, pCMV.  The effect of NleH2 on NF-κB is negligible, 
as there is no increase or decrease compared with the control, pCMV.  OspG 
decreases NF-κB activation by ~17.5%, which is markedly lower compared to the 
70% reduction previously reported (Kim et al., 2005).  Upon closer assessment of 
the experimental conditions employed in this study, the authors assayed 
tranfections with increasing concentrations of OspG plasmid, and the 70% 
reduction in NF-κB activation is observed when there is 5 times more OspG (0.5 
µg) than the NF-κB reporter (0.1 µg) transfected.  In my assay, equivalent 
concentrations of effector and NF-κB reporter plasmids were transfected (0.4 
µg); the previous study reported a 30% decrease in NF-κB activation when 
equivalent concentrations of OspG and reporter plasmid were transfected.  This 
provides explanation to the reduced effect of OspG on NF-κB activation in my 
results compared to those reported by Kim and authors (Kim et al., 2005).  
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Therefore, these results suggest that NleH1 and NleH2 do not have the same 
effect upon NF-κB as its homolog OspG. 
 
4.4 Elucidating the host protein targets of NleH  
NleH is regulated, expressed and secreted by E. coli O157:H7, has Ser/Thr 
protein kinase activity with the ability to autophosphorylate, and contains ELMs 
within its primary sequence.  These characteristics suggest that NleH may have a 
function within the host cell.  In order to identify potential host cell proteins 
which are modified by or interact with NleH, two dimensional differential gel 
electrophoresis (2D-DiGE) and yeast-two hybrid screening were used. 
4.4.1 2D Differential Gel Electrophoresis 
2D-DiGE was first described in 1997 (Unlu et al., 1997) and can be used to 
identify post-translational modifications (PTM) and differences in protein 
abundance by directly comparing the proteomes from two separate conditions, 
e.g. wild-type vs. mutant.  The two samples are differentially labelled with 
CyDyes and co-separated on the same gel, and therefore the samples are both 
treated with the same handling conditions.  This technique is two dimensional as 
it first separates proteins by their relative charge on the basis of their pI, using 
isoelectric focussing, then by molecular mass using SDS-PAGE.  After separation, 
the gel is exposed to wavelengths of light that excite the chosen fluorophores, 
an image is taken for each sample and the images overlaid to determine any 
differential expression or PTM of the proteins. 
2D-DiGE analysis of the proteome of HEK293T cells transfected with NleH1 was 
compared against that of HEK293T cells transfected with kinase-dead mutant 
NleH1 K159A.  16 hours after transfection, the cells were stimulated with TNF-α 
(25 ng/ml) for 20 minutes prior to harvesting, as described in Materials and 
Methods.  The proteins from NleH1-1 WT transfected cells were labelled with 
Cy3 and those from NleH1-1 K159A transfected cells labelled with Cy5.  These 
samples were mixed together and separated first by isoelectric focusing then by 
SDS-PAGE.  The gel is scanned with a Typhoon scanner to excite the 
 126 
fluorophores, first Cy3 (Ex/Em; 540 nm/590 nm) for the HEK293T+NleH1 sample 
then Cy5 (620 nm/680 nm) for HEK293T+K159A (Figure 4-3). 
 
Figure 4-3 Typhoon scans of NleH1 WT and K159A  
HEK293T cells were transfected with NleH1 or its kinase dead mutant K159A, stimulated 
with TNF-α (25 ng/ml) for 20 minutes before harvesting and prepared for DiGE by labelling 
all the proteins from WT with Cy3 (A) and K159A with Cy5 (B).  The proteins were then 
separated first by isoelectric focusing then by electrophoresis. 
 
The 2D-DiGE gel was analysed using DeCyder analysis software.  The DeCyder 
analysis software isolates each of the protein ‘spots’ on the gel and assesses 
differences between their positions and volumes/concentrations.  Spots (Figure 
4-4 A) which show any significant difference are labelled blue and areas of no 
change are labelled yellow.  The threshold can be set to various stringency 
values, but even the most relaxed threshold did not resolve any significant 




Figure 4-4 Example view of DeCyder analysis software 
A.  The Typhoon scans are loaded into the software which isolates each protein spot and 
the densitometry compared between the two samples; yellow indicates no change and blue 
indicates a significant difference between the gels.  B.  The graph plots the volume ratio for 
each spot with the vertical line each side representing the threshold chosen.  C.  A spot can 
be selected for individual analysis.  D.  Detailed analysis of each individual spot is provided 
in the table. 
 
4.4.2 Yeast-two hybrid screen 
Yeast-two hybrid analysis can identify protein-protein interactions by the 
successful transcription of a reporter gene which can occur only when the DNA-
binding domain of a transcription factor, e.g. Gal4, genetically fused to the 
protein of interest (X), is brought into close proximity with its activation 
domain, genetically fused to a protein (Y) which interacts with protein X (Fields 
& Song, 1989). 
NleH1 and NleH2 ORF sequences from E. coli O157:H7 TUV93_0 were cloned into 
Gateway™ vector pDONR207 (Invitrogen, Scotland) as described in Materials and 
Methods.  These constructs were sent to Prof Jürgen Haas at University of 
Edinburgh for his laboratory to subclone NleH1 and NleH2 into their yeast two 
hybrid Gateway™ expression vector, pGBKT7-DEST, via an LR reaction 
(Stellberger et al., 2010).  They have access to an array-based yeast two hybrid 
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screening system allowing NleH1 and NleH2 to be screened, as bait, against a 
human cDNA (prey) library, comprising of about 100,000 targets, to test for 
protein-protein interactions.   
 
Figure 4-5  Yeast-two hybrid screen with vectors described by (Stellberger et al., 2010) 
A.  NleH1 and NleH2 ORFs are introduced into the Gateway
®
 vector pGBKT7-DEST via an LR 
reaction to create vector pGBKT7-NleH1/H2 (Bait; Gal4 DNA binding domain).  B.  This bait 
vector is transformed into haploid AH109 (gal4::his3) yeast cells, and selected on media 
without the addition of tryptophan, to select for plasmid uptake.  C.  Haploid Y187 yeast 
cells are transformed with a library of human cDNA vectors, pGADT7-human ORF (Prey; 
Gal4 activation domain), and selected on media without the addition of leucine to select for 
plasmid uptake.  D.  Prey cells are plated, with each ORF represented in duplicate, in an 
array and mated with bait cells; diploid cells are selected by growth in media without both 
leucine and tryptophan to confirm mating.  E.  Diploid cells are then transferred for growth 
in media without leucine, tryptophan and histidine to select for protein-protein interactions.  
Growth (due to transcription of gal4::his3) in both wells indicates protein-protein 
interaction, growth in only one well indicates a false positive result, and no growth indicates 
that no interaction has occurred. 
 
Each pairwise interaction is tested in duplicate to reduce the number of false 
positive interactions, which can occur due to overexpression of the hybrid 
proteins in the yeast.  Three hits were found with NleH1 and two with NleH2 in 
this screen, unfortunately they were all false positives.  It was anticipated that 
the screen would pick out the published NleH1 binding partners BI-1 and/or 
RPS3.  A commercial human testes cDNA library from Clontech was used for the 
screen, so it cannot be known conclusively whether these proteins are 
represented in the screen.  However, other published work demonstrates that 
both BI-1 (Walter et al., 1995) and RPS3 (Schlecht et al., 2004) are expressed in 
this tissue type; therefore these may be considered as false negatives within this 
screen. 
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4.5 Translocation reporter iLOV 
In collaboration with Dr John Christie, University of Glasgow, we tested the 
application of iLOV (improved Light Oxygen Voltage sensor domain) as a reporter 
protein in E. coli O157:H7 (Chapman et al., 2008).  LOV domains are part of the 
photosensing Ser/Thr protein kinases (phototropins) in plants and when the 
domain was recombinantly expressed in E. coli, it fluoresced when exposed to 
UV light (Salomon et al., 2000; Swartz et al., 2001).  The LOV domain was 
subjected to molecular evolution in order to improve its fluorescence and 
recovery after photobleaching to create iLOV (Chapman et al., 2008).  As proof-
of-principle, iLOV was then shown to be successfully applied in the localisation 
of a viral protein in planta, overcoming the problems observed with GFP as a 
reporter (Chapman et al., 2008).  iLOV is less than half the size of GFP, Table 
4-1, making it a suitable candidate to test as a reporter for T3S-mediated 
translocation. 
Table 4-1 Properties of GFP and iLOV 
Property Fluorescent Protein 




Size (kDa) 26 10 
Additional factors 
required for fluorescence 





Preliminary data from our laboratory demonstrated that genetically fusing iLOV 
to the C-terminal end of Tir, a T3S effector of E. coli O157:H7, did not interfere 
with its secretion and translocation.  We also found that a plasmid expressing 
Tir-iLOV can complement a ZAP193Ftir mutant and still function to form actin 
rich pedestals viewed with FAS staining.  Therefore, translational fusions of 
NleH1 and NleH2 to iLOV, under the control of an IPTG inducible promoter, were 
constructed to provide further data in the characterisation of this protein as a 
reporter in E. coli O157:H7.  The translocation and localisation of NleH in the 
host cell was investigated. 
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E. coli O157:H7 TUV93_0 transformed with pJ284 (ptac::iLOV), pAHE27 
(ptac::NleH1-iLOV) or pAHE28 (ptac::NleH2-iLOV) were added to EBL cells and 
incubated for 5, 10, 30 and 180 minutes before applying CellMask™ plasma 
membrane stain and fixing the cells with paraformaldehyde.  E. coli were 
immunostained with α-O157 antibodies raised in rabbits, followed by α-rabbit 
IgG AlexaFluor-555 conjugate antibodies.  Samples were viewed using a Zeiss 
AxioImager M1 and all z-stack images were acquired with the same acquisition 
protocol and excitation wavelength exposure times.  Micrographs (Figure 4-6) 
show that iLOV from ptac::iLOV expressing cells, is within the α-O157 labelled 
area indicating that it is contained within the bacterial cytoplasm.  However, 
there is no green signal seen within the red labelled E. coli with NleH1-iLOV and 
NleH2-iLOV expressing cells, instead it is found within the blue outlines 
indicating NleH1- and NleH2-iLOV is within the mammalian cell.  The green 
signal is not just diffuse within the cell, but appears localised to the cytoplasm, 
with some bright punctate areas visible.  The boxed areas (Figure 4-6 Merge) 
were selected for additional analysis with Volocity 3D restoration software 
(PerkinElmer).  These areas were viewed from above, side and below as shown 
in the diagram on the right-hand-side of Figure 4-7.  From this, it can be seen 
that the bacteria are associated with the cell periphery, indicated by the blue 
stain.  The side perspective shows that bacteria are either on or above the level 
of the membrane stain.  This perspective also shows that the green signal from 
NleH1- and NleH2-iLOV is localised within the mammalian cell as it is found at a 
greater depth than the bacteria and mammalian membrane.  This is also 
supported by the view from below, where NleH1-iLOV can be seen beneath the 
α-O157 stain labelling the bacteria.  The punctate areas of NleH-iLOV seem to be 
either near the plasma membrane or perinuclear.
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Figure 4-6  Fluorescence microscopy of NleH-iLOV upon contact with EBL cells 
TUV93-0 were transformed with plasmids expressing iLOV (pJ284), NleH1-iLOV or NleH2-iLOV and grown in inducing conditions (MEM+Amp+IPTG) 
before adding to EBL cells and incubated at 37°C, 5% CO2 before removing supernatant and fixing cells.  The panel of images was taken from the 30 




Figure 4-7 Three dimensional viewing of bacteria adhering to EBL cells. 
Boxed images from Figure 4-6 were analysed with 3D opacity Volocity software (PerkinElmer) to show the spatial localisation of membrane (membrane 




NleH1 and NleH2 are non-LEE encoded effectors which are translocated into the 
host cell via the T3SS (Tobe et al., 2006; Garcia-Angulo et al., 2008).  When 
NleH1 and NleH2 were first identified, a BLASTp search found that it shared 
significant sequence identity with S. flexneri effector OspG (Tobe et al., 2006).  
An alignment of the primary sequence of NleH1, NleH2 and OspG (Figure 4-1) 
shows that this similarity lies mainly within its conserved protein kinase 
domains.  A study of enterohaemorrhagic E. coli serogroup O111 confirms that 
NleH is distantly related to OspG; ospG homologues, with >90% protein identity, 
are present in non-O157 serogroups and Yersinia enterolitica (Nobe et al., 2009).  
The Y. enterolitica OspG homologue YspK was previously identified in a 
proteomic screen of effectors secreted via the Ysa T3S which is present only in 
Y. enterolitica Biovar 1B (Matsumoto & Young, 2006). 
NleH1 and NleH2 have 33 and 36 ELMs in their primary sequence, respectively, of 
which the PDZ binding domain has been characterised for NleH1 in EPEC 
(Martinez et al., 2010).  Although ELMs are present, they are not always used or 
modified.  For example, in a study of neuronal proteins with SUMO modification 
motifs, only 14 of the 39 motifs where sumoylated in vitro (Wilkinson et al., 
2008).  Regardless of this, assessing the ELMs present in a protein of interest 
provides areas of sequence which can be targeted by site-directed mutagenesis 
to investigate the function and/or localisation of the protein. 
The effects of NleH on NF-κB activation were assessed in vitro with HEK293T 
transfections.  The results (Figure 4-2) indicate that NleH1 activates NF-κB, 
which correlates with a previous report that Citrobacter rodentium NleH 
increases NF-κB activity in vivo (Hemrajani et al., 2008).  This was demonstrated 
through infection of NF-κB-luc reporter mice with C. rodentium or its isogenic 
FnleH mutant and semiquantitative RT-PCR of TNF-α RNA transcript extracted 
from the infected colons (Hemrajani et al., 2008).  E. coli O157:H7 NleH1 shares 
protein identity with CRNleH, as they both lack the 10 amino acid indel 
sequence, which supports the shared effect upon NF-κB activation (Hemrajani et 
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al., 2008).  However, these results also contradict with a previous report that E. 
coli O157:H7 NleH1 inhibits and NleH2 stimulates NF-κB activation (Gao et al., 
2009).  CRNleH tested under the same conditions inhibited NF-κB activation to 
similar levels as E. coli O157:H7 NleH1, which contradicts the activation 
observed in vivo in the previous study (Hemrajani et al., 2008).  Luciferase 
reporters were transfected into HEK293T cells in a manner similar to what was 
carried out in this study, however cells were stimulated with 4 times more TNF-α 
and analysed 1 hour post-stimulation.  Similar to the OspG study (Kim et al., 
2005), the effector plasmid and the NF-κB reporter plasmid were transfected at 
a 4:1 ratio which appears to amplify the effect (to a similar degree) observed 
with equivalent concentrations of vectors (Gao et al., 2009).  Studies in EPEC 
have shown that both NleH1 and NleH2 reduce NF-κB activity, by interfering 
with IKK-β induced NF-κB activation resulting in a suppression of IκB-α 
degradation (Royan et al., 2010).  This study also used transfection assays, but 
TNF-α was not used to stimulate NF-κB activation instead it was stimulated by 
the co-transfection of IKK-β or p65 (Royan et al., 2010).  The conclusion that 
NleH interferes with IKK-β induced activation of NF-κB was supported in part by 
further collaborative work with Philip Hardwidge and Michael Lenardo’s groups 
investigating the role of RPS3 in NF-κB activation, where they show that E. coli 
O157:H7 NleH1 can inhibit the phosphorylation of RPS3 by IKK-β (Wan et al., 
2011).  Inhibiting the phosphorylation of RPS3 restricts its translocation into the 
nucleus, reducing transcription of RPS3 dependent κB sites (Wan et al., 2007; 
Gao et al., 2009; Wan et al., 2011).  Regardless of this, transcription of genes 
controlled by non-RPS3 dependent κB sites can still occur, providing some 
explanation as to why NleH1 and NleH2 did not significantly affect NF-κB 
activation in my assay.  Royan and authors also report that EPEC NleH1 and 
NleH2 can inhibit ubiquitination of phosphorylated IκBα, which was observed 
alongside an OspG positive control, and this effect is dependent upon their 
intrinsic kinase activity (Royan et al., 2010).  Yet, it has not been shown that 
NleH specifically interact with E2 ubiquitin-conjugating enzymes like that of 
their OspG homolog. 
2D-DiGE shows no significant changes in the proteomes of HEK293T cells 
transfected with NleH1 or its kinase-dead mutant K159A.  This may be due to 
limitations in the technique in resolving proteins of low abundance.  To improve 
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upon this, additional sample preparation steps could have been introduced to 
better resolve low abundance proteins, such as subcellular fractionation or 
phosphoprotein enrichment using immobilised metal-affinity chromatography 
(IMAC).  Additional post-separation techniques include staining for 
phosphorylated proteins using Pro-Q Diamond stain (Molecular Probes) or 
immunoblotting with phosphomotif antibodies.  Alternative results may be 
obtained by altering the incubation time between transfection and stimulation 
and/or the period during which the cells undergo stimulus.  Another point to 
consider is that any affect of NleH on the host target protein may be transient 
and therefore the host target may be difficult to identify using this method. 
NleH1 and NleH2 were assessed in an array based yeast-two hybrid screen to test 
for possible protein-protein interactions with human proteins, Figure 4-5.  Only 
false positive hits were found, and as the proteins are recombinantly expressed 
in yeast, false negative results are possible.  False negative results arise because 
heterologous protein expression in yeast does not guarantee that all the possible 
PTMs of a protein will be represented.  NleH1 and NleH2 were shown to interact 
with Bax inhibitor 1 (BI-1) via a yeast-two hybrid screen (Hemrajani et al., 
2010), and with ribosomal protein subunit 3 (RPS3) via affinity purification with 
HeLa cell lysates and co-immunoprecipitation (Gao et al., 2009).  Based on these 
reports, these interactions may be considered as false negative results within 
our assay.  The yeast two hybrid cDNA library used in this approach was 
constructed from one tissue type (testes), and although it provides a large range 
of possible targets for NleH interaction; the range of mRNA expressed, splice 
variants and post translational modifications can vary between different cell 
types.  The yeast two hybrid assay may have provided positive interactions using 
a cDNA library constructed from a different tissue type, for example from human 
embryonic tissue, brain tissue or bovine tissue.   
iLOV is a fluorescent protein which is less than half the molecular mass of GFP 
and is able to recover after photobleaching (Chapman et al., 2008).  A 
translational fusion of iLOV to the C-terminus of Tir can complement a Tir 
deficient strain of E. coli O157:H7 and form actin pedestals (K. Velentza, I. 
Houghton, A. Holmes and A. Roe; unpublished results).  NleH-iLOV can be 
translocated into the host cell, as determined by fluorescence microscopy, 
Figure 4-6 andFigure 4-7.  NleH-iLOV localises to the cytoplasm of the 
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mammalian cell, with bright punctate areas visible.  These punctate areas near 
the plasma membrane may be where NleH localises when it is interacting with 
the NHERF2 scaffold protein (Martinez et al., 2010).  The possible perinuclear 
localisation of NleH-iLOV would have to be confirmed by nuclear staining, e.g. 
with DAPI, but this localisation correlates with the other host proteins which 
have been shown to interact with NleH, RPS3 (Gao et al., 2009; Wan et al., 
2011) and BI-1 (Hemrajani et al., 2010).  These micrographs differ from what 
was observed with pAHE8 and pAHE22 (nleH::gfp) as GFP is too large to be 
translocated through the T3SS.  It is interesting that NleH-iLOV is detected 
within the host cytoplasm soon after cell attachment.  This may be because the 
bacteria were grown in T3SS inducing conditions (MEM) therefore the apparatus 
was already displayed when contact was made with the host cell.  Also, NleH-
iLOV expression is induced by the addition of IPTG suggesting that 
overexpression of an effector may ‘override’ the control mechanisms of the 
T3SS, such as the chaperones.  It would have been interesting to test the 
translocation of NleH-iLOV under the control of its native promoter. 
In conclusion, NleH1 and NleH2 are Ser/Thr protein kinases, with the ability to 
autophosphorylate.  NleH-iLOV localises to the cytoplasm, plasma membrane 
and around the nucleus.  DiGE analysis and yeast-two hybrid assays were not 
successful in trying to elucidate a human kinase target or interacting partner of 
NleH1 or NleH2.  Other groups have shown that NleH1 interferes with RPS3- 
dependent transcription of NF-κB sites (Gao et al., 2009) by inhibiting RPS3 
phosphorylation by IKK-β, retaining RPS3 in the cytoplasm (Wan et al., 2011).  
The kinase activity of NleH1 is required to inhibit RPS3 phosphorylation by IKK-β 
but it does not directly phosphorylate either protein.  NleH in EPEC inhibits 
ubiquitination of phosphorylated IκBα in vitro, which is dependent upon its 
kinase activity.  NleH also inhibits the pro-apoptotic pathway via its interaction 
with BI-1 (Hemrajani et al., 2010).  A phosphorylation target of NleH has yet to 
be elucidated.  These results suggest that NleH is a multi-functional protein, 
which is not an uncommon trait of E. coli O157:H7 effector proteins, e.g. it has 
been described for EspF (Holmes et al., 2010).  iLOV can be genetically fused to 
T3S effectors without hindering their secretion, translocation or function.  This 
newly developed fluorescent protein provides a useful tool for the study of T3S 
effectors. 
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5 Enhancing the fluorescent toolbox of 
Streptococcus pneumoniae 
5.1 Summary 
Green Fluorescent Protein (GFP) was first identified from the Aequorea species 
of bioluminescent jellyfish in 1979 by Osamu Shimomora, but the gene was not 
cloned until 1992 by Douglas Prashner (Prasher et al., 1992).  Over the years, 
the wild-type (WT) GFP has been modified to improve certain properties (such as 
brightness) and to produce variants emitting in the blue (BFP), cyan (CFP) and 
yellow (YFP) regions of the spectra.  GFP has a β-barrel structure likened to that 
of the bacterial porins and the majority of amino acid mutations to produce the 
colour variants occur within the central alpha helix, where the chromophore (or 
fluorophore) is positioned.  The chromophore is responsible for the protein’s 
fluorescent properties and GFP does not require any additional co-factors from 
Aequorea victoria, for example aequorin needs calcium ions and luciferase 
requires ATP and other substrates in order to fluoresce.  This was demonstrated 
by heterologous expression of GFP in E. coli and C. elegans (Chalfie et al., 
1994).  However, GFP is dependent upon the availability of molecular oxygen for 
maturation of the chromophore after protein translation to form the fluorophore 
(Heim et al., 1994).  GFP is a weak dimer, but a monomeric form of GFP can be 
produced by replacing Alanine residue 260 with Lysine or Valine.  Regardless of 
the numerous combinations of single mutations introduced, emission in the 
orange and red regions of the spectra was unachievable; until the discovery of 
DsRed.  DsRed is a red fluorescent protein identified from the Discosoma species 
of non-bioluminescent red coral (Matz et al., 1999).  It is an obligate tetramer, 
and its monomer shares the β-barrel conformation of GFP.  The excitement of 
the discovery of a red fluorescent protein (RFP) was short-lived due to problems 
with its application as a reporter protein.  DsRed exhibits a slow maturation time 
(i.e. time to fold into a mature protein) and an intermediate green state (Jakobs 
et al., 2000).  Its tetrameric character results in a tendency to aggregate within 
the cytoplasm of the expressing cells, protein fusions can mislocalise or 
aggregates can be toxic to the host cell.  Work in Roger Tsien’s laboratory was 
paramount to the generation of monomeric RFP and coloured variants.  Through 
 138 
both direct mutagenesis, based on beneficial mutations found in GFP, and 
indirect mutagenesis with error-prone PCR, it was found that 33 mutations were 
required to make DsRed monomeric (Campbell et al., 2002), creating mRFP1.  
The first and last 7 residues of GFP were added to the N- and C-terminus of 
DsRed, respectively, to enable the stable fusion of a protein to either terminus 
of the mRFP (Shaner et al., 2004).  In order to further improve the qualities and 
expand the emission spectra of mRFP1, single point mutations were introduced 
indirectly via somatic hypermutation (Wang et al., 2004) and error-prone PCR 
(Shaner et al., 2004), and mutants screened by fluorescence-activated cell 
sorting (FACS).  The mutations involved in improving mRFP occur throughout the 
protein, and are not concentrated in the region of the chromophore like that for 
GFP.  The emission spectrum variants of mRFP were called mFruits, so named 
due to the wide range of emission spectra covered by the different FP’s and the 
‘m’ denotes their monomeric property [reviewed in (Shaner et al., 2007)]. 
The availability and development of fluorescent proteins has enabled the study 
of gene regulation, expression and protein localisation in all orders of organisms, 
from bacteria and fungi to higher eukaryotes.  Fluorescent proteins have been 
exploited to prolific effect in labelling systems such as Brainbow (Livet et al., 
2007) and Fucci (fluorescent, ubiquitination-based cell cycle indicator) (Sakaue-
Sawano et al., 2008).  Brainbow is a neuronal labelling system that has a number 
of different colour emitting fluorescent proteins encoded in tandem with lox 
recombination sites on a transgene.  The addition of Cre recombinase results in 
shuffling of these tandem genes (by recombination or inversion), resulting in one 
of up to 90 different colour hues to be expressed, which was used to map the 
neuronal network architecture in vitro and in vivo (Livet et al., 2007).  The 
Fucci system expresses E3 ubiquitin ligase substrates Cdt1, which is expressed 
highest during G1 phase, and Geminin, highest during S/G2/M phases, which have 
been genetically fused to red and green fluorescent proteins respectively, 
enabling tracking of the cell cycle progression from G1 phase (red) to S/G2/M 
phases (green) in vitro and in vivo (Sakaue-Sawano et al., 2008).   
To date, fluorescent proteins have been used in a very limited number of 
pneumococcal studies; as a transcriptional reporter, as a live cell marker and for 
pneumococcal protein localisation.  The expression of pneumococcal genes was 
investigated using differential fluorescence induction where a plasmid library 
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was created with random fragments of S. pneumoniae chromosomal DNA cloned 
upstream of a promoterless gfp gene (Bartilson et al., 2001; Marra et al., 2002).  
This library was cloned into S. pneumoniae D39 and the library clones subject to 
different growth conditions to assess pneumococcal gene induction evident by 
the expression of GFP.  GFP expressing cells were selected by fluorescence 
activated cell sorting (FACS) and the differentially expressed genes identified 
through sequencing the selected clones.  Growth conditions tested in vitro 
include the presence of competence stimulating peptide (CSP) (Bartilson et al., 
2001), carbon dioxide, high osmolarity, low iron, blood and change in 
temperature; gene expression during in vivo growth was also assessed (Marra et 
al., 2002).  One can only assume that the assessment of gene expression under 
different growth conditions was not continued using this technique due to the 
advances in, and cost reduction of, DNA microarray platforms. 
S. pneumoniae transformed with a plasmid containing gfp under the control of 
an uncharacterised pneumococcal promoter was used to track the migration of 
whole pneumococcal cells in lung tissue in vivo (Kadioglu et al., 2001).  This 
study showed that GFP expressing pneumococci could be identified in murine 
lung histology samples, specifically within the broncho-epithelial cells 4 and 24 
hours, after intranasal challenge.  However, the GFP fluorescence exhibited by 
these pneumococci was not considered bright (personal communication, Prof 
Tim Mitchell).  Upon closer assessment of the micrographs from this publication 
there is evidence of background fluorescence from the mammalian cells, which 
implies that a long exposure time was required in order to generate an adequate 
emission from the pneumococci expressing GFP.  Whether this lack of brightness 
is due to poor GFP expression in vivo, the GFP allele chosen, or reduced activity 
of GFP due to insufficient fluorophore maturation, is unknown. 
The localisation of proteins involved in S. pneumoniae choline metabolism, 
LicABCD, has been investigated using translational fusions to a fast-folding 
variant of GFP (Eberhardt et al., 2009).  The authors describe two plasmids 
which can integrate into the chromosome to create single copy genetic fusions 
to gfp at the 3’ end, where the fusion is under the control of the native gene 
promoter due to integration of the plasmid at the native locus, or the 5’ end 
where the fusion is under the control of a zinc-inducible promoter integrated at 
the non-essential S. pneumoniae bgaA gene locus.  After proof-of-principle 
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experiments with these constructs successfully correlated the localisation of an 
already characterised protein, the localisation of GFP-LicABCD fusion proteins 
were assessed with fluorescence microscopy, where cytoplasmic and membrane 
localisation could clearly be distinguished. 
The aim of the work reported in this chapter was to enhance the applications of 
fluorescent proteins in Streptococcus pneumoniae, by designing and 
characterising GFP, YFP and RFP, with their codon usage optimised for S. 
pneumoniae expression, as tools for future pneumococcal research. 
 
5.2 Codon-optimised fluorescent proteins 
The majority of the available genes for fluorescent proteins have a eukaryotic 
codon usage that can affect expression in prokaryotes.  Codon usage can vary 
between different organisms; therefore a protein with heterologous prokaryotic 
codon usage may not be efficiently expressed due to underrepresentation of a 
particular tRNA.  Therefore, the coding sequences for GFP, YFP and RFP were 
optimised to S. pneumoniae TIGR4 codon usage and synthesised by DNA2.0 
(California, USA).  DNA 2.0 uses the Codon Usage Database 
(http://www.kazusa.or.jp/codon) to optimise their products’ codon usage to 
the species/strain specified.  His, LumioTM and FLAG tags were included in the 
gene design at the 5’ end of the coding sequence.  The constitutive promoter 
from the S. pneumoniae aminopterin resistance operon (ami) was included in the 
design to ensure transcription of the genes in the pneumococcus (Alloing et al., 
1990; Beard et al., 2002), Figure 5-1.  Therefore, if any problems arise with 
expressing the heterologous genes in the pneumococcus, they may be attributed 




-35                                           -10                                             
CTCTAGAAGGAGGATAACAT|ATG|GCT|AAT|AAA|CAT|CAC|
RBS Met  Ala   Asn  Lys  His   His
CAT|CAC|CAC|CAC|GGA|GGA|GGT|TGT|TGT|CCT|GGA|TGT|
His   His   His   His Gly   Gly   Gly   Cys  Cys  Pro  Gly   Cys
TGC|GGT|GGC|GGT|GAT|TAC|AAA|GAT|GAT|GAT|GAT|AAG|
Cys Gly   Gly   Gly Asp  Tyr   Lys  Asp  Asp  Asp Asp  Lys  
Figure 5-1 Nucleotide sequence added upstream of the ATG start codon in designed 
constructs from DNA2.0. 
The lowercase letters denote the -35 and -10 promoter region and RBS is the ribosome 
binding site of the ami promoter from S. pneumoniae.  A hexaHis tag is highlighted in red, 
Lumio
TM
 (FlAsH) tag in green and FLAG tag in blue.  The translated three letter amino acid 
code is included beneath the nucleotide sequence. 
 
The synthesised genes were supplied by DNA2.0 in pUC-based vectors therefore 
the gene products were sub-cloned into low-copy number shuttle vector pAL2YI 
((Ibrahim et al., 2004), as described in Materials and Methods, to allow 
expression in S. pneumoniae.  GFP, YFP and RFP are all monomeric fluorescent 
proteins with approximately the same molecular weight of 30kDa (including the 
3kDa tags).  The excitation wavelengths (nm) are well separated between the 3 
proteins, with GFP at 482nm, YFP at 508nm and RFP at 588nm.  The shuttle 
vector fluorescence constructs, Table 5-1, were transformed into S. pneumoniae 
strain D39 and characterised using western blotting, LumioTM detection and 
fluorescence microscopy. 
Table 5-1 Details of codon-optimised fluorescent protein constructs 







pAHS4 GFP:3tags* 30 482 505 
pAHS5 YFP:3tags* ~30 508 524 
pAHS8 RFP:3tags* ~30 588 635 
* 3 tags = His, FLAG and LumioTM 
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5.3 Characterisation of S. pneumoniae codon-optimised 
GFP, YFP and RFP 
5.3.1 Expression of fluorescence during growth 
Once the plasmids were successfully transformed into D39, the levels of 
fluorescence were measured during the course of growth in BHI using a 
fluorescence plate reader.  This tests if the proteins are being expressed 
constitutively, as expected being under the control of the ami promoter, and 
that the values are greater than that of any autofluorescence from the 
pneumococcus itself.   
In a preliminary experiment, the fluorescence was measured directly from the 
culture in BHI, including a BHI only (blank) control, however it became apparent 
that this could not be continued in the protocol as the blank BHI control had 
similar fluorescence levels to that of the cultures.  This phenomenon had been 
previously reported (Acebo et al., 2000).  To address the problem of BHI 
autofluorescence, instead of testing alternative media such as tryptone soy 
broth, the bacteria were pelleted from a 1ml sample and suspended in 1ml PBS 
before being analysed for fluorescence, thus giving a standard protocol that can 
be applied to any growth media.  To account for the additional treatment viable 
counts were taken from the suspension in PBS, not from the BHI culture, to 
consider any potential cell loss.  This potential cell loss can be considered as 
minimal, because the viable counts are reproducible from the biological 
replicates seen in Figure 5-2 D. 
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Figure 5-2 Expression of 
fluorescent proteins during 
growth in S. pneumoniae D39 
20ml of BHI was inoculated 
with 5x10
5
 cfu/ml D39; D39 
pAHS4 (A; green); D39 pAHS5 
(A; yellow) and D39 pAHS8 (B; 
red).  At regular intervals, 1ml 
of culture was removed and 
OD600 measured (C); the 
remaining culture was 
incubated at 37°C.  The 1ml 
sample was centrifuged and 
the bacterial pellet suspended 
in 1ml PBS; 200µl aliquots 
were analysed in triplicate for 
fluorescence (GFP/YFP = Ex. 
485nm; Em. 520nm  RFP = Ex. 
544nm; Em. 620nm) in 
FLUOstar plate reader (BMG) 
and 20µl for viable count (C). 
D39 acted as a control for 
background fluorescence; 
fluorescence was plotted 
against OD600nm using 
Microsoft Excel software and a 
line of best fit obtained.  Using 
this method, data were 
corrected for background 
fluorescence.  The mean±SEM 
of three biological repeats is 
plotted and lines represent the 
line of best fit for 
fluorescence. 
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The codon-optimised green, yellow and red fluorescent proteins are 
constitutively expressed as the increase in fluorescence follows a similar trend 
to that of the growth curve until the late stationary phase, where fluorescence 
begins to decline (Figure 5-2 A, B and C).  The decline in fluorescence correlates 
with the decline in cell number due to autolysis (Figure 5-2 D), however at this 
stage of growth the pH of the culture media is likely to be acidic.  Acidic 
conditions can inhibit fluorescent protein activity, which is optimum at pH 7 
(Tsien, 1998).  There was no obvious indication of plasmid burden upon the cells 
as the growth curves and viable counts are comparable to D39 alone (results not 
shown).   
The greatest levels of GFP/YFP fluorescence are during late-exponential phase 
(~OD600 = 1).  YFP (pAHS5) gives a ~6-fold greater fluorescence than GFP 
(pAHS4), which may be attributed to the consensus that YFP is generally 
‘brighter’ than GFP.  Although expression of RFP follows the same trend as 
GFP/YFP; RFP fluorescence is first observed after 3 hours growth, an hour later 
than GFP and YFP.  This lag cannot be attributed to reduced cell number, as the 
viable counts for all three cultures are similar throughout the growth curve 
(Figure 5-2 D).  It may be that RFP has a longer maturation time than GFP/YFP 
or that more protein has to accumulate within the cell to overcome the 
background autofluorescence from the bacterial cell alone.  Owing to this, RFP 
may not be suitable for use as a transcriptional or translational reporter. 
 
5.3.2 Fluorescence microscopy 
Once fluorescence of a population was assessed during growth through 
measurement on a fluorescence plate reader, the transformed bacteria were 
assessed on a single cell basis by fluorescence microscopy.  
S. pneumoniae D39 cells expressing GFP (pAHS4) and YFP (pAHS5) were grown to 
mid-exponential phase before fixing with paraformaldehyde and mounted onto 
microscope slides.  Images were captured with the same acquisition protocol and 
cells were exposed to the excitation wavelength for the same period.  The 
pneumcoccoal cells that are expressing YFP appear brighter than those 
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expressing GFP, Figure 5-3 A and B, which correlates with the previous results 
with the population assay.  By comparing the DIC image with the fluorescent 
image, it can be seen that all the cells express GFP or YFP but RFP expression is 
not as consistent between cells. 
 
Figure 5-3 Fluorescence microscopy of D39 pAHS4/5/8 
S. pneumoniae strain D39 was transformed with pAHS4 (GFP), pAHS5 (YFP) or pAHS8 
(RFP), grown in BHI to OD600 = 0.6, washed twice in PBS before fixing cells with 
paraformaldehyde.  Cells were spotted onto a microscope slide and images captured with 
Zeiss AxioImager M1 microscope as described in Materials and Methods.  GFP and YFP 
viewed with FITC filter, RFP with DsRed filter.  
 
Once it was established that the pneumococci were indeed expressing the 
fluorescent proteins, immunofluorescence was used to show that the exterior of 
the pneumococcal cell could be distinguished from the interior, which is 
essential for future localisation studies.  S. pneumoniae strain TIGR4 
transformed with pAHS5 (YFP) was fixed onto a microscope slide and the capsule 
stained as described in Materials and Methods.  The pneumococcal cells are all 
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expressing YFP, and the capsular stain is confined to the outer edges of the cell, 
with no obvious overlap between the two signals observed, Figure 5-4.  This 
would account for a gap created by the cell wall between the plasma 
membrane, maintaining the cytoplasm stained green (YFP), and the capsule 
envelope, stained red (α-Type 4). 
 
Figure 5-4 Immunofluorescence microscopy with fluorescent pneumococci 
TIGR4 was transformed with pAHS5 (YFP), grown in BHI to OD600=0.6, washed twice in PBS 
before fixing cells with paraformaldehyde.  Cells were spotted and dried onto a microscope 
slide and incubated with α-capsule type 4 antibodies and α-rabbit AlexaFluor 555 conjugate 
antibodies as described in Materials and Methods.   
 
Turner and colleagues described a method of using the Cy labelling dyes 
(Amersham), which are traditionally used to label antibodies and nucleic acids, 
to stain bacteria (Turner et al., 2000).  As this could provide a tool to generally 
stain pneumococcal cells for colocalisation studies, without the need for 
additional antibodies, it was tested on TIGR4 expressing YFP (pAHS5).  The 
pneumococcal cells were incubated with Cy5 dye for 15 minutes, washed with 
PBS and spotted onto a microscope slide.  A z-stack of micrographs were taken 
using a Zeiss AxioImager M1 microscope, as shown in Figure 5-5.  It can be 
observed that the Cy5 dye localises to the outer surface of the cell, as initial 
images only detect YFP (green).  The increase in z (height), moving left to right 
across the panel of images, begins to introduce some Cy signal (blue) at the 
periphery of the cell, gradually increasing across the upper outer surface of the 
cell.  This occurs with the reduction of the detection of YFP in the internal space 




Figure 5-5 Z-stack (thickness) of D39 pAHS5 labelled with Cy5 
S. pneumoniae strain D39 was transformed with pAHS5 (YFP; green in image) and washed 
in PBS prior to being mixed with Cy5 dye (Amersham; blue in image), incubated, washed, 
and fixed with paraformaldehyde and applied to a microscope slide.  The top left image is a 
DIC image of the bacterial cells and each fluorescence image from left to right is a 0.25µm 
increase in the z plane (height) of the lens up from the microscope slide, shown in the 
diagram on the far right. 
 
5.3.3 Detection of LumioTM and FLAG tags 
As mentioned previously, each fluorescent protein has a His, LumioTM and FLAG 
tag at its N-terminus.  These tags were included to allow purification (His), 
immunodetection (FLAG) and substrate-dependent fluorescence (LumioTM) of 
reporter fusions.  The LumioTM tag is a tetracysteine motif (CCPGCC) that binds a 
fluorescein arsenical binding hairpin (FlAsHTM) reagent (Griffin et al., 1998), by 
forming covalent bonds between the arsenical molecules and the cysteine 
residues of the motif, unquenching the fluorescein and subsequently making it 
fluorescent when excited by the correct wavelength.  The LumioTM Green In-Gel 
detection kit (Invitrogen) can detect 1pmole of a Lumio fusion protein run on a 
SDS-PAGE gel, and detects the tag in all three fluorescent constructs from 
pneumococcal lysates, Figure 5-6. 
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Figure 5-6  In-Gel Lumio
TM
 Tag Detection 
Pneumococcal lysates D39, D39/pAHS4 (GFP), D39/pAHS5 (YFP) and D39/pAHS8 (RFP) were 
separated into soluble (WC) and insoluble (Pellet) fractions.  The samples were prepared 
using Lumio
TM
 Green detection kit and proteins separated in NuPAGE 4-12% Bis-Tris SDS-
PAGE gel (Invitrogen).  Viewing the gel under UV transilluminator detects the fluorescence 
from the biarsenical-conjugated Lumio
TM
 tag fused to the fluorescent proteins.  
 
The FLAG epitope present at the N-terminus of the fluorescent proteins can be 
confidently detected by western blotting, Figure 5-7.  Evidence of dimerisation 
is visible, which is most likely due to the LumioTM tag because the SDS-PAGE gel 
was not reduced, the tetracysteine motif is unstable in oxidising conditions and 
as a result complexes with another motif to stabilise by forming disulphide 
bonds. 
 
Figure 5-7 Western detection of FLAG-Fluorescent protein – monoclonal α-FLAG antibodies 
Lysates, separated into soluble and insoluble (pellet) fractions, from pneumococcal strains 
D39 and TIGR4 transformed with plasmids expressing GFP/pAHS4 (4), YFP/pAHS5 (5) or 
RFP/pAHS8 (8) were probed with monoclonal antibody to FLAG (Stratagene) to detect 
expression of the fluorescent protein.  Whole cell D39 lysate (WC D39 WT) was included as 
a FLAG negative control. 
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5.4 Application of fluorescent proteins for the 
pneumococcus 
5.4.1 Transcriptional reporter 
Fusions to reporter genes such as beta-galactosidase, chloramphenicol 
acetyltransferase (CAT), and fluorescent proteins have been used extensively to 
determine the expression of genes of interest in both bacterial and mammalian 
cell types.  Fusions can be transcriptional or translational, where transcriptional 
fusions have the putative promoter region of a gene cloned upstream of a 
reporter and translational fusions also include the coding sequence of the gene 
of interest.  The use of translational GFP fusions to investigate gene expression 
has been successful for NleH in E. coli O157:H7, therefore I wanted to test if this 
would be successful in the pneumococcus using the reagents developed. 
An expression vector, pAHS12, was constructed where promoterless YFP was 
cloned into pAL2YI with two restriction sites upstream to permit any promoter of 
interest to be inserted.  YFP was chosen as the reporter gene as it gave the 
highest levels of fluorescence when constitutively expressed.  To assess the 
efficacy of the expression vector, the uncharacterised NanA promoter was 
tested.  Analysis of the NanA sequence indicates that there are three putative 
promoters of NanA (Camara et al., 1994), each of which were cloned upstream 
of YFP in pAHS12, detailed in Figure 5-8.  NanA is a surface-anchored protein of 
S. pneumoniae which cleaves sialic acid from mucin in the secretions of the 
human nasopharynx.  The presence of mucin in culture media as a carbon source 
as been shown to increase nanA transcription by ~24-fold, measured by RT-PCR 
(Yesilkaya et al., 2008). 
The transcriptional reporters were transformed into S. pneumoniae strain R6, 
which is the uncapsulated derivative of D39. 
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Figure 5-8 Putative promoter sequences of NanA  
The nucleotide sequence of the sequences cloned upstream of YFP in pAHS12 are labelled 
promoter -246 (green); promoter -291 (orange) and promoter -405 (purple).  The deduced 
amino acid sequence of NanA is included, with putative the two putative start (ATG) codons 
underlined in red.  Two putative -35 and -10 promoter sequences are labelled and ribosome 
binding sites (Shine-Dalgarno sequences) are underlined in blue.  The amino acid sequence 
underlined denotes a putative secretion signal sequence with a signal peptidase site 
indicated by a star. Figure is based on (Camara et al., 1994) 
 
YFP is expressed when under the control of the NanA promoters and is greatest 
during the early stages of growth (Figure 5-9 A, B, C).  Unfortunately, due to the 
high levels of variance in the fluorescence readings between the constructs, a 
statistically significant conclusion cannot be made from the different lengths of 
 151 
putative NanA promoter.  To further validate the application of this construct as 
a transcriptional reporter, the results from this expression assay can be 
compared to transcriptomic data prepared from pneumococcal cells at OD600nm = 
0.6.  The mRNA extraction, purification and cDNA synthesis experiments were 
carried out by Jiang Tao Ma and the sequencing data analysed by Jenny Herbert 
and Dr Andrea Mitchell.  RPKM (reads per kilobase of exon model per million 
mapped reads) is a measure of transcript concentration, where the number of 
sequencing reads of a length of RNA transcript is normalised against the total 
number of reads in the sample.  The RPKM value of the ami (SP_1891) transcript 
is 385.67 and the NanA (SP_1693) transcript is 8.87.  The NanA transcriptional 
fusions are 2-fold less fluorescent compared to the ami fusion, which is 
supported by the difference seen in the transcriptomic data. 
Although the transcriptional reporter is not sensitive enough to compare the 
putative promoters of NanA, the expression profile differs to that from the ami 
promoter (Figure 5-2 B).  This demonstrates that the vector can be used to 
compare expression of different pneumococcal genes. 
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Figure 5-9 Expression of NanA 
promoter reporter fusions in S. 
pneumoniae strain R6 
20ml of BHI was inoculated 
with 1x10
5
 cfu/ml R6 pAHS12; 
R6 -246NanA; R6 -291NanA; 
R6 -405NanA.  At regular 
intervals, 1ml of culture was 
removed and OD600 measured; 
the remaining culture was 
incubated at 37°C.  The 1ml 
sample was centrifuged and 
the bacterial pellet suspended 
in 1ml PBS and 200µl aliquots 
were analysed in triplicate for 
fluorescence (YFP = Ex. 
485nm; Em. 520nm) in 
FLUOstar plate reader (BMG) 
and 20µl used for viable count 
(graph B). R6 pAHS12, 
promoterless YFP plasmid, 
acted as a control for 
background fluorescence; 
fluorescence was plotted 
against OD600 using Microsoft 
Excel software and a line of 
best fit obtained.  Using this 
method, data were corrected 
for background fluorescence.  
The mean±SEM of the three 




Since the gene encoding Green Fluorescent Protein was first cloned in 1992 and 
shown to be expressed in heterologous organisms in 1994, it has been used as a 
reporter of gene transcription, gene regulation and protein localisation in 
bacteria, fungi, plants and eukaryotes.  However the applications of GFP, and its 
derivatives, as gene expression and protein localisation reporters do not appear 
to have been used extensively in previous pneumococcal research.  Therefore 
constructs containing S. pneumoniae codon-optimised GFP, YFP or RFP, under 
the control of a pneumococcal promoter, were developed as tools for future 
pneumococcal research. 
The fluorescent proteins are constitutively expressed in S. pneumoniae, as 
fluorescence intensity increases as the cell number increases in population 
assays, Figure 5-2.  However, upon entry into the stationary phase of growth 
there is a sharp decline in fluorescence intensity.  This decline may be 
attributed to the decrease in pH of the culture media which can inhibit 
fluorescent protein activity.  Fluorescent proteins need to be post-translationally 
oxidised in order to mature into a functioning protein, and due to the 
microaerophilic nature of pneumococcal growth, the availability of oxygen will 
be reduced upon entry into the stationary phase, consequently reducing the 
amount of mature fluorescent protein to below detectable limits.  Western 
blotting analysis of pneumococcal lysates from the later stages of growth 
(OD600nm = 1-1.2) would determine whether the decrease in fluorescence 
intensity is due to the reduced activity of the fluorescent protein or protein 
degradation.  It would also be interesting to ascertain if this decline happens 
when the bacteria are cultured in buffered media, which would maintain the pH 
to optimum levels, or aerated before measuring fluorescence by introducing a 
plate shaking step in the FLUOStar plate reader.  If these potential problems 
with their use in the stationary phase of growth cannot be alleviated, they can 
still be useful reagents for investigations during the dynamic exponential phase 
of growth. 
The fluorescent proteins were characterised by fluorescence microscopy showing 
that expression was evident within the cell cytoplasm (Figure 5-3), which is 
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supported by labelling the pneumococcal surface by immunostaining the capsule 
polysaccharide (Figure 5-4) or CyDye labelling of free lysine residues (Figure 
5-5).  The inclusion of His, FLAG and Lumio tags allows the expression of the 
proteins to be assessed by In-Gel detection of the LumioTM tag (Figure 5-6) and 
western blot detection of the FLAG epitope with monoclonal α-FLAG antibodies 
(Figure 5-7). 
To assess the application of YFP as a transcriptional reporter in the 
pneumococcus, a plasmid containing a promoterless YFP gene was created, 
pAHS12.  Three putative nanA promoter sequences, -246nanA, -291nanA and -
405nanA, were cloned upstream of the yfp gene in this plasmid and the 
expression of YFP monitored during growth in BHI (Figure 5-9).  Due to the high 
variance in fluorescence levels from the NanA constructs, it cannot be concluded 
which promoter length is true for NanA expression; primer extension would 
define the NanA promoter.  Another option could be to perform Q-PCR on the 
yfp transcript under the control of the various promoter lengths.  Unfortunately 
the expression from nanA promoters cannot be determined during stationary 
phase, as YFP fluorescence levels decline even when under the control of a 
known constitutive promoter.  Additional experiments would have to be carried 
out to determine if the decline observed is attributed to the NanA promoter or 
the culture effects discussed previously.  If not for time constraints, it would 
have been interesting to design and test an assay to utilise the Lumio tag 
included in the YFP sequence, to quantify the YFP present in each sample during 
stationary phase, once corrected for the pAHS12 promoterless YFP background 
control.  Overall the results indicate that nanA expression, and the regulation of 
its expression, in the pneumococcus is complex.  To reiterate, the main 
objective of this experiment was not to define the nanA promoter and nanA 
expression, but to test the application of pAHS12 as a transcriptional reporter 
plasmid in the pneumococcus with an uncharacterised promoter sequence.  The 
results confirm that pAHS12 can be used as a transcriptional reporter in S. 
pneumoniae as the YFP expression data can be corroborated with the 
transcriptomic data generated from another independent experiment. 
This work demonstrates that codon-optimised fluorescent proteins can be 
expressed in S. pneumoniae and detected in pneumococcal lysates by western 
blotting.  The fluorescent proteins can be viewed by fluorescence microscopy, 
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and a cytoplasmic distribution can be characterised with the addition of indirect 
immunofluorescence techniques, staining for the capsule, or indiscriminate 
labelling of the outer surface using CyDyes.  The transcriptional reporter plasmid 
pAHS12 can be used to reveal the native expression of S. pneumoniae genes.  
Additional proof-of-principle work has to be completed in order to demonstrate 
the use of these reagents as tools for protein localisation studies within the 
pneumococcus.
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6 Localisation of pneumolysin (Ply) within the 
pneumococcus 
6.1 Summary 
Ply is a well characterised toxin important for pneumococcal pathogenesis due 
to its toxicity to eukaryotic cells and its complement activating activity at sub-
lytic concentrations.  Ply is a cholesterol dependent cytolytic toxin which is 
mainly contained within the cytoplasm, as it does not possess a secretion signal 
sequence (Johnson, 1977; Walker et al., 1987).  There have been reports that it 
can localise to the cell wall (Price & Camilli, 2009) and be released without the 
action of autolysin (LytA) (Balachandran et al., 2001).  The aim of the work 
described in this chapter was to develop and characterise codon optimised 
versions of Ply and test their expression.  Expression was tested by 
complementing a previously constructed Ply negative mutant of S. pneumoniae 
type 2 strain D39.  These vectors were used to explore alternative methods to 
determine the localisation of Ply within/on the pneumococcal cell.  A S. 
pneumoniae strain deficient in both autolysin and pneumolysin was created, by 
introducing a LytA-Ply gene fusion amplified from equine strain A45 into the 
chromosome of sequenced strain TIGR4.  This mutant was used to determine if 
the genes immediately upstream of Ply and/or LytA are responsible for the cell 
wall localisation of Ply.  The impact of the introduction of this LytA-Ply gene 
fusion upon TIGR4 virulence in a murine model of infection will also be tested.  
The potential implications of the cell wall localisation of Ply to pneumococcal 
pathogenesis are also discussed. 
 
6.2 Ply constructs and expression analysis 
Codon optimised Ply was synthesised with His, FLAG and Lumio (FlAsH) tags at 
the N-terminal end, so as not to interfere with its biological activity, and cloned 
into plasmids by DNA 2.0 (California, USA).  DNA 2.0 uses the Codon Usage 
Database (http://www.kazusa.or.jp/codon) to optimise their products codon 
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usage to the species/strain specified.  To ensure gene expression in the 
pneumococcus, the constitutive promoter from the aminopterin resistance 
operon (ami) (Alloing et al., 1990) was cloned upstream of the gene in the 
plasmid and the fragment was subcloned into pAL2YI as described previously for 
the fluorescent protein constructs, producing vectors described in Table 6-1.   
Table 6-1 Ply vectors 
Construct Description 
pAHS1 Ply domains 123:3tags 




3 tags = His, FLAG and Lumio 
These vectors were transformed into S. pneumoniae Ply knockout strain 
(D39FPlySTOP), created by Dr Calum Johnston through Janus mutagenesis (Sung 
et al., 2001) of S. pneumoniae strain D39, introducing a single T nucleotide after 
the 6th base in Ply sequence generating a stop codon after the second amino 
acid.  To test the episomal complement of the Ply mutant, the Ply expression 
from the constructs was characterised through western blotting, LumioTM 
fluorescence and haemolytic assays.   
 
6.2.1 Western blotting and LumioTM analysis 
Western blotting with a pneumolysin polyclonal antibody, shows that D39 
expresses wild-type protein with a predicted size of 53kDa, D39FPlySTOP does 
not express any Ply protein unless complemented with pAHS1, expressing Ply 
Domains123 (43kDa), or pAHS3, expressing Ply:3tags (56kDa), Figure 6-1.  
D39FPlySTOP pAHS2, expressing Ply Domain 4, did not resolve a band with the 
predicted size of 16kDa which may be due to the low sensitivity of the chloro-
naphthol detection method used.   
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Figure 6-1  Western blot analysis of pneumococcal lysates – polyclonal antibody 
Pneumococcal lysates were probed against a polyclonal Ply antibody raised from rabbit.  
D39 is a positive Ply control; D39∆Ply-stop ‘WT’ is a negative Ply control.  D39∆Ply-stop 
was transformed with Ply constructs pAHS1, pAHS2 and pAHS3.   
 
The blot was repeated using monoclonal antibody (mAb PLY-5) specific for an 
epitope present in Ply Domain 4 and detection using chemiluminescent substrate 
to increase sensitivity.  Due to overexposure of the film on the membrane, there 
are unspecific bands present on the blot which can be eliminated through 
comparison with the D39FPlySTOP Ply protein negative control (WT), Figure 6-2.  
The Ply protein products are highlighted by arrows, showing detection of Ply 
Domain 4 (2; 16kDa), GFP-Domain 4 (7; 43kDa), RFP-Ply (6; 83kDa) and purified 
Ply (Ply; 53kDa). 
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Figure 6-2  Western blot analysis of pneumococcal lysates – monoclonal antibody 
Pneumococcal lysates were probed with monoclonal Ply (mAb PLY-5) antibody.  
D39∆PlySTOP (WT) was transformed with Ply constructs pAHS2, pAHS6 and pAHS7.  
Purified Ply and Ply domain 4 (D4) were included as protein positive control.  
 
As described previously, the Lumio tag allows substrate mediated fluorescence, 
which can be detected in SDS-PAGE gels by treating bacterial lysates containing 
the LumioTM tagged protein with the LumioTM Green Detection Reagent 
(Invitrogen).  The arsenical treated lysates are separated on an SDS-PAGE gel, 
alongside a BenchMarkTM fluorescent protein marker (Invitrogen), and viewed 
under a transilluminator to excite the fluorescein bound to the fusion protein.  
Figure 6-3 A shows that the LumioTM fusion proteins, Domain 4 (2; 16kDa), Ply (3; 
56kDa) and RFP-Ply (6; 83kDa), are expressed in the complemented mutant 
lysates, with no signal detected for D39FPlySTOP (WT) alone with equivalent 




Figure 6-3  Lumio
TM
 tag detection of Ply complements in D39∆PlySTOP 
Pneumococcal lysates D39∆PlySTOP WT, pAHS2, pAHS3 and pAHS6 were treated with 
Lumio Green Detection kit (Invitrogen) and subsequently run on NuPAGE 4-12% Bis-Tris 
SDS-PAGE gel (Invitrogen) for detection of fluorescent Lumio
TM
 tagged fusion proteins (*) 
under UV transilluminator (A) and the same gel was subsequently Coomassie stained (B). 
 
6.2.2 Analysis of haemolytic activity 
All Ply constructs were assessed for haemolytic activity with D39 lysates as a 
positive control and PBS as a negative control, Table 6-2.  Lysates prepared from 
D39FPly-stop WT was also included as a control, to show that haemolysis could 
be attributed to the complementation of Ply from the plasmid and not due to 
another protein in the pneumococcal proteome.  pAHS3 and pAHS6 complement 
the Ply knockout and pneumococcal whole cell lysates of these strains have a 
higher haemolytic activities compared to the D39 control, where the pAHS6 
(RFP-Ply) titre is 8 times that of the D39 WT; pAHS3 (Ply) titre is 64 times.    As 
expected, there is no haemolytic activity when D39FPlySTOP is complemented 
with Ply Domains123 (pAHS1), Domain 4 (pAHS2) or GFP-Domain 4 (pAHS7).  Ply 
binding to membranes is mediated by Domain 4, but polymerisation and 
membrane insertion is mediated by Domains 123 (Gilbert et al., 1999; Tilley et 
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al., 2005) therefore Domain 4 can bind to membranes but cannot progress to 
form pores and Domains123 cannot interact with membranes at all. 
Table 6-2 Haemolytic activity of whole cell lysates from D39∆PlySTOP episomally 
complemented with Ply 
Strain Haemolytic Activity (HU) 
D39 40 
D39FPly-stop 0 
D39FPly-stop pAHS1 (Ply Domains123) 0 
D39FPly-stop pAHS2 (Ply Domain 4) 0 
D39FPly-stop pAHS3 (Ply) 2560 
D39FPly-stop pAHS6 (RFP-Ply) 320 
D39FPly-stop pAHS7 (GFP-Ply Domain 4) 0 
 
 
6.2.3 Binding of RFP-Ply to erythrocytes. 
The ability of RFP-Ply to bind cholesterol containing membranes was confirmed 
by visualising sheep erythrocytes pre-incubated with D39FPlySTOP pAHS6 lysate 
with fluorescence microscopy.  It can be seen that cells treated with PBS alone 
are smooth and rounded and upon exposure to RFP-Ply, the cells become larger 
and irregular due to lysis when viewed under differential interference contrast 
(DIC) microscopy (Figure 6-4).  Fluorescence microscopy (Figure 6-4, RFP) shows 
that no RFP is detected in PBS treated cells whereas the membranes from the 
erythrocyte ghosts, show punctate areas of RFP-Ply.  These punctate areas of 
RFP are likely to be supramolecular structures (200-300nm) containing a mixture 




Figure 6-4 Erythrocytes treated with PBS and D39∆PlySTOP pAHS6 lysate 
Fluorescence microscopy, using x100 objective, of sheep erythrocytes incubated with 50µl 
PBS or 50µl D39∆PlySTOP pAHS6 lysate, containing RFP-Ply.  Images were magnified an 
additional 2.5 times. 
 
6.3 Construction of isogenic mutant TIGR4∆LytA-Ply::Chl 
6.3.1 Rationale for construction of LytA-Ply fusion in TIGR4 
The paradigm that Ply is intracellular until its release by cell lysis in the 
stationary phase was supported by a Ply localisation study (Johnson, 1977) which 
tested the haemolytic activity of pneumococcal fractions, showing that Ply is not 
linked to the membrane and therefore cytoplasmic; the lack of a secretion signal 
peptide within its primary sequence (Walker et al., 1987); and the observations 
that haemolytic activity is not detected in the culture supernatant until late 
stationary phase.  This paradigm is challenged by reports that in select strains 
Ply can be released before stationary phase (Benton et al., 1997b) by an 
autolysin-independent mechanism (Balachandran et al., 2001) and that 
fractionation of pneumococcal cells followed with detection of Ply protein by 
western blotting shows it can localise to the cell wall (Price & Camilli, 2009).  
The observations that Ply is released only in certain strains but can be found in 
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the cell wall fraction of many strains suggest that the secretion, cell wall 
localisation and/or release of Ply may be controlled by the presence of 
particular genes.  It is possible that these genes are defective or missing in the 
strains which can release Ply prior to the stationary phase of growth.  A Ply and 
LytA deficient strain of S. pneumoniae was created to further investigate the 
possible mechanisms behind the localisation and autolysin-independent release 
of Ply. 
Upon assessment of the genetic location of Ply in the TIGR4 sequence, it can be 
seen that Ply (SP_1923) and the genes downstream, SP_1924, SP_1925 and 
SP_1926, are very close together and may be transcribed as a single mRNA, i.e. 
an operon, Figure 6-5.   
 
Figure 6-5  Genes surrounding Ply in TIGR4 
(SP_1923; highlighted red) adapted from http://www.ncbi.nlm.nih.gov/gene/931915. 
 
From the aforementioned RNA-seq analysis of transcriptomic data generated by 
colleagues, Ply (SP_1923) is transcribed within a polycistronic message including 
SP_1926, SP_1925, SP_1924 and SP_1922 (personal communication, Dr Andrea 
Mitchell).  SP_1924-26 ORFs encode hypothetical proteins of 136, 202 and 158 
amino acids respectively, with no putative conserved domains found when 
submitted into a BLASTp search (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  The 
SP_1922 ORF encodes a hypothetical protein, of 238 amino acids, consisting of a 
DUF28 domain, a domain of unknown function found in bacterial and some yeast 
proteins. These four ORFs are also all found in the sequenced strains of 
pneumococci, indicating that these genes are conserved with Ply.  A poster was 
presented at the 7th International Symposium on Pneumococci and Pneumococcal 
Diseases (ISPPD) from Richard Malley’s group in Boston, reporting results testing 
the hypothesis that SP_1924 and SP_1925 have a role in the localisation of Ply to 
the cell wall (Yadav, P., Thompson C., Lu Y.-J., Malley R.; Abstract No. 19).  
Through haemolytic assays and western blotting of cell wall and protoplast 
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fractions, testing a SP_1924 and SP_1925 double mutant with its TIGR4 isogenic 
parent, it was concluded that SP_1924 and SP_1925 ‘participate indirectly in the 
translocation of Ply to the cell surface’.  Owing to this, I wanted to 
independently test if SP_1924, SP_1925 and SP_1926 have a role in Ply 
localisation/secretion by investigating if Ply can still localise to the cell wall 
when expressed in a S. pneumoniae strain lacking these genes.   
Naturally occuring LytA Ply deficient strains of pneumococci, isolated from 
horses, have been characterised (Whatmore et al., 1999).  Interestingly, only 
pneumococci with capsular serotype 3 are isolated from horses, which are 
commonly colonised by other species of Streptococci such as S. zooepidemicus 
and S. equi (Burrell et al., 1986).  A panel of serotype 3 pneumococcal isolates 
from horses were analysed and it was found that the LytA and Ply genes have 
been fused together by a recombination event (Whatmore et al., 1999), 
resulting in the loss of the LytA and Ply functional proteins.  Although these 
isolates lack two important virulence factors in murine models of infection 
(Berry et al., 1989b; Berry et al., 1992; Canvin et al., 1995; Berry & Paton, 
2000), Whatmore and authors note that the S. equi isolated from horses also do 
not encode a CDC toxin like streptolysin O, and postulate that the toxin genes 
were lost over time due to a selective disadvantage in the equine host.  This 
natural mutant (Figure 6-6) has not only lost Ply and LytA but also the 
intervening genes, including SP_1924-26, therefore this fusion was introduced 
into TIGR4 to generate a strain deficient in all these genes, TIGR4FLytA-Ply. 
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Figure 6-6  Artemis Comparison Tool (ACT) of TIGR4 at position SP_1923 (Ply) and A45 
This image demonstrates the natural ‘fusion’ of LytA and Ply seen in equine S. pneumoniae strain A45.  Red bars denote homology between the two 
sequences, yellow bars highlight SP_1923 (Ply) and SP_1936 (LytA) which are ~7kB apart in TIGR4 but adjoined in A45.  
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This TIGR4FLytA-Ply mutant was constructed to serve two purposes: to assess 
whether the genes upstream of Ply, and/or the action of autolysin, are involved 
in Ply secretion, localisation and/or release; and to compare the virulence of the 
LytA-Ply mutant to its isogenic parent to determine if this natural fusion alone 
contributes to the reduced virulence of equine serotype 3 strain A45 compared 
to other serotype 3 isolates.  This mutation was made in serotype 4 strain TIGR4 
because serotype 3 pneumococci are not amenable to in vitro transformation (Dr 
Andrea Mitchell; personal communication) and the murine pneumonia and 
bacteraemia model data is already available for TIGR4. 
 
6.3.2 Confirmation of successful lytA-ply deletion in TIGR4 
The LytA-Ply fusion was introduced into the TIGR4 genome by PCR amplification 
of the sequence from S. pneumoniae (equine) strain A45 gDNA, cloning it into a 
pUC18 vector.  A cat resistance cassette, under the control of the ami promoter, 
was introduced into the BamHI site present in the fusion gene to allow selection 
for recombinants, Figure 6-7 (1) and (2).  This construct (pUCLytAPly::Chl) was 
transformed into TIGR4 and the success of the recombination event was 
confirmed by PCR, sequencing, gram staining, haemolytic activity and western 
blot using the polyclonal α-Ply antibody. 
Chl resistant clones generated from recombination of the cat cassette into the 
chromosome were selected and genomic DNA extracted to test for successful 
insertion of the fusion and the removal of the intervening 7kB DNA by PCR.  
Primers 52Q and 52R amplify a 350bp region of Ply, which is present in TIGR4 but 
not in A45; primers W99F and 52R amplify across the LytA-Ply fusion, which is 
present in A45 but not TIGR4.   Chl resistant clones 3 and 4, Figure 6-8, are 
negative for 52Q/R PCR product and positive for the presence of the LytA-Ply 
fusion like A45, indicating successful recombination.  Note the product of the 
LytA-Ply PCR product is larger than the A45 wild-type due to the presence of the 
cat resistance cassette.  
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Figure 6-7  Introducing the 
LytA-Ply genetic fusion 
from A45 into TIGR4 
genome. 
The LytA-Ply fusion gene 
was PCR amplified with 
flanking sequence, 
homologous to TIGR4 
sequence, using primers 
27R and LytA up and the 
product cloned into pUC18.  
A Cat resistance cassette, 
with ami promoter, was 
PCR amplified from S. 
pneumoniae FP28 and 
cloned into the LytA-Ply 
pUC18 construct at the 
BamHI site present in the 
fusion gene to create 
pUCLytA-Ply::Chl.  This 
construct was transformed 
into TIGR4 and 
homologous 
recombination (grey 
crosses) of the fusion gene 
into the TIGR4 
chromosome was selected 
for through resistance to 




Figure 6-8 Confirmation of successful deletion by PCR 
PCR of crude gDNA extract from Chl resistant clones to confirm recombination of LytA-Ply 
fusion into TIGR4 chromosome, with TIGR4 and A45 as controls.  Primer pair 52QR 
amplifies a 350bp region of Ply and W99F52R amplifies across the LytA-Ply fusion; N 
denotes a no DNA PCR control for each primer pair.  The Cat cassette was amplified from 
FP28, using CatF and CatR, PCR results not shown.  Only clones 3 and 4 underwent 
successful recombination due to the absence of Ply (52QR) product. 
 
Recombinants confirmed by PCR were selected and the region was amplified in 3 
sections and sent for sequencing.  The sequencing contigs were aligned against 
the A45 sequence, with the cat cassette inserted in silico at the appropriate 
position, to map the area where recombination has occurred between the 
plasmid insert and the TIGR4 genome.  An alignment of A45 and TIGR4 sequences 
using CLC software, Figure 6-9, labels the single polynucleotide polymorphisms 
(SNPs) present in the A45 or TIGR4 sequence as ‘conflicts’.  By working across 
the consensus sequence, from left to right, the SNPs present in the TIGR4FLytA-
Ply sequence data should first represent those found in the TIGR4 genome 
(green) and then A45 (red) from the inserted sequence, returning to TIGR4 SNPs 
after the insert.  Therefore, the left recombination area can be mapped 
between a TIGR4 and an A45 SNP, and the right recombination area between an 
A45 and a TIGR4 SNP, boxed conflicts on Figure 6-9.  Due to the great sequence 
identity of this region of the genome, it is not possible to narrow the 
recombination region any further. 
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Figure 6-9 Sequence 
alignment of TIGR4 Ply 
and LytA against A45 
sequence, including the 
inserted Cat cassette. 
Genomic DNA was 
extracted from 
TIGR4∆LytA-Ply::Chl and 
3 PCR products covering 
the recombination region 
were sent for 
sequencing.  Conflicts, 
which are SNPs present 
in either A45 (red) or 
TIGR4 (green) sequence, 
are labelled on the TIGR4 
vs A45 consensus.  The 
area where homologous 
recombination has 
occurred (labelled 
recomb region; grey 
arrows) can be mapped 
on the TIGR4∆LytA-Ply 
sequence as the area 
between a TIGR4 SNP, 
boxed green, and an 
adjacent A45 SNP, boxed 
red. 
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The disruption of the LytA gene in A45 leads to the formation of long chains of 
pneumococci compared to the diplococcus morphology characteristic of S. 
pneumoniae, reported by Whatmore and authors (Whatmore et al., 1999).  To 
characterise the mutant in TIGR4, a Gram stain was performed on TIGR4, A45 
and TIGR4FLytA-Ply::Chl as described in Materials and Methods.  Figure 6-10 
shows that A45 and TIGR4FLytA-Ply form long chains of greater than 15 
pneumococci, and TIGR4 is a mixture of diplococci and shorter chains of 5-8 
pneumococci. 
 
Figure 6-10  Analysis of pneumococcal chain length  
S. pneumoniae strains TIGR4 (A), A45 (B) and TIGR4∆LytA-Ply::Chl (C) were grown in BHI at 
37°C until mid-exponential phase and 10µl heat fixed onto a microscope slide.  Grams stain 
was applied before examining under x100 magnification on Zeiss Axioskop microscope. 
 
Another phenotypic characteristic of A45 is the lack of haemolytic activity due 
to lack of pneumolysin production.  The haemolytic activity of the isogenic 
parent TIGR4 was lost due the introduction of the fusion in TIGR4FLytA-Ply and 
this could be restored through episomally produced pneumolysin from plasmid 
pAHS3, Figure 6-11.  There is no haemolytic activity in extracts from 
TIGR4FLytA-Ply transformed with pAHS1 (Ply Domain 4) or pAHS2 (Ply 




Figure 6-11  Haemolytic assay of TIGR4∆LytA-Ply, isogenic parent and episomal 
complement whole cell lysates. 
 
The loss of haemolytic activity was shown to be due to no production of Ply 
through western blotting using the polyclonal Ply antibody.  The western blot 
(Figure 6-12) shows that Ply is produced by the wild-type TIGR4 but not A45 nor 
the TIGR4FLytA-Ply mutant (TdLP WT).  Ply is detected in the complemented 
mutant with pAHS1 (Ply domains 123) and pAHS3 (Ply).  The amount of Ply 
protein in the TdLP pAHS3 sample is greater than the parent strain as there are 
multiple copies of the Ply gene complementing the mutant; the plasmid has a 
copy number of 8 (Macrina et al., 1982).  No signal is detected for pAHS2 (Ply 
domain 4; not shown).   Purified Ply was included as a positive control.   
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Figure 6-12 Western blot of TIGR4∆LytA-Ply – polyclonal α-Ply antibody 
Western blot of TIGR4∆LytA-Ply (TdLP) mutant (WT) with plasmid complements pAHS1 (1), 
pAHS2 (2) and pAHS3 (3).  TIGR4 (T4), A45 and purified Ply were included as controls.   
 
6.4 Pneumococcal localisation of Ply. 
Once the downstream genes of Ply, SP_1924-26, and LytA were deleted in TIGR4 
to create TIGR4FLytA-Ply, this mutant could now be used to elucidate whether 
the products of these genes have a role in the localisation and/or secretion of 
Ply from the pneumococcus.  The mutant was complemented for Ply using the 
vector reagents, pAHS3 or pAHS6, developed and characterised previously.  The 
localisation of Ply was assessed by pneumococcal cell fractionation with western 
blotting and immunofluorescence microscopy. 
 
6.4.1 Fractionation analysis 
The approach taken to determine the localisation of Ply within the 
pneumococcus was to separate a population of pneumococci into cellular 
fractions followed by Ply detection by western blotting.  This provides a clearer 
indication of which fraction contains Ply compared to assaying each fraction for 
haemolytic activity (Johnson, 1977), as any fractioned Ply may not necessarily 
be functional or present at levels below the detection limit of the assay. 
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A number of fractionation experiments were carried out using D39 and its Ply 
negative mutant, D39FPlySTOP, to optimise the fractionation protocol outlined 
by Katherine Price and Andrew Camilli (Price & Camilli, 2009).  The first 
adjustment to the aforementioned protocol was to reduce the concentration of 
mutanolysin present in the cell wall digestion buffer from 300U/µl to 300U/70µl.  
The first fractionation experiment detected Ply in the cell wall fraction (results 
not shown), and upon further scrutiny of the protocol, a number of control steps 
were tested.  The control steps were carried out in parallel to allow comparison 
between the protocols and included: washing the bacterial cell pellet with PBS 
and retaining the wash to test for the presence of Ply protein; passing the BHI 
culture supernatant through a 0.2µm syringe filter before TCA precipitation to 
remove any remaining intact cells; and adding Dnase I to the protoplast fraction.  
The wash samples tested did not contain any Ply protein as determined by 
western blotting.  Before filtration, the D39 broth supernatant was haemolytic 
and after it was reduced to below the detection limit with no Ply protein 
detected by western blotting.  The addition of Dnase I to the protoplast fraction 
facilitated sample loading (results not shown).  Therefore these additional steps 
were added to the fractionation protocol, and applied to D39 and D39FPlySTOP 
cultures.  These samples were probed with α-SecA antibodies raised in rabbit 
against purified Bacillus subtilis SecA (a kind gift from Prof Arnold Driessen, 
University of Groningen, Netherlands) as a cytoplasmic protein control, but no 
signal was detected (results not shown).  Attempts to purify recombinant S. 
pneumoniae TIGR4 SecA, to generate antibodies in-house, were unsuccessful 
(results not shown) and α-TrxA antibody (a kind gift from Dr Jetta Bijlsma, 
University of Groningen, Netherlands) was tested but unable to provide a 
reproducible result (results not shown). Therefore antibodies against GroEL, a 
commonly used cytoplasmic protein control, were tested against pneumococcal 
lysates and provided consistent results. 
The localisation of Ply was assessed in TIGR4, the autolysin and pneumolysin 
negative mutant TIGR4FLytA-Ply, and the mutant complemented for Ply with 




Figure 6-13  Fractionation of TIGR4, TIGR4∆LytA-Ply (T∆LP) and T∆LP with pAHS3. 
Fractionation was carried out as described in Materials and Methods, yielding extracellular 
(E), cell wall (CW) and cell (C) fractions. Samples were loaded onto 4-12% Bis-Tris precast 
NuPAGE gel (Invitrogen) and run at 75V for 25 mins, then 125V for 90 minutes.  Proteins 
were stained for by coomassie blue (A) or transferred onto PVDF membrane to probe for Ply 
(B; i. for 2 min; ii. for 30 min) or GroEL (C). 
 
Ply was detected in the cell wall and protoplast fractions, Figure 6-13, and not 
in the extracellular fraction from culture supernatant.  However, GroEL is 
present in the cell wall fraction indicating pneumococcal cell lysis has occured 
during the preparation of this fraction.  Owing to this, the method of cell wall 
digestion was assessed to establish if the buffer could be adjusted to improve 
removal of the cell wall without inducing any stress or cell lysis.   
The cell wall digestion buffer was adjusted by increasing the concentration of 
Tris buffer from 10mM to 100mM and increasing the ionic strength of the buffer 
by adding MgCl2 (2mM), conditions which have previously been used to induce 
spontaneous protoplast formation in pneumococci without the additional action 
of muralytic enzymes (Lacks & Neuberger, 1975).  Micrographs show that the cell 
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wall is removed when the sample is incubated at 37°C for 30 minutes or 30°C for 
60 minutes, as there are cells present which are Gram stained pink, Figure 6-14 
(see arrows), which indicates a reduction of cell wall thickness to retain the 
crystal violet-iodine complexes.  Incubation of the sample at 25°C for 30 
minutes does yield some pink stained pneumococci but not to the same 
proportion as that seen with the other incubation times.  It also appears that 
some of the pneumococci in the 30°C and 37°C samples stain a lighter purple 
colour compared to the untreated control, implying some loss of cell wall 
thickness. 
 
Figure 6-14  Gram staining of pneumococci after cell wall digestion treatment 
Pneumococcal strain D39 alone (untreated) or after incubation in cell wall digestion buffer 
(100mM Tris-HCl pH7.5, 2mM MgCl2, protease inhibitor and 30% sucrose) at 25°C or 37°C for 
30 minutes or 30°C for 60 minutes was heat-fixed onto a microscope slide and Gram stained 
as outlined in Materials and Methods.  Lower panel is close up of boxed areas.  Arrows 
indicate pink (cell wall digested) S. pneumoniae.  E. coli was included as a Gram negative 
stain control. 
 
From the results, it was concluded that future cell wall digestion should be 
carried out by resuspending the bacterial pellet in 500µl of cell wall digestion 
buffer (100mM Tris-HCl pH7.5, 2mM MgCl2, 1 x protease inhibitor, 30% sucrose, 
1mg/ml lysozyme, 600U/ml mutanolysin) and incubating at 30°C for 90 minutes.  
However, it should also be noted that although the cell wall fraction will contain 
cell wall fragments as there is evidence of cell wall digestion from whole cells, 
Figure 6-14, it cannot be conclusively said that the previously called protoplast 
fraction does not contain some cells with residual cell wall, therefore it will 
henceforth be referred to as the cell fraction. 
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TIGR4, TFLP and TFLP pAHS3 were grown to OD600 = 0.6, incubating at 25°C for 
10 hours, then 37°C until the optical density was reached.  The cultures were 
fractionated with the new cell wall digestion protocol, the proteins separated by 
SDS-PAGE, and western blotted for Ply and GroEL.  GroEL (58kDa) was only 
detected in the cell fraction (Figure 6-15 C) showing that there was no whole 
cell carryover or lysis in the extracellular or cell wall fractions.  Ply was 
detected in all three fractions; the extracellular supernatant, the cell wall and 
intracellular cell fraction.  It is very interesting to note that Ply is detected in 
the extracellular fraction under these growth conditions, as it was not previously 
found when cultures were grown at 37°C from inoculation (Figure 6-13).   
 
Figure 6-15 Fractionation with alternative cell wall digestion buffer 
TIGR4, TIGR4∆LytA-Ply and T∆LP pAHS3 were grown to OD600nm = 0.6 and separated into 
extracellular (E), cell wall (CW) and cell (C) fractions as described in Materials and Methods.  
Pneumococcal cells were incubated in 0.5ml Cell wall digestion buffer (100mM Tris-HCl 
pH7.5, 2mM MgCl2, protease inhibitor cocktail, 30% sucrose, 600U/ml mutanolysin, 1mg/ml 
lysozyme) for 90 minutes.  Samples were prepared and separated on 10% Bis-Tris SDS-
PAGE, proteins stained with Coomassie Blue (A) or transferred onto PVDF membrane and 
probed for Ply (B) or GroEL (C).  Ply has two sizes, wildtype TIGR4 is 53kDa or His, FLAG, 
Lumio tagged Ply from pAHS3 is 56kDa.  GroEL is a cytoplasmic protein with a predicted 
size of 58kDa, and the western shows an unspecific band highlighted by star. 
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6.4.2 Fluorescence microscopy analysis 
It was interesting to not only detect Ply in the cell wall by fractionation and 
western blotting but to also to determine if Ply displays a particular distribution 
on the bacterial cell surface using the reagents developed.  The localisation of 
Ply was assessed on S. pneumoniae strains D39, TIGR4 and their Ply deficient 
mutants complemented with plasmids expressing epitope and LumioTM tagged 
Ply, pAHS3 or pAHS6.  These reagents allow additional approaches to labelling 
Ply, either via indirect immunofluorescence using α-FLAG antibodies or by the 
addition of LumioTM substrate.   If Ply localises to a distinct point on the 
pneumococcal surface, it may indicate that a specific interaction is occurring 
which could mediate its autolysin independent release. 
 
6.4.2.1 Immunofluorescence 
A number of immunofluorescence experiments were carried out on 
paraformaldehyde fixed mid-exponential phase (OD600nm = 0.6) cultures of D39 
and D39FPly-STOP using polyclonal α-Ply antibodies and polyclonal α-capsule 
type 2 antibodies, both raised in rabbits.  Immunofluorescence with the α-
capsular antibody provided consistent results, with the outer edges of the 
pneumococcal cells labelled (Figure 6-16 B) showing that the conditions were 
optimum for this antibody.  However, in-direct labelling of Ply was more 
difficult, whereby AlexaFluor 488 signal colocalised to pneumococcal cells at 
distinct points but this could not be conclusively attributed to Ply on D39 due to 
similar, albeit reduced in comparison, background fluorescence with the Ply 
negative mutant.  Addition of BSA to PBS washes reduced the presence of this 
background signal in samples, and there is no AlexaFluor signal detected without 
prior incubation of the sample with primary α-pneumococcal antibody.  This 
indicates that the antibody concentration applied may not be optimum or there 
may be too many cells applied to the slide reducing the amount of antibody 
available to label Ply associated with each individual cell.  Immunofluorescence 
labelling of D39FPlySTOP and TIGR4FLytA-Ply complemented with pAHS3 (Ply) 
was tested to utilise the FLAG epitope fused to Ply.  Also, the monoclonal α-
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FLAG antibody was raised in mice which enabled double labelling (FLAG-Ply and 
capsule) of pneumococci to be trialed. 
Results from immunofluorescence microscopy with a single antibody (Figure 6-16 
A Merge) show that not all D39FPlySTOP/pAHS3 and TIGR4FLytA-Ply/pAHS3 cells 
are labelled with α-FLAG antibodies and the cells which are labelled display a 
universal distribution of FLAG-Ply on the cell.  The double-labelling experiment, 
α-FLAG then α-capsule primary antibodies, shows that the capsule is confidently 
stained (blue) with the highest levels of fluorescence distributed at the 
periphery of the cells for both strains (Figure 6-16 B α-capsule).  FLAG-Ply 
(green) appears stained for in majority of cells, again with a general 
distribution, and some punctate areas of signal are present a number of which 










To ascertain the 
cellular localisation 
of Ply, pneumococci 
were grown to mid-
exponential phase in 
BHI, the cells fixed 
then indirectly 
stained for (A) 
FLAG-Ply (green) 
with α-FLAG and α-
mouse AlexaFluor 
488, or (B) for both 





blue).  Three (A) or 
two (B) separate 
fields of view are 
depicted for the 
samples.
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6.4.2.2 LumioTM substrate dependent fluorescence 
The localisation of Ply on the pneumococcal surface was assessed by adding 
LumioTM reagent to live mid-exponential (OD600nm = 0.6) BHI cultures of D39FPly-
STOP, D39FPlySTOP pAHS3 (Ply) and D39FPlySTOP pAHS6 (Ply) to label the 
introduced tetracysteine motif at the N-terminal end of Ply.  The labelled cells, 
on poly-L-lysine coated microscope slides, were viewed using a Zeiss AxioImager 
M1 microscope and images captured as described in Materials and Methods.  
LumioTM labelling of fusion proteins has not been previously described in Gram 
positive bacteria; reports were only available for Gram negative bacteria species 
such as E. coli (Ignatova & Gierasch, 2004), Shigella (Enninga et al., 2005) and 
Salmonella (Sciara et al., 2008).  These studies used LumioTM to study real-time 
protein production and aggregation, protein localisation and protein 
secretion/translocation respectively. 
From the micrographs, it can be seen that there is some background 
fluorescence seen with the negative control, LumioTM reagent treated D39FPly-
STOP (Figure 6-17 A), however this background fluorescence is little in 
comparison to the fluorescence observed with D39FPlySTOP expressing 
tetracysteine tagged Ply (Figure 6-17 B and C).  The LumioTM fluorescence 
localises to the pneumococcal cell, although it can be seen for the right half of 
D39FPlySTOP/pAHS3 panel that there is some signal displaced, which is likely 
due to slight movement of the cell during the imaging protocol.  The distribution 
of LumioTM appears consistent across the cell (Figure 6-17 B) and from analysis of 
each individual z-slice this distribution continues through the cell (data not 
shown).  This is expected as the reagent is membrane permeable therefore it is 
able to travel through the cell wall and membrane to label the intracellular pool 
of Ply.  No fluorescence ‘displacement’ is seen with the cells expressing 
D39FPlySTOP/pAHS6, indicating that the cells have successfully been 
immobilised by the poly-L-lysine coating on the microscope slide.  As these cells 
are expressing both LumioTM and RFP tagged Ply, it is interesting to compare the 
distribution of these two signals (Figure 6-17 C).  The RFP fluorescence imaged 
can be attributed solely to the production of RFP-Ply, as there is no RFP 
detected when the identical image acquisition protocol was applied to 
D39FPlySTOP/pAHS3 (results not shown).  Areas that are yellow in colour 
indicate the presence of both LumioTM (green) and RFP (red) fluorescence, seen 
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Figure 6-17 C (L+R).  When observed with Volocity 3D restoration software 
(Figure 6-18), the LumioTM signal surrounds the RFP signal with areas of yellow 
and pneumococcal cells which are more red than green/yellow in the 





Figure 6-17  Lumio
TM
 labeling of D39∆PlySTOP expressing tagged-Ply 
S. pneumoniae D39∆PlySTOP (A), D39∆PlySTOP/pAHS3 (B; Ply) and D39∆PlySTOP/pAHS6 
(C; RFP-Ply) cells were incubated with Lumio
TM
 reagent, washed and spotted onto a poly-L-
lysine coated slide.  Z-stacks with 0.2µm spacing were acquired with FITC (Lumio) and 
DsRed (RFP) filters. 
 
 
Figure 6-18  3D analysis of D39∆PlySTOP/pAHS6 with Lumio™ substrate 
Pneumococci cells from Figure 6-17 were analysed with Volocity 3D restoration software 
(PerkinElmer) in order to determine the distribution of Lumio™ fluorescence in relation to 
RFP-Ply expressed by the cells.  The cells were viewed from above (A), an elevated side 
view (B), and directly adjacent (C); images to the right describe the perspective viewed.  A 
transverse view, indicated by the blue line in the bottom perspective diagram, was also 
observed to determine the distribution within the cell (D). 
 
The localisation of LumioTM tagged Ply was also assessed with TIGR4FLytA-Ply 
pAHS3 alongside a negative control and in comparison with D39FPlySTOP pAHS3, 
which was cultured and labelled in parallel.  Again, background fluorescence is 
observed with the Ply negative controls (Figure 6-19 A and C) but this differs 
markedly from the cells expressing tetracysteine tagged Ply.  
D39FPlySTOP/pAHS3 displays the same distribution of LumioTM seen previously in 
Figure 6-17 B, which is a general distribution of Ply throughout the cell.  
LumioTM-Ply is also detected throughout TIGR4FLytA-Ply/pAHS3 cells, however a 
brighter signal is observed surrounding the outer boundary of the cell than from 
the central area, Figure 6-20.  This suggests that LumioTM-Ply localises to the 
periphery of TIGR4FLytA-Ply cells.
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Figure 6-19  Fluorescence microscopy of pneumococci incubated with Lumio
TM
 reagent 
S. pneumoniae strains D39∆PlySTOP (A), D39∆PlySTOP/pAHS3 (B), TIGR4∆LytA-Ply (C) 
and TIGR4∆LytA-Ply/pAHS3 (D) were incubated with Lumio
TM
 reagent, washed and spotted 
on a poly-L-lysine slide.  Micrographs were acquired as described in Materials and Methods. 
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Figure 6-20  3D analysis of TIGR4∆LytA-Ply/pAHS3 with Lumio™ substrate 
Pneumococci cells from Figure 6-19 were analysed with Volocity 3D restoration software 
(PerkinElmer) in order to determine the distribution of fluorescence from Lumio™ tag-Ply 
expressed by the cells.  The cells were viewed from above (A), an elevated side view (B), 
and directly adjacent (C); images to the right describe the perspective viewed.  A transverse 
view, indicated by the blue line in the bottom perspective diagram, was also observed to 
determine the distribution within the cell (D). 
 
6.5 Virulence analysis of TIGR4∆LytA-Ply::Chl  
S. pneumoniae serotype 3 strain A45 has reduced virulence in our murine 
bacteraemia and pneumonia models compared to other serotype 3 (OXC141) 
pneumococci (Dr Andrea Mitchell, unpublished results).  Therefore, assessing the 
virulence of TIGR4FLytA-Ply in our murine models of infection will determine 
whether this natural recombination event between LytA and Ply provides an 
explanation for the reduced virulence seen with A45.  Whether Ply provides a 
selective advantage in the murine model of infection can also be tested by 
complementing the TIGR4FLytA-Ply mutant with episomally expressed Ply.  For 
this study, a tagless version of codon-optimised Ply under the control of the ami 
promoter was introduced into pAL2YI to create pAHSTLPly.  Animal experiments 
testing the survival of mice infected with TIGR4, TIGR4FLytA-Ply::Chl or 
TIGR4FLytA-Ply/pAHSTLPly are currently underway. 
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6.6 Discussion 
Ply is a cholesterol dependent cytolysin of S. pneumoniae.  It is the only CDC 
which does not have a typical Sec secretion signal and has been considered to be 
cytoplasmic (Johnson, 1977), and released upon cell lysis mediated by autolysin 
A (LytA).  However, there have been reports that Ply can be released in a 
number of serotypes during early-stationary phase of growth (Benton et al., 
1997b), without the effect of LytA-dependent autolysis in a serotype 3 strain 
WU2 (Balachandran et al., 2001) and can localise to the cell wall in a number of 
serotypes (Price & Camilli, 2009).  Ply is not the only predicted cytoplasmic 
protein due to the absence of conserved signal and/or anchoring sequences, in 
the pneumococcal proteome, which is secreted and surface associated. 
Examples include the plasmin(ogen) binding proteins enolase (Bergmann et al., 
2001; Bergmann et al., 2003) and GAPDH (Bergmann et al., 2004), PavA (Holmes 
et al., 2001) and PcsB (Mills et al., 2007).  There is further evidence from other 
Gram positive organisms of predicted cytoplasmic proteins being secreted into 
the extracellular milieu without any evidence of cell lysis through what is being 
termed a non-classical secretion pathway, reviewed in (Bendtsen et al., 2005).  
Enolase is also secreted from B. subtilis via a non-classical secretion pathway 
and it has recently been elucidated that an α-helical membrane-embedding 
domain within its protein structure is required for its lysis-independent release 
from the cell (Yang et al., 2011). 
To further characterise the localisation and potential release of Ply from the 
pneumococcal cell, N-terminal tagged codon-optimised versions of Ply were 
developed as reagents.  These reagents were episomally expressed in a Ply 
negative mutant of D39, D39FPlySTOP, and detected through western blotting 
with α-Ply antibodies, LumioTM substrate mediated fluorescence and restored 
haemolytic activity.  pAHS3 and pAHS6 complement the D39 Ply knockout and 
have a higher haemolytic output compared to the D39 control where the pAHS6 
(RFP-Ply) titre is 8 times that of the D39 WT; pAHS3 titre is 64 times.  The copy 
number of the shuttle vector is 8 (Macrina et al., 1982), therefore this provides 
explanation as to why the RFP-Ply titre is 8 times that of D39 WT.  However the 
pAHS3 titre is 8 times that of pAHS6 and as both Ply fusions are cloned into the 
same vector, under the control of the same promoter, this implies that the rfp+ 
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tag may affect oligomerisation of the toxin molecules to form a pore, thereby 
reducing haemolytic activity.  The addition of DTT to the assay eliminates the 
possibility of dimers being formed through disulphide bonds between 
tetracysteine residues in the LumioTM motif, which was evident when 
characterising the fluorescent protein reagents in the previous chapter.  Also, 
previous and current work by colleagues in the lab have demonstrated that the 
genetic fusion of Ply to a fluorescent protein (eGFP) does not affect its 
haemolytic activity (Douce et al., 2010).  Western analysis shows that pAHS6 is 
highly expressed to a comparable level of that shown by pAHS3 (Figure 6-3), 
therefore the reduced haemolytic activity is not likely due to RFP-Ply instability 
and degradation in the pneumococcus.  Another explanation for the higher 
haemolytic titre of pAHS3 compared to pAHS6 may be a difference in cell 
number between the two samples, as although the protein concentrations were 
comparable, there may have been 8 times more D39 pAHS3 pneumoccocal cells 
than D39 pAHS6 in the sample.  In hindsight, a viable count of the cultures could 
have been measured before pelleting the cells for sample preparation to ensure 
comparable numbers of pneumococcal cells were sonicated. 
The introduction of the LytA-Ply fusion mutation, naturally occuring in equine S. 
pneumoniae strains, into TIGR4 allows the investigation of whether episomally 
expressed N-terminally tagged Ply is released without the action of autolysin or 
the genes which are co-transcribed with Ply.  Through an optimised fractionation 
protocol, results show that Ply is present in the cell wall fraction, even when N-
terminally tagged, in both the TIGR4 parent and FLytA-Ply mutant which 
supports the previous report (Price & Camilli, 2009).  This also suggests that the 
cell wall localisation of Ply is not dependent upon the function of autolysin or 
the intervening gene products.  Although GroEL was detected in the cell wall 
fraction for all strains (Figure 6-13), as western blotting is assaying a population, 
it can be seen particularly in the TIGR4 WT that the GroEL found in the cell wall 
fraction is less compared to the cell fraction.  This indicates that it is a small 
proportion of cells which have lysed and yet a larger amount of Ply is found in 
this fraction compared to the cell fraction.  The difference in proportions of 
GroEL to Ply implies that some of the Ply found in the cell wall fraction has been 
liberated from cell wall digestion and not just from cell lysis.  This is supported 
by subsequent results (Figure 6-15) which show that Ply is present in the cell 
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wall fraction without any cell lysis, indicated by the detection of GroEL.  A very 
interesting result arose the pneumococcal culture grown from a smaller 
inoculum and extended incubation time at a lower temperature, given that Ply 
was detected in the extracellular fraction without any indication of cell lysis, 
i.e. no GroEL was present in the fraction (Figure 6-15).  There was no evidence 
of this release of Ply occurring when cultures were grown at 37°C from 
inoculation (Figure 6-13 and results not shown from D39 data).  This suggests 
that this in vitro culture condition is required for Ply release into the 
extracellular milieu from the pneumococcus in an autolysin-independent 
mechanism.  However, these results merit further research to determine if this 
is a common phenomenon due to the low incubation temperature, extended lag 
phase and/or low population density; if it is active or passive secretion of Ply; or 
if it is an artefact.  It would have been interesting to have investigated if the Ply 
truncates, Domains123 and Domain 4, can localise to the cell wall in both 
D39FPlySTOP and TIGR4FLytA-Ply strains. 
There are many difficulties with fractionation, such as cell lysis during bacterial 
culture or experimental procedure, incomplete cell wall digestion, and whole 
cell contamination of early fractions.  The addition of appropriate controls to 
the fractionation procedure can reduce the occurrence of cell lysis or cross 
contamination of fractions.  Pneumococcal protoplast formation in previous 
studies was measured by the reduction in absorbance when the suspension is 
added to a hypotonic solution inducing lysis by osmotic shock (Lacks & 
Neuberger, 1975; Vijayakumar & Morrison, 1986).  However, Gram negative 
bacterial cells would also be sensitive to osmotic shock in hypotonic solution and 
these cells still possess a thin peptidoglycan cell wall, therefore this method 
would not confirm complete cell wall removal from the cell.  Similar reasoning 
applies to Gram staining of cells as Gram negative cells stain pink, as would 
Gram-positive cells with reduced cell wall thickness and bacterial protoplasts.  
Owing to this, it is possible to hypothesise that a pool of Ply may exist in the 
space between the cytoplasmic membrane and cell wall (periplasm).  This 
hypothesis is challenged by published work, where Ply can be liberated from the 
pneumococcal surface by SDS and digested from the surface by proteinase K 
(Price & Camilli, 2009).  However, there may have been incomplete cell wall 
digestion in this study, leading this pool of periplasmic Ply being considered as 
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intracellular as successful cell wall digestion was confirmed by blotting fractions 
with α-RrgB, the major protein subunit of pneumococcal pili (LeMieux et al., 
2006).  Blotting with this antibody showed that the high molecular weight 
complexes were mainly present in the cell wall fraction but there is a faint band 
visible in the protoplast fraction.  Also, the presence of RrgB can only be 
confirmed in TIGR4 as D39 does not carry the pilus (rlr) pathogenicity island 
(Tettelin et al., 2001; Price & Camilli, 2009).  In fact, the sortase genes encoded 
on the rlr pathogenicity island are only present in approximately 17% (14/82) of 
pneumococcal clinical isolates (Paterson & Mitchell, 2006).  This demonstrates 
the difficulty in choosing a suitable cell wall control protein to detect by 
western blotting in order to confirm complete cell wall digestion. 
Immunofluorescence microscopy of D39FPlySTOP/pAHS3 and TIGR4FLytA-
Ply/pAHS3 with α-Ply and α-FLAG antibodies will require further optimisation of 
experimental conditions, as FLAG-Ply was detected using α-FLAG antibodies only 
on a number of cells, with a general distribution of FLAG-Ply on the surface of 
the cell (Figure 6-16).  To further support the evidence for extracellular 
localisation of FLAG-Ply, the samples were co-stained for the capsule 
polysaccharide to label the outermost of the cell.  FLAG-Ply was detected on 
most cells in this co-labelling experiment and the lack of FLAG-Ply seen in the 
D39FPlySTOP/pAHS3 left-hand-side panel is likely due to insufficient antibody 
staining rather than all the cells in the other panels being labelled due to 
AlexaFluor647 signal bleed through in the FITC filter.  This explanation is 
supported by the experimental procedure employed as the same image 
acquisition protocol was applied to all samples, and AlexaFluor 647 was chosen 
because its excitation and emission spectra has no overlap with that of 
AlexaFluor 488.  The general extracellular distribution of Ply on the 
pneumococcal cell is further supported by the LumioTM fluorescence microscopy 
data.  LumioTM fluorescence was largely detected on the periphery of 
D39FPlySTOP/pAHS6 (Figure 6-17 C and Figure 6-18) and TIGR4FLytA-Ply/pAHS3 
(Figure 6-19 D and Figure 6-20).  The peripheral localisation LumioTM-Ply in 
D39FPlySTOP/pAHS6 (Figure 6-18) may be due to insufficient substrate to label 
the intracellular pool or because the cells were imaged live, super-resolution 
microscopy would be needed to detect both signals within an individual voxel. 
Comparing the distribution of TIGR4FLytA-Ply/pAHS3 (Figure 6-19 D) with 
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D39FPlySTOP/pAHS3 (Figure 6-19 B), the peripheral signal is brighter in the 
complemented TIGR4 mutant than in the D39 mutant which suggests that there 
is more LumioTM-Ply present on the surface.  This implies that although the genes 
deleted in the TIGR4 mutant do not inhibit the localisation of Ply to the cell 
surface, they may play a role in controlling the amount of Ply which is present 
on the surface.  The background fluorescence observed with cultures not 
expressing LumioTM fusion proteins may be reduced by including β-
mercaptoethanol in PBS washes (Langhorst et al., 2006).  LumioTM binding to 
endogenous cysteine-rich proteins has previously been reported (Stroffekova et 
al., 2001), yet the occurrence of this should be limited in these conditions as the 
LumioTM reagent is pre-complexed with ethanedithiol (EDT) to ensure specific 
labelling.  Nonetheless, additional control experiments still need be carried out 
to confirm these results, which could not be done during the course of my study 
due to time constraints. Also, it would have been interesting to test the 
localisation of Ply, using immunofluorescence and/or Lumio™ labelling, on 
pneumococci grown in the in vitro conditions in which Ply was released into the 
extracellular milieu, as seen in the fractionation experiment (Figure 6-15). 
Ply can localise to the cell wall during in vitro growth, and is broadly distributed 
on the cell surface.  The cell wall localisation of Ply is not dependent upon 
autolysin (LytA) or the open reading frames present between Ply and LytA, as 
the phenotype is still observed by fractionation and fluorescence microscopy 
with TIGR4FLytA-Ply.  However, one (or more) of the deleted genes may control 
the amount of Ply displayed on the surface, as there appears to be more Ply 
present on TIGR4FLytA-Ply/pAHS3 surface compared with D39FPlySTOP/pAHS3.  
The production of Ply has been shown to be advantageous for continued growth 
of a Ply deficient type 2 mutant PLN-A in vivo during co-infection with D39 in a 
murine sepsis model of infection (Benton et al., 1995), which suggests the 
presence of an extracellular pool of Ply during the early stages of bacterial 
growth in the blood to cause inflammation which promotes acute sepsis.  The 
authors hypothesised that this extracellular Ply was from autolysin-dependent 
release of Ply in vivo, however the data from this study offers another 
hypothesis in that Ply may be released from the pneumococcal cell wall in vivo, 
potentially by a host dependent mechanism, before autolysis.  Sublytic 
concentrations of Ply have been shown to activate complement (Mitchell et al., 
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1991) and deposition of C3 is greater on strains deficient in Ply production 
compared to parent strains (Yuste et al., 2005).  In addition to this, sublytic 
concentrations (100 ng/ml) of Ply can also modulate the host cell cytoskeleton 
resulting in microtubule bundling and the formation of actin stress fibres, 
filopodia and lamellipodia contributing to the pathology caused pneumococcal 
meningitis (Iliev et al., 2007; Iliev et al., 2009; Förtsch et al., 2011).  This 
concentration of Ply can also mediate the uptake of peptidoglycan from 
competing colonising species, such as Haemophilus influenzae, by epithelial 
cells inducing a host immune response (via Nod1) against the co-colonising 
species (Ratner et al., 2007).  It would be advantageous if these activities were 
induced either by the Ply associated with the cell surface or Ply released by an 
autolysin-independent mechanism, as this could be considered to be a controlled 
approach compared to the large general Ply release from whole cell lysis.  S. 
pneumoniae activates nitric oxide (NO) production by macrophages in a 
mechanism dependent on Ply, as there is little NO produced with the Ply 
deficient mutant, PLN-A (Braun et al., 1999).  The nitrite concentration 
produced by macrophages incubated with sublytic concentrations of recombinant 
Ply protein was 50-fold that found with pneumococcal cell wall extracts, which 
suggests that there is no cell wall localised Ply, otherwise a greater nitrite 
concentration would have been observed.  This observation can be explained by 
the cell wall preparation protocol, whereby the extracts were treated with SDS, 
which has been shown to remove Ply from the cell wall fraction (Price & Camilli, 
2009).  Taking this into consideration, these results provides additional support 
for the cell wall localisation of Ply and possibly LytA-independent Ply release, as 
NO production is observed in cultures before late-stationary phase without cell 
lysis.  It has recently been observed that Ply can be released from S. 
pneumoniae TIGR4 strain treated with lysozyme (LysM), which degrades 
peptidoglycan and is present on mucosal surfaces, and this was necessary for 
Nod2 stimulation, production of the chemokine CCL2 and monocyte/macrophage 
influx (Davis et al., 2011).  This study also provides a plausible in vivo mode of 
Ply release from the pneumococcal cell wall.   
In conclusion, the codon-optimised Ply reagents developed can complement a 
Ply deficient S. pneumoniae strain and the full-length version retains its 
haemolytic activity.  Autolysin and the genes co-transcribed with Ply are not 
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required for Ply secretion across the cytoplasmic membrane, for its cell wall 
localisation or its release from the cell wall; which is supported by the following 
results: 
• The N-terminal tagged Ply can still localise to the cell wall, therefore the 
tag does not interfere with its secretion, suggesting its secretion across 
the cytoplasmic membrane is not by a classical pathway. 
• Ply can localise to the cell wall in the TIGR4FLytA-Ply mutant shown by 
cell fractionation (Figure 6-15) and LumioTM fluorescence microscopy 
(Figure 6-19 and Figure 6-20). 
• Ply is released from the wild-type (TIGR4) and mutant (TIGR4FLytA-Ply) 
cell wall, without any evidence of cell lysis, when pneumococci are grown 
from a low inoculum at a low temperature (25°C) (Figure 6-15). 
The quantity of Ply on the pneumococcal cell surface, observed by fluorescence 
microscopy (Figure 6-19), is greater on TIGR4FLytA-Ply/pAHS3 than 
D39FPlySTOP/pAHS3 which suggests that one (or more) of the deleted genes may 
play a role in limiting the amount of Ply displayed on the cell surface.  Whether 
this gene(s) role is involved in the secretion of Ply across the cytoplasmic 
membrane or mediating the interaction of Ply with the cell wall remains to be 
elucidated.  The release of Ply may be a more controlled and gradual process 
without the requirement that members of the population undergo lysis.  This 
gradual release may assist the ‘subtle’ functions of Ply which include 
complement activation, rearrangement of the host cytoskeleton, nitric oxide 
production from macrophages and pneumococcal survival in the host via Nod1 
and Nod2 sensing. 
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7 Final Discussion 
The general aim of this project was to characterise conditions which may be 
conducive for protein translocation; for two E. coli O157:H7 non-LEE encoded 
T3S effector homologs and for a predicted cytoplasmic toxin of S. pneumoniae. 
Regulation of the LEE PAI is complex as it not only regulates its own expression, 
but it is regulated by other horizontally acquired factors, such as pch or 
indirectly by psr genes.  Upon assessment of the literature, the regulatory 
pathway of the LEE has also integrated into regulatory networks endogenous to 
E. coli, such as quorum sensing (qseABCDEFG), phosphorelay systems (rcsABCDF), 
and stress response pathways (gadE and rpoS).  This complex regulatory network 
enables the LEE to be expressed at the most optimum time, i.e. upon detection 
of host factors (such as epinephrine) or cell contact.  As expression of the T3SS 
apparatus, and the LEE-encoded effectors, is under the influence of so many 
factors, it is interesting to determine which factors influence the expression of 
non-LEE encoded effectors.  NleH1 and NleH2 are carried on separate 
horizontally acquired O-Islands (OI-36 and OI-71 respectively) and share 87% 
protein identity.  Analysis of the 5’ UTR of both alleles revealed that the 
sequence similarity decreased further from the ORF, which implied that the 
genes may be differentially expressed or regulated.  Assessment of translational 
fusions to gfp, in E. coli O157:H7 strain ZAP193, showed that expression of both 
NleH1 and NleH2 is enhanced when cultured under in vitro conditions which 
stimulate expression of the T3SS and that maximal expression of NleH1 required 
531bp of the upstream untranslated region but NleH2 only required 113bp.  This 
indicates that a regulatory factor binds the 5’ UTR of NleH1 controlling its 
expression whereas NleH2 expression is not as strictly controlled.  This 
observation was supported by results testing Pch regulation of the EDL933L 
genome, which predicted that Pch binds to the promoter of NleH1 but not NleH2 
(Abe et al., 2008).  The LEE-encoded effectors Ler and GrlA are indirectly 
involved in the positive regulation of NleH1 and NleH2 in vitro, therefore 
providing a basal level of co-ordinate expression with the apparatus that 
translocates them.  However, this co-ordinate expression is not strict as NleH is 
expressed in cells which do not have an assembled T3SS.  This suggests that NleH 
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may be regulated at the post-transcriptional or post-translational level.  This 
hypothesis is supported by research investigating the regulation of C. rodentium 
NleH, which is regulated post-translationally by LonP-mediated degradation in 
this background (Garcia-Angulo et al., 2008).  This ‘loose’ co-ordination of 
expression with the LEE may ensure that non-LEE encoded effectors are 
available for secretion by the T3SS, once the LEE encoded effectors have been 
translocated or if the transcription of the LEE effectors is repressed later in the 
infection process.  Host cell binding repressed NleH expression and the timing, 
and level, of NleH expression during active in vitro infection of cells remains to 
be determined. 
NleH proteins are predicted serine/threonine kinases and homologues of OspG, a 
T3SS effector of S. flexneri.  Similar to its homolog, NleH1 can 
autophosphorylate in the presence of ATP and Mg++.  OspG has been 
characterised as a modulator of the host immune response by interacting with E2 
ubiquitin-conjugating enzymes resulting in the inhibition of NF-κB activation.  
Owing to this, the effect of NleH on NF-κB activation was tested, using 
luciferase reporter constructs, but its effects were not significant.  This 
contradicts other reports where NleH has been shown to modulate NF-κB 
activation. However in most of these studies, NleH is highly overexpressed in 
comparison to the NF-κB reporter, which may be very different to the 
physiological scenario, potentially giving an incorrect assessment of NleH 
functionality.  Another research group have reported that EPEC NleH can 
function as an anti-apoptotic factor which is dependent upon interaction with 
Bax-inhibitor 1 (BI-1) (Hemrajani et al., 2010).  This interaction with BI-1 is 
dependent upon the C-terminal end of NleH but not its kinase activity; this 
region of NleH shares high protein identity with OspG yet OspG does not interact 
with BI-1.  This supports the hypothesis that NleH may have multiple functions 
within the host cell.  The phosphorylation of a host protein has not been 
described for NleH therefore DiGE analysis was performed on lysates from 
HEK293T cells transfected with NleH or its kinase-dead mutant K159A.  
Unfortunately, no targets were identified and a yeast two hybrid screen of NleH1 
and NleH2 also did not provide a potential eukaryotic binding partner.  In 
conclusion, I feel there still remains some controversy regarding NleH function 
and it is very likely that further eukaryotic targets will be discovered for this 
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effector although this may require using more appropriate tools such as bovine 
based Y2H screens. 
LOV domains are part of the photosensing Ser/Thr protein kinases (phototropins) 
in plants and when the domain was recombinantly expressed in E. coli, it 
fluoresced when exposed to UV light (Salomon et al., 2000; Swartz et al., 2001).  
The LOV domain was subjected to molecular evolution in order to improve its 
fluorescence and recovery after photobleaching to create iLOV (Chapman et al., 
2008).  iLOV is less than half the size of GFP, making it a suitable candidate to 
test as a reporter for T3S-mediated translocation.  A translational fusion of iLOV 
to the C-terminus of Tir can complement a Tir deficient strain of E. coli O157:H7 
and form actin pedestals (K. Velentza, I. Houghton, A. Holmes and A. Roe; 
unpublished results).  NleH-iLOV can be translocated into the host cell, as 
determined by fluorescence microscopy, and its distribution correlates with 
previous reports (Gao et al., 2009; Hemrajani et al., 2010; Martinez et al., 2010; 
Wan et al., 2011).  In conclusion, iLOV can be genetically fused to T3S effectors 
without hindering their secretion, translocation or function.  This newly 
developed fluorescent protein provides a useful tool for the study of T3S 
effectors. 
Codon-optimised fluorescent proteins were developed as reagents for future 
pneumococcal research as they have not been used extensively, in comparison to 
the Gram positive organism B. subtilis, in past studies.  Fluorescent proteins as 
reporter genes can be useful for gene expression studies, like the NleH study, 
and assessment of protein localisation.  These proteins were successfully 
expressed to detectable levels, determined by fluorimeter measurement and 
fluorescence microscopy, in the pneumococcus from lag phase to early 
stationary phase of growth.  Fluorescence levels decreased during the stationary 
phase which may be due to lack of oxygen, which is required for protein 
maturation.  The inclusion of His, FLAG and Lumio™ tags at the N-terminus of 
the proteins provide the possibility of additional approaches to be employed to 
assess protein localisation, such as immunofluorescence and substrate (Lumio™) 
mediated fluorescence.  The pneumococcal transcriptional reporter pAHS12 was 
constructed and can be successfully used to characterise gene expression in 
vitro, which was exemplified by testing the nanA promoter.  Although 
transcriptional fluorescent reporters may not be as sensitive as other 
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techniques, such as Q-PCR, it can be a valuable tool for preliminary tests and to 
track gene expression during growth in vitro. 
The predicted cytoplasmic toxin of S. pneumoniae, Ply, was found to be 
detected in the extracellular environment prior to entry into the stationary 
phase in certain strains, when the intracellular pool of Ply is first detected 
(Benton et al., 1997b).  This may suggest that these strains of S. pneumoniae 
which can ‘secrete’ Ply have additional genes in their genome to provide this 
phenotype.  However Ply is detected in the cell wall in all strains tested to date 
(Price & Camilli, 2009), which contradicts the hypothesis that Ply ‘secretory’ 
strains have additional genes in their genomes to control Ply secretion from the 
cell.  Therefore the hypothesis that particular genes may contribute to the 
secretion, cell wall localisation and/or release of Ply was tested by constructing 
the mutant TIGR4FLytA-Ply.  This mutant has a LytA-Ply fusion gene, which is 
naturally present in equine pneumococcal strains, inserted in the genome which 
results in the deletion of the intervening sequence and loss of Ply and LytA 
expression.  Fractionation and immunofluorescence studies of this mutant 
complemented with labelled Ply suggest that the quantity of Ply present on the 
cell surface may be controlled by a product encoded between Ply (SP_1923) and 
LytA (SP_1937).  However, none of these genes are required for Ply secretion 
across the cytoplasmic membrane, cell wall localisation or even cell wall release 
as these processes were not affected in TIGR4FLytA-Ply.  Secretion of predicted 
cytoplasmic proteins has been previously described in the pneumococcus 
(Bergmann et al., 2001; Holmes et al., 2001; Bergmann et al., 2003; Bergmann 
et al., 2004; Mills et al., 2007).  Enolase can be secreted from B. subtilis and its 
secretion does not require accessory gene products but it does depend upon a 
particular domain within the enolase structure (Yang et al., 2011).  This suggests 
that Ply secretion across the cytoplasmic membrane may occur via the non-
classical secretion pathway and controlled by the structure of the protein.  The 
presence of a protein domain in Ply which confers the ability to be secreted has 
not been investigated in this study. Ply was released from cells grown in 
particular culture conditions, of low cell density and incubation at low 
temperature (25°C).  Whether these conditions are required for the expression 
of a gene which is required for Ply release from the cell wall or induces the 
function of a protein which catalyses the release of Ply remains to be 
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elucidated.  By discovering these ‘secretion’ inducing conditions it suggests that 
all pneumococcal strains which can localise Ply to their cell wall may also have 
the potential to release it into the extracellular milieu.  The ability to release 
Ply into the environment without the need for cell lysis implies that Ply can be 
released in a controlled manner from the cell during earlier stages of population 
growth.  The cell wall localisation and potential for controlled release of Ply has 
major implications on this toxin’s contribution to pneumococcal pathogenesis.  
Many recent publications have determined functions of Ply present at sub-lytic 
or physiological concentrations.  Such functions include host cytoskeleton 
rearrangements contributing to disease pathology (Iliev et al., 2007; Iliev et al., 
2009; Förtsch et al., 2011) and activating the complement pathway.  An 
interesting consequence of the cell wall localisation of Ply is during colonisation 
of the mucosal surfaces with other species such as H. influenzae.  Lysozyme is 
present on the host mucosal surface which is an enzyme that degrades the 
peptidoglycan in bacterial cell walls.  This degradation results in release of Ply 
from the pneumococcus (Davis et al., 2011) which can induce an immune 
response against competing Gram negative colonising species by Ply dependent 
delivery of their peptidoglycan products into the epithelial cell (Ratner et al., 
2007).   
In conclusion, Ply is secreted from the pneumococcus via a non-classical system, 
displayed on the cell surface and can be released into the extracellular 
environment.  Ply secretion, localisation and release mechanisms are not 
controlled by genes which are encoded between Ply and LytA in the TIGR4 
genome however there is evidence that the quantity of Ply displayed on the cell 
surface may be controlled by one or more of these genes.  The gene(s) involved 
in the quantity control of surface-localised Ply may be characterised by assessing 
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